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Chapter 1: INTRODUCTION 
At the beginning of this century it was already known to physiologists 
that injection of blood serum causes vasoconstriction (Janeway et al., 
1918) and a vagally-mediated reflex resulting in bradycardia (Brodie, 
1900), whereas injection of blood plasma did not show these effects. 
Page, who was searching for a humoral agent responsible for 
hypertension, was intrigued by this phenomenon. In cooperation with 
Green and Rapport this humoral agent was isolated, cristallized, its 
structure characterized and named serotonin (Rapport et al., 1948). These 
investigators were unaware of the experiments done by Erspamer and 
Vially, who demonstrated that extracts of the stomach and intestine 
caused constriction of the uterus. The active agent in this extract was 
called enteramine and it was shown later that enteramine was identical to 
serotonin (5-hydroxytryptamine; 5-HT) (Erspamer & Asero, 1952). 
In the intestines and the brain 5-HT is synthetized from the essential 
amino-acid L-tryptophan. 5-HT can be released from the intestines into 
the blood, where 5-HT is either taken up by thrombocytes or removed 
from the blood by the liver or endothelial cells in the lungs, mainly 
resulting in the formation of 5-hydroxyindolacetic acid (5-HIAA). Since 
5-HT does not cross the blood-brain barrier, there exists a clear 
distinction between its central and its peripheral function. In the central 
nervous system 5-HT is involved in appetite, sleep, memory, 
thermoregulation, sexual behaviour, hallucinations, anxiety and depression. 
In the periphery 5-HT plays a role in the aggregration of 
thrombocytes, constriction of smooth muscle cells, presynaptic inhibition, 
and stimulation of nerve fibers. In 1957 Gaddum & Picarelli showed that 
5-HT can act on different subtypes of 5-HT receptors within the same 
tissue. The development of novel 5-HT agonists and antagonists and the 
use of radioligand-binding techniques allows us nowadays to even further 
discriminate between the different subtypes of receptors, as will be 
discussed in Chapter 2. 
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Aim of the thesis 
Until recently, mainly rats, guinea pigs, rabbits, cats and dogs were used 
to study the cardiovascular effects of 5-HT. From these studies it was 
clear that for some effects of 5-HT (e.g. 5-HT-induced tachycardia) there 
exists a large heterogeneity with respect to receptor subtype(s) and 
mechanism(s) (see Saxena, 1986). Therefore, the first part of the thesis 
deals with the mechanism and receptor type involved in the 5-HT-induced 
heart rate changes in the cat and the pig. 
In the second part of the thesis the effect of 5-HT and, other agonists at 
the 5-HT receptors on total carotid blood flow and its distribution are 
described. 5-HTz receptors have been shown to play a minor role in 
carotid blood flow changes (Verdouw et al., 1984). Therefore, the role of 
5-HTt-like and 5-HT3 receptors has been determined. 
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Chapter 2: 5-HT RECEPTOR CLASSIFICATION 
Gaddum & Picarelli (1957) suggested the existence of two types of 5-HT 
receptors based on the study of 5-HT-induced contractions of the 
isolated guinea pig ileum. These contractions could be partially blocked 
by morphine (M) or dibenzyline (D), but were completely antagonized by 
the combined use of both compounds. In the dibenzyline-pretreated 
ileum, atropine and cocaine were also able to block the effect of 5-HT, 
whereas in the morphine-pretreated ileum, lysergic acid diethylamide 
(LSD), 2-bromo-lysergic acid diethylamide and dihydroergotamine 
antagonized the effect of 5-HT. They concluded that 5-HT must act by 
two different mechanisms and receptors: aM-receptor located on nervous 
tissue, mediating the release of ac;etylcholine from nerve endings, and a 
D-receptor, located on the smooth muscles. However, neither morphine 
nor dibenzyline are specific 5-HT receptor antagonists. 
In the following two decades no important progress in the classification 
of 5-HT receptors was made, until Bennett & Aghajanian (1974) reported 
the first successful radioligand binding study of 5-HT receptors, using 
d-[3H)-LSD. [3H]-5-HT also showed a high affinity, but because of 
discrepancies between the binding of [3H]-LSD and (3H]-5-HT, a 
recognition site with two different states was suggested (Bennett & 
Snyder, 1976; Fillion et al., 1978). However, studies with [3H]-spiperone 
and [3H]-5-HT revealed that at least two distinct 5-HT recognition sites 
exist in the cerebral membranes: a 5-HTl recognition site with a high 
affinity for (3H]-5-HT and a 5-HT2 recognition site with a high affinity 
for (3H]-spiperone (Peroutka & Snyder, 1979). More recently, 5-HT1 
recognition sites have been shown to be heterogeneous: 5-HTlA, 5-HTlB, 
5-HTlc and 5-HTlo subtypes have been described (Pedigo et al., 1981; 
Schnellman et al., 1984; Asarch et al., 1985; Hoyer et al., 1985; Heuring & 
Peroutka, 1987). The development of ketanserin, a compound with a high 
affinity for the 5-HT2 recognition sites (Leysen et al., 1981), made it 
possible to correlate 5-HT2 recognition sites with functional D-receptors, 
which are renamed as 5-HT2 receptors. The effects mediated by the M-
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receptor can be blocked by selective antagonists, like MDL 72222 (Fozard, 
1984) and ICS 205-930 (Donatsch, 1984; Richardson et al., 1985). Since 
both compounds did not label recognition sites in the brain, these 
receptors were called 5-HT3 receptors. However, more recently, 5-HT3 
recognition sites have been described in the brain by Kilpatrick et al. 
(1987). Since 5-HT also has a high affinity for 5-HTt recognition sites 
and some effects of 5-HT cannot be blocked by 5-HTz or 5-HT3 receptor 
antagonists, an international committee proposed the presence of 
5-HTl-like receptors (Bradley et al., 1986). According to their criteria 
5-HTt-like receptors are not blocked by ketanserin, cyproheptadine, 
MDL 72222 or ICS 205-930, but can be stimulated by 5-carboxamido-
tryptamine. Furthermore, methiothepin, a compound with affinity for 
both 5-HTt and 5-HTz recognition sites, must block the effects of 
5-hydroxytryptamine and 5-carboxamidotryptamine. Unfortunately, no 
selective 5-HTt receptor antagonist is available yet. 
The committee (Bradley et al., 1986) already indicated that further 
research would lead to the discovery of 5-HT receptors that cannot be 
classified as 5-HTt-like, 5-HTz or 5-HT3 receptors, and warned for the 
defining of further 5-HTx receptors, without 'controlled studies with 
potent, selective, competitively acting receptor blocking drugs'. 
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Chapter 3: 5-HYDROXYTRYPTAMINE-INDUCED HEART RATE CHANGES 
IN MAMMALS. 
Among the many cardiovascular effects of 5-hydroxytryptamine (5-HT), 
changes in heart rate have been demonstrated by many investigators. 
Both bradycardia, bradycardia followed by tachycardia, and tachycardia 
have been described depending on the species, anaesthesia, experimental 
model and way of administration. The various mechanisms by which 5-HT 
can induce heart rate changes are summarized in Table 1. 
Table 1. Mechanisms for heart rate changes induced by 5-HT. 
1. Bradycardia. 
-stimulation of afferent vagal nerve fibers, inducing centrally mediated 
reflexes. 
-presynaptic inhibition of cardiac efferent nerve fibers. 
-decrease in cardiac efferent sympathetic nerve fibers and/or increase in 
efferent vagal nerve activity (by e.g. baroreflexes). 
2. Tachycardia. 
-stimulation of cardiac 5-HT receptors. 
-release of noradrenaline from cardiac efferent sympathetic nerve fibers 
a) 5-HT receptor-mediated. 
b) by a tyramine-like action of 5-HT. 
-release of adrenaline and noradrenaline from the adrenal medulla. 
-stimulation of cardiac afferent sympathetic nerve fibers, inducing 
(supra)spinal reflexes. 
-stimulation of cardiovascular chemoreceptors resulting in an increase 
in efferent sympathetic nerve activity. 
-increase in cardiac efferent sympathetic nerve activity and/or decrease 
in efferent vagal nerve activity. 
Since the mechanisms involved in 5-HT-induced heart rate changes show 
a large variability between species, each species will be discussed 
separately, followed by the results obtained in the pig (Chapter 4). 
7a 
Table 2. 
Bradycardia due to 5-HT receptor stimulation in different species. 
Species 
Dog 
Cat 
Rabbit 
Rat 
Man 
Condition 
Intact 
Intact 
Intact 
Intact 
Intact 
Intact 
Isolated 
Intact 
Intact 
Receptor 
5-HT? 
5-HTiA 
Mechanism of action 
Cardiopulmonary afferent nerve 
fiber stimulation 
Presynaptic sympathetic inhibition 
Baroreflex during cardiogenic 
hypertensive reflex 
Cardiopulmonary afferent nerve 
fiber stimulation 
Changes in autonomic outflow 
Cardiopulmonary afferent nerve 
fiber stimulation 
Nodose ganglion stimulation 
Cardiopulmonary afferent nerve 
fiber stimulation 
Changes in autonomic outflow 
Presynaptic sympathetic inhibition 
von Bezold-Jarisch reflex 
7b 
Table 3. 
Tachycardia due to 5-HT receptor stimulation in different species. 
Species Condition Receptor Mechanism of action 
Dog Isolated ----- Tyramine-like action on 
isolated right atrium 
Intact ----- Tyramine-like action 
Intact 5-HT Adrenal catecholamine release 
Cat Isolated 5-HTt-like Myocardial effect in right atria 
from reserpinized kitten 
Spinal 5-HTt-like Myocardial effect 
Rabbit Isolated 5-HT3 Catecholamine release from 
cardiac sympathetic nerve 
endings 
Pig Intact 5-HT? Myocardial effect 
Guinea pig Isolated ----- CGRP release ? 
Spinal ----- Tyramine-like action 
Rat Intact 5-HT2 Myocardial effect 
Ganglion- 5-HT2 Myocardial effect 
blocked 
Pithed 5-HT2 Myocardial effect 
Man Intact Unknown 
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Bradycardia in the dog. 
Injections of 5-HT into the pulmonary artery causes a bradycardia, the 
onset of which coincides with the increase in mean arterial blood 
pressure (MacCanon & Horvath, 1954). A lowering of heart rate is also 
observed during intra-aortic infusion of 5-HT, an effect which can be 
blocked by methysergide (Vyden et al., 1967). More recently, Kimura & 
Satoh (1983) demonstrated that 5-HT lowers heart rate during electrical 
stimulation of the ansa subclavia. This effect cannot be blocked by 
pretreatment with atropine or cyproheptadine. Their results suggest that 
5-HT causes presynaptic inhibition of cardiac catecholamine release, which 
is not mediated by 5-HT2 receptors. Direct infusion of 5-HT into the 
sinus node artery causes a dose-dependent decrease in heart rate, which 
is resistant to atropine and/or bilateral cervical vagotomy (James, 1964). 
In later studies James et al. (1975) described the cardiogenic hypertensive 
chemoreflex. Injections of 5-HT into the left atrium or small branches of 
the proximal left coronary artery produce a rapid increase in mean 
arterial blood pressure and a decrease in heart rate followed by an 
increase in heart rate, whereas 5-HT injections in the distal part of the 
left circumflex or left anterior descending artery produces the von 
Bezold-Jarisch reflex: bradycardia and a fall in blood pressure. Based on 
histological studies, revealing the presence of a structure resembling a 
chemoreceptor, it was suggested that 5-HT stimulates this chemoreceptor, 
resulting in a reflex increase in efferent vagal and sympathetic nerve 
activity. Cyproheptadine abolishes the cardiogenic hypertensive reflex in 
atropine-pretreated dogs, whereas methysergide or morphine are 
ineffective (Hageman, et al., 1977). Efferent sympathetic nerve activity 
increases markedly after 5-HT injections and preceeds the increase in 
blood pressure (Hageman et al., 1980). Urthaler et al. (1978) have 
demonstrated that atropine pretreatment and bilateral stellectomy, 
followed by occlusion of the adrenal arteries and veins, almost completely 
abolishes the effects of 5-HT. Based on the results of Humphrey & 
Feniuk (see later) the cardiogenic hypertensive reflex can also be 
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explained as a mixture of baroreflexes and 5-HT-induced catecholamine 
release from the adrenals. However, the increa~e in sympathetic nerve 
activity cannot be explained by the above-mentioned mechanisms and 
might be the result of spinal reflexes or stimulation of cardiovascular 
chemoreceptors. A possible role of 5-HT3 receptors has been described 
by Berthold et al. (1989). The inhibition of the 5-HT-induced cardiogenic 
hypertensive chemoreflex by ICS 205-930 shows a possible mediation by 
5-HT3 receptors, but the location of the 5-HTa receptors remains 
unknown. A possible location at afferent cardiac sympathetic nerve 
fibers has to be considered. The state of the preparation and the 
anaesthesia also plays an important role in these effects as has been 
demonstrated by Zucker & Cornish (1980) in both conscious and 
anaesthetized closed chest and open chest dogs. In conscious dogs a von 
Bezold-Jarisch reflex is followed by a delayed tachycardia and 
hypertension, whereas in anaesthetized dogs the von Bezold -Jarisch reflex 
is markedly attenuated and the tachycardia and hypertension are 
enhanced, especially in open-chest dogs. 
In conclusion, 5-HT-induced bradycardia can be caused by: 1) stimulation 
of afferent vagal nerve fibers, resulting in the von Bezold-Jarisch reflex: 
bradycardia and inhibition of sympathetic nerve activity, resulting in 
hypotension; 2) a presynaptic inhibition of cardiac sympathetic nerve 
activity and 3) a baroreflex or chemoreflex-mediated inhibition of efferent 
sympathetic nerve activity caused by the sudden increase in blood 
pressure or stimulation of chemoreceptors. 
Tachycardia in the dog 
1. Isolated right atrium. 
In isolated right atrium preparation perfused via the sinus node artery 
with heparinized blood from a donor dog at a constant pressure, low 
doses of 5-HT show a slight negative chronotropic effect, whereas higher 
doses cause tachycardia (Chiba, 1977). The negative chronotropic effect 
is not reduced by atropine or methysergide. Pretreatment with 
propranolol completely prevents the tachycardic response to 5-HT and 
noradrenaline, whereas desimipramine only suppresses the effects of 5-HT. 
Furthermore, the responses to tyramine are potentiated during 5-HT 
infusion (Chiba, 1978). These results suggest that the positive 
chronotropic effect of 5-HT in the isolated right atrium of the dog might 
be caused by a tyramine-like action of 5-HT, leading to the release of 
catecholamines from sympathetic nerve endings. 
2. Intact dog. 
5-HT-induced tachycardia in anaesthetized dogs has been reported by 
many investigators (McCawley et al., 1952; Maxwell et al., 1959; Noble et 
al., 1959). This increase in heart rate coincides with a fall in mean 
arterial blood pressure. Therefore, it was unclear whether 5-HT was 
acting directly on the heart or by other mechanisms (e.g. baroreflexes). 
To reduce reflex effects, Fillion et al. (1971) used ganglion blocked 
(atropine- and chlorisondamine-pretreated) dogs. Low doses of 5-HT 
cause a dose-dependent increase in noradrenaline concentration of 
coronary sinus blood and a high dose of 5-HT also causes an increase in 
noradrenaline concentration of vena caval blood, which cannot be 
explained by noradrenaline release from the heart alone. Intracoronary 
injections of 5-HT also cause an increase in noradrenaline concentration 
of coronary sinus blood. Stimulation of the cardioaccelerator nerves 
causes an increase in heart rate and a release of 3H-5-HT from 
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3H-5-HT-preloaded nerve endings. This tachycardia can be blocked by 
propranolol, but the 3H-5-HT release is unaffected. In 
reserpine-pretreated dogs no tachycardia can be induced by 5-HT (Jacob 
& Fillion, 1967). However, the 5-HT-induced tachycardia in untreated 
dogs can be reduced by ergotamine and methylergotamine. Furthermore, 
methylergotamine does not interfere with the increase in heart rate 
caused by electrical stimulation of the cardioaccelerator nerves. 
In order to discover the extracardiac source of catecholamines released 
into the blood after 5-HT administration, Feniuk & Humphrey (1979) 
studied the effects of drugs and bilateral adrenalectomy in 
mecamylamine-pretreated dogs. Cyproheptadine and methysergide 
dose-dependently inhibit the 5-HT-induced tachycardia. Pretreatment 
with the catecholamine depleting agent syrosingopine reduces the 
tachycardia and completely blocks the release of noradrenaline and 
adrenaline into the blood. In adrenalectomized dogs the tachycardia is 
also reduced by 43% (Feniuk et al., 1981). These results are in 
agreement with those of Kimura and Satoh (1983) who demonstrated that 
5-HT causes a dose-dependent increase in heart rate in vagotomized and 
cardiac decentralized dogs, which can be antagonized by cyproheptadine 
or bufetolol. 
From this one can conclude that the 5-HT-induced tachycardia in the dog 
is partially mediated by catecholamine release from the adrenals, 
probably by an action on 5-HTz receptors on adrenal medullary 
chromaffin cells. Since bilateral adrenalectomy did not completely 
abolish the tachycardia, a 5-HTz receptor-mediated release of adrenaline 
and noradrenaline from other sources has to be considered. Furthermore, 
at higher doses a tyramine-like action of 5-HT can also contribute to the 
tachycardia. 
However, Breuer et al. (1985) have demonstrated that intravenous 
infusion of 5-HT causes an increase in heart rate, which is not markedly 
reduced by the 5-HTz receptor antagonist ketanserin (100 pg kg-1 i.v.), a 
dose which decreases arterial blood pressure in dogs (Phillips et al., 
1985). 
12 
Bradycardia in the cat. 
1. Reflex-mediated bradycardia. 
Rapid intravenous injections of 5-HT result in bradycardia and 
hypotension. This bradycardia can be blocked by procaine or bilateral 
vagotomy, which prevents the increase in afferent vagal nerve activity, 
or by atropine, which blocks the effects of reflex-mediated enhanced 
release of acetylcholine from efferent vagal nerve endings. 
2-Methyl,3-ethyl,5-amino indole pretreatment can also antagonize the 
reflex effects (Comroe et al., 1953). 5-HT injections into the left 
ventricle also induce this reflex, but injections of 5-HT into the aortic 
arch are ineffective. Besides the increase in efferent vagal activity, an 
inhibition of sympathetic outflow is induced by 5-HT, resulting in an 
increase in hind limb blood flow, which cannot be blocked by atropine 
(Kottegoda & Mott, 1955). Intracoronary injection of 5-HT into the left 
coronary artery increases afferent vagal nerve activity as demonstrated by 
Gilev (see: Zakusov, 1962). This increase can be reduced by 
2-methyl-3-methyl-5-aminoindole or by a thiopyranoindole derivative 
named thipindole, but not by reserpine, which has been shown to· depress 
the von Bezold-Jarisch reflex, probably by a central action. In all the 
above-mentioned studies it is not completely clear which population of 
afferent fibers is stimulated: pulmonary vagal afferents, cardiac vagal 
afferents, chemoreceptors in the aortic bodies (Kirby & McQueen, 1984), 
or 5-HT receptors on the nodose ganglia (Jacobs & Comroe, 1971) (see 
also: Paintal, 1964, 1973). In order to avoid stimulation of different 
populations of afferent nerve fibers, 5-HT can also be injected into the 
pericardia! sac to induce the von Bezold-Jarisch reflex. This results in a 
stimulation of 5-HT receptors located on vagal afferent nerve fibers in 
the epicardium, without affecting 5-HT receptors on afferent nerve fibers 
in other areas. Nicotine also elicits this reflex. The effects of 5-HT, 
but not of nicotine, are blocked by the selective 5-HT3 receptor 
antagonists MDL 72222 (Mohr et al., 1987) and ICS 205-930 (Born, 
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unpublished results), showing that the blockade is not caused by a local 
anaesthetic effect on the nerve fibers (see Chapter 4). The bradycardia 
induced by intravenous injection of 5-HT can also be blocked by 
MDL 72222 (Saxena et al., 1985). From this one can conclude that most 
of the 5-HT receptors involved in reflex bradycardia belong to the 5-HTa 
receptor subtype. Phenylbiguanide mimicks the reflex effects of 5-HT in 
the cat (Dawes & Mott, 1950; Dawes & Fastier, 1950; Barer & Nuesser, 
1958; Fastier et al., 1959). These effects can be blocked by MDL 72222 
or ICS 205-930 (Born, unpublished results). Therefore, phenylbiguanide 
can be used as an agonist at these 5-HTa receptors. 
2. Centrally-induced bradycardia. 
5-HT itself cannot cross the blood brain barrier, but several drugs with a 
high affinity for central 5-HT receptors do. Compounds with a high 
affinity for 5-HTiA recognition sites, like 8-hydroxy-2-(di-n-
propylamino)tetralin (8-0H-DPAT), N,N dipropyl-carboxamidotryptamine 
(DP-5-CT), flesinoxan, ipsapirone, p-aminophenyl-ethyl-m-
trifluoromethylphenyl piperazine (P APP), I- (2-methoxyphenyl)piperazine 
(2-MPP) and spiperone, lower heart rate, whereas compounds with a high 
affinity for 5-HT1a recognition sites - 1- (3-trifluoromethyl)piperazine 
(TFMPP), 1-(3-chlorophenyl)piperazine (mCPP) - or 5-HT2 recognition 
sites - I-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOl), 
piperazinyl-6-chloropyrazine (MK 212), cinanserin, 6-methyl-1-(1-
methylethyl)ergoline-8-carboxylic acid,2-hydroxy-l-methyl propyl 
ether(z)-butanedioate (LY 53857) -do not decrease heart rate (Doods et 
al., 1988; McCall et al., 1987; Ramage, 1985a,I985b; Ramage & Fozard, 
1987; Wouters et al., 1988). However, ritanserin, ketanserin and 
methysergide cause a fall in heart rate (Antonaccio & Taylor, 1977; 
Ramage, 1985a,1985b; Tadepalli et al., 1979; Van Zwieten et al., 1987). 
Copeland & Bentley (1985) reported no significant changes in heart rate 
by ketanserin. 
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Tachycardia in the cat. 
1. Isolated heart. 
Using the Langendorff preparation Reid (1952) and Schneider & Yonkman 
(1953) demonstrated that 5-HT exerts a positive chronotropic action on 
the cat heart. On isolated cat atria Trendelenburg (1960) has shown 
that 5-HT causes an increase in contraction frequency, which is not 
affected by pretreatment of the animals with reserpine. The tachycardic 
response is attenuated by low concentrations of lysergic acid diethylamide 
(LSD) and high concentrations of cocaine or TM 10, a compound which 
prevents the release of noradrenaline from adrenergic nerve endings. 
Therefore the effect of low doses of 5-HT on beating atria can be 
explained by direct receptor stimulation. In right atria from 
reserpine-pretreated kitten the positive chronotropic effect of 5-HT can 
be blocked irreversibly by phenoxybenzamine and can be competitively 
antagonized by methysergide. Ketanserin, MDL 72222 and yohimbine are 
ineffective, suggestive for the involvement of 5-HT1-like receptors. 
8-0H-DPAT and tryptamine also cause an increase in beating rate 
(Kaumann, 1985). 
2. Intact cat. 
Intrapericardial injection of 5-HT induces an epicardial chemoreflex 
(bradycardia and sympathoinhibition, resulting in hypotension), followed 
by tachycardia, which can not be antagonized by ketanserin or 
MDL 72222 (Mohr et al., 1987). 5-HT also causes tachycardia in 
vagotomized, spinal cats (Weidmann & Cerletti, 1957). This effect can be 
antagonized by pizotifen, mesulergine, methiothepin, metergoline and 
methysergide, whereas ketanserin and ritanserin are ineffective (Saxena et 
al., 1985; Saxena, 1988). Adrenalectomy did not modify this action of 
5-HT despite the fact that 5-HT can liberate adrenaline from the feline 
adrenal medulla (Reid, 1952). 5-Carboxamidotryptamine, a compound with 
15 
a high affinity for 5-HTl recognition sites, also induces tachycardia 
(Saxena et al., 1985; Connor et al., 1986). Other agonists for 5-HTl-like 
receptors, like BEA 1654, 8-0H-DPAT and RU 24969 also do this, but are 
less potent (Saxena, 1988). 
According to the data of Hoyer (1988) all the antagonists for the 
tachycardic effect of 5-HT share a high affinity for the 5-HTlc 
recognition site. However, 5-carboxamidotryptamine, which is more 
potent than 5-HT in this effect, has a low affinity for this recognition 
site. 
Therefore we can conclude that 5-HTl-like receptors in the right atrium 
of the cat are mediating the tachycardic response, but it is still 
impossible to characterize the putative 5-HTl receptor subtype, since 
there is no clear relationship between the cardioaccelarator effect of 
selective agonists and their affinity for subtypes of 5-HTl recognition 
sites. 
Bradycardia in the rabbit. 
Intravenous bolus injection of 5-HT in the conscious rabbit induces the 
von Bezold-Jarisch reflex. The bradycardia can be blocked by 
methscopolamine and the fall in blood pressure by the combination of 
methscopolamine and propranolol. Ketanserin is ineffective, excluding 
the mediation by 5-HT2 receptors (Wright & Angus, 1983). 
Phenyldiguanide and 5-carboxamidotryptamine also result in the von 
Bezold-Jarisch reflex. MDL 72222 blocks the reflex effects of all three 
agonists. In reserpine-pretreated rabbits, the 5-HT-induced reflex is 
enhanced, whereas 5-carboxamidotryptamine is ineffective. Pretreatment 
with fluoxetine, a 5-HT uptake inhibitor, reduces the bradycardic effect 
of 5-carboxamidotryptamine and even reveals a small tachycardic effect of 
this compound, whereas 5-HT shows a small increase and prolongation of 
the von Bezold-Jarisch reflex (Wright & Angus, 1989). These authors 
suggest that 5-carboxamidotryptamine releases 5-HT from platelets. In 
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anaesthetized rabbits both 5-HT and phenyldigunanide induce this renex 
(Dawes & Mott, 1950). The reflex induced by both compounds can be 
antagonized by 2-naphtyl-guanidine and bufotenine (Fastier et al., 1959) 
and also by MDL 72222, showing that both drugs act on 5-HTa receptors 
(Armstrong & Kay, 1985). 5-HT also stimulates receptors which are 
present in the nodose ganglion (Higashi & Nishi, 1983) and in nerve fibers 
of the vagus (Riccioppo Neto, 1978). These receptors belong to the 
5-HTa subtype, since they can be blocked by MDL 72222, ICS 205-930 and 
metoclopramide (Donatsch et al., 1984; Fozard et al., 1985) 
Tachycardia in the rabbit. 
1. Isolated heart. 
5-HT has positive chronotropic and inotropic effects on the isolated 
right atrium of the rabbit which cannot be blocked by atropine, 
hexamethonium, and low doses of LSD (Levy & Michel-Ber, 1956). In the 
Langendorff preparation 5-HT also causes an increase in beating rate 
which can be antagonized by propranolol (Jacob & Poite-Bevierre, 1960; 
Fozard & Mwaluko, 1976; F.ozard and Mobarok Ali, 1978). Using the 
selective 5-HTa receptor antagonist MDL 72222 Fozard (1984) 
demonstrated that 5-HT increases beating rate by an action on 5-HTa 
receptors located at the terminal sympathetic nerve fibers resulting in a 
release of catecholamines. 
2. Intact rabbits. 
Initially, 5-HT induces the von Bezold'-Jarisch reflex in conscious rabbits, 
which is later followed by tachycardia (Bolt & Saxena, 1985). 
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Tachycardia in the guinea pig. 
1. Isolated heart. 
The increase in beating rate in the isolated right atrium of the guinea 
pig induced by 5-HT is not modified by pretreatment with atropine, 
hexamethonium or LSD, but is reduced by ephedrine, a compound which 
releases catecholamines from nerve endings. After stimulation with 
nicotine, the response to 5-HT is also attenuated, suggestive for a 
neuronal action of 5-HT (Levy & Michel-Ber, 1956). However, 
Magistretti & Valzelli (1955) have shown that LSD reduces the positive 
chronotropic effect of 5-HT, which has been confirmed by Trendelenburg 
(1960). In right atria from reserpine-pretreated guinea pigs 5-HT causes 
a biphasic positive chronotropic effect (Walter et al., 1984), which cannot 
be blocked by (-)-bupranolol, (-)-pindolol or both compounds given 
together. Since (-)-pindolol has a high affinity for 5-HTlA and 5-HTIB 
recognition sites (Hoyer, 1988), it is unlikely that the effect of 5-HT is 
mediated by the putative 5-HTlA or 5-HT!B receptor subtypes or by 
release of noradrenaline, which was confirmed by Eglen & Whiting (1989). 
These authors showed that 8-0H-DPAT and 5-carboxamidotryptamine are 
inactive, whereas 5-HT causes an uniphasic dose-response curve, in 
contrast to the results from Walter et al. This might be explained by the 
addition of normetanephrine and pargylline to the incubation solution in 
Eglen's study, which reduces extraneuronal uptake and MAO activity, 
respectively. Neither pretreatment with methysergide, metergoline, 
ketanserin, MDL 72222, ICS 205-930, phentolamine, hexamethonium or H2 
receptor antagonists, nor reserpinization modify the response to 5-HT. 
However, in this study pindolol and atenolol showed a noncompetitive 
antagonism. 
It is still unclear whether 5-HT acts on a 5-HT receptor, which is 
different from the 5-HTI-like, 5-HT2 or 5-HT3 receptors. The possible 
5-HT-induced release of calcitonin gene-related peptide (CGRP) must also 
be considered, since it has been demonstrated that CGRP is present in 
18 
the guinea pig sinus node and that CGRP has a positive chronotropic 
action (Saito et al., 1986). 
2. Intact animal 
In spinal, vagosympathectomized guinea pigs 5-HT also increases heart 
rate dose-dependently. This is not affected by pretreatment with 
methiothepin, ketanserin or MDL 72222, but can be blocked by 
propranolol or atenolol (Dhasmana et al., 1988). The 5-HT uptake 
inhibitor indalpine reduces the heart rate effect of 5-HT, but from this 
study it is not clear whether this is caused by an increase in heart rate 
by indalpine itself, as observed in the pig (Bom et al., 1988), or not. In 
reserpinized animals the effect of tyramine is almost completely 
suppressed and 5-HT does not show a dose-dependent action on heart rate 
anymore, in contrast to the results of Eglen & Whiting (1989) in isolated 
atria. 
In conclusion, the positive chronotropic action of 5-HT seems not to be 
mediated by 5-HTi-like, 5-HT2 or 5-HT3 receptors. The mechanism(s) by 
which 5-HT is acting is still not clear. 
Bradycardia in the rat. 
1. Reflex bradycardia 
In the anaesthetized rat 5-HT evokes the von Bezold-Jarisch reflex, 
which can be blocked by metoclopramide (Fozard & Host, 1982), 
MDL 72222 (Fozard, 1983) or ICS 205-930 (Richardson et al., 1985). As in 
the rabbit, 5-HT also de polarizes cervical vagus nerve fibers, which is 
mimicked by phenylbiguanide and 2-methyl-5-hydroxytryptamine. This 
effect can be blocked by metoclopramide, MDL 72222, ICS 205-930, 
quipazine, tropacaine and m-chloro-phenylpiperazine (mCPP) (Ireland & 
Tyers, 1987). 
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2. Centrally-acting drugs 
8-0H-DPAT, a compound with high affinity for the 5-HTIA recognition 
site, reduces heart rate in both normotensive Sprague-Dawley rats and 
spontaneous hypertensive rats (Gradin et al., 1985a,b), which can be 
prevented by the combination of atropine and propranolol, suggestive for 
a central action of 8-0H-DPAT on efferent vagal and sympathetic nerve 
activity. In these studies methiothepin, metergoline, cianserine and 
pirenperone did not antagonize the 8-0H-DPAT-induced bradycardia. 
However, Martin & Lis (1985) have shown that methiothepin blocks the 
8-0H-DPAT-induced bradycardia in spontaneous hypertensive rats, 
whereas cyproheptadine and metergoline are ineffective. 8-0H-DPAT 
also reduces heart rate in Wistar-Kyoto, two-kidney Goldblatt 
hypertensive and DOCA-salt hypertensive rats. This response cannot be 
blocked by metergoline, methysergide or LY53857, but is attenuated by 
the dopamine antagonist sulpiride (Main et al., 1984). More recently, 
Fozard et al. (1987) have shown that 8-0H-DPAT lowers heart rate and 
blood pressure in spontaneous hypertensive rats, which is not affected by 
p-chloro-phenylalanine (pCPA), a compound which reduces the synthesis 
of 5-HT in the brain. In pithed animals 8-0H-DPAT did not cause 
marked changes in heart rate. 8-0H-DPAT did not modify the increase in 
heart rate during electrical stimulation of the spinal cord, excluding a 
possible presynaptic inhibitory action of this drug. Furthermore, when 
blood pressure was increased with angiotensin II, 8-0H-DPAT, no change 
in blood pressure or heart rate occurred. Cisternal administration of 8-
methoxy-2-(N-2-chloroethyl-N-n propyl) aminotetralin (8-MeO-ClePAT) 
markedly reduces the effects of 8-0H-DPAT. Also metergoline, 
methiothepin, (±)-pindolol, (±)-cyanopindolol, buspirone, yohimbine, 
idazoxan and WY 26392 act as antagonists, whereas prazosin, MDL 72222 
and cis-flupenthixol are ineffective. A low dose of ketanserin (0.1 
mg kg-1 , s.c.) did not affect the response to 8-0H-DPAT, whereas a 
higher dose of ketanserin lowered heart rate by itself, thereby reducing 
the bradycardic effect of 8-0H-DPAT. In this study the doses of 
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metergoline and methiothepin were higher than those used by Martin & 
Lis (1985) or Gradin et al. (1985), which might explain the conflicting 
results. Fozard et al. (1987) concluded that 8-0H-DPAT lowers blood 
pressure and heart rate by an action on the central nervous sytem, 
probably by a direct action on 5-HTlA receptors. Indirectly, a 
a2-adrenoceptor-mediated action also plays a role, since a2-adrenoceptor 
blockade also inhibited the response to 8-0H-DPAT. 
Methysergide also loweres heart rate in spontaneous hypertensive rats, 
whereas cyproheptadine is ineffective. Since methysergide does not 
antagonize the responses to spinal cord stimulation or noradrenaline and 
tyramine a central action of this drug has been suggested (Antonaccio & 
Cote, 1976). 
In vagotomized, pithed rats, pretreated with atropine, captopril and 
ketanserin, preganglionic stimulation of the sympathetic nerves results in 
an increase in heart rate, which can be reduced by 5-methoxytryptamine, 
suggestive for presynaptic inhibition. However, this effect cannot be 
blocked by rauwolscine or low doses of methiothepin. Higher doses of 
methiothepin causes an increase in noradrenaline release and heart rate 
and therefore cannot be used for comparison. The noradrenaline-induced 
tachycardia can also be reduced by 5-methoxytryptamine in this model, 
but higher doses are necessary (Goethert et al., 1986). 
Tachycardia in the rat. 
1. Isolated heart. 
In blood-perfused isolated hearts 5-HT causes only minor changes in 
heart rate, whereas LVdP/dt and coronary perfusion pressure are 
increased. Methysergide has no effect on these parameters, but reduces 
the effects of 5-HT. Propranolol does not modify the response to 5-HT 
(Sakai & Akima, 1979). In the Langendorff preparation 5-HT causes an 
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increase in heart rate, which can be blocked by methysergide and 
propranolol, but not by atenolol (Higgins et al., 1981). 
2. Intact rat. 
In pithed Wistar rats 5-HT causes tachycardia, which can be antagonized 
by cyproheptadine, but not by the 5-HTz receptor antagonist R 50656 
(Krstic & Katusic, 1982). In untreated Wistar rats 5-HT does not induce 
tachycardia, probably due to the reflex bradycardia. However, in 
mecamylamine-induced ganglion-blocked rats the bradycardia is abolished 
and a tachycardic response revealed, which can be blocked by ketanserin 
or cyproheptadine (Saxena & Lawang, 1985). In pithed Wistar rats the 
5-HT-induced tachycardia can be reduced by ketanserin, but at high 
doses 5-HT also exhibits a tyramine-like action, which can be reduced by 
desipramine or propanolol. Despite pretreatment with ketanserin and 
desipramine 5-HT still shows a positive chronotropic effect, which might 
be explained by a 5-HT-induced release of CGRP (see Tachycardia in the 
guinea pig). 5-methoxytryptamine also causes tachycardia, but this 
tachycardia can be blocked by ketanserin or methysergide, but not by 
propranolol or desipramine (Goethert et al., 1986). In pithed spontaneous 
hypertensive rats 5-carboxamidotryptamine, 8-0H-DPAT, ipsapirone and 
RU 24969 do not induce tachycardia, showing that 5-HTl-like receptors_ 
are not involved, whereas the 5-HT-induced tachycardia can be reduced 
by ketanserin, LY 53857, methysergide or propranolol (Docherty, 1988). 
These results suggest that 5-HTz receptors are mediating the tachycardia 
in the rat, but at higher doses a tyramine-like action and another 
mechanism (CGRP ?) can also contribute to this effect. 
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Tachycardia in the isolated atrium of the hamster. 
In this species the 5-HT-induced tachycardia is partly mediated by 
receptor stimulation and partly by a tyramine-like action of 5-HT 
(Gonzalez & Garcia, 1977). The dose-response curve is neither modified 
by pretreatment with a combination of phentolamine and propranolol, nor 
by pretreatment with phenoxybenzamine (Gonzalez & 'Garcia, 1978). 
Tachycardia in non-human primates. 
Infusions of 5-HT into the external carotid artery induces tachycardia in 
the baboon (African papiopapiogera), whereas blood pressure remains 
unchanged. However, infusion of 5-HT in the internal carotid artery 
does not cause any change in heart rate (Grimson et al., 1969). This 
might be explained by a high amount of arteriovenous anastomotic 
shunting in the tissues supplied by the external carotid artery, allowing a 
large fraction of the blood flow to go directly to the heart. The amount 
of unbound 5-HT in the blood reaching the heart will therefore be higher 
during external carotid infusions. 
Heart rate changes in man. 
Many investigators have shown that slow intravenous injection or 
infusions of 5-HT cause a dose-dependent increase in heart rate 
(Hollander et al., 1957; LeMessurier et al., 1959; Parks et al., 1959). 
Harris et al. (1960) demonstrated that rapid injection of 5-HT into the 
right atrium induces an asystole and a drop in blood pressure followed 
by bradycardia (resembling the von Bezold-Jarisch reflex observed in 
animals). The bradycardia in this patient was later followed by a period 
of tachycardia. 
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Conclusion 
As shown in the above-mentioned studies 5-HT induces heart rate changes 
by a whole spectrum of mechanisms and receptors. Therefore we studied 
the epicardial chemoreflex in cats (Chapter 4) and the tachycardic 
response to 5-HT in the pig (Chapter 5) in order to find by which 
mechanisms and receptor-subtypes 5-HT was acting. 
REFERENCES 
Antonaccio, M.J. & Cote, D. (1976) Centrally mediated antihypertensive 
and bradycardic effects of methysergide in spontaneously hypertensive 
rats. Eur. J. Pharmac., 36, 451-454. 
Antonaccio, M.J. & Taylor, D.G. (1977) Reduction in blood pressure, 
sympathetic nerve activity and centrally evoked pressor responses by 
methysergide in anesthetized cats. Eur. J. Pharmac., 42, 331-338. 
Armstrong, D.J. & Kay, I.S. (1985) MDL 72222 antagonizes the pulmonary 
depressor and respiratory chemoreflexes evoked by phenylbiguanide in 
the anaesthetized rabbit. J. Physiol. (London), 365, P104. 
Barer, G.R. & Nuesser, E. (1958) Cardiac output during excitation of 
chemoreflexes in the cat. Br. J. Pharmac., 13, 372-377. 
Berthold, H., Scholtysik, G. & Engel, G. (1989) Inhibition of the 
5-HT-induced cardiogenic hypertensive chemoreflex by the selective 
5-HTs receptor antagonist ICS 205-930. Naunyn-Schmiedeberg's Arch. 
Pharmac., 339, 259-262. 
Born, A.H., Duncker, D.J., Saxena, P.R. & Verdouw, P.D. (1988) 
5-Hydroxytryptamine-induced tachycardia in the pig: possible 
involvement of a new type of 5-hydroxytryptamine receptor. Br. J. 
Pharmac., 93, 663-671. 
Breuer, J., Meschig, R., Breuer, H-W.M. & Arnold, G. (1985) Effects of 
serotonin on the cardiopulmonary circulatory system with and without 
5-HT2 receptor blockade by ketanserin. J. Cardiovasc. Pharmac., 7, 
Suppl. 7, S64-S66. 
Bolt, G.R. & Saxena, P.R. (1985) Cardiovascular profile and hypotensive 
mechanism of ketanserin in conscious renal hypertensive rabbits. 
Hypertension, 7, 499-506. 
Chiba, S. (1977) Pharmacologic analysis of chronotropic and inotropic 
responses to 5-hydroxytryptamine in the dog heart. Jap. J. Pharmac., 27, 
727-734. 
Chiba, S., Kobayashi, M. & Furukawa, Y. (1978) Potentiation of tyramine 
action of 5-hydroxytryptamine in the dog heart. Jap. J. Pharmac., 28, 
160-162. 
24 
Comroe, J.H., Van Lingen, B., Stroud, R.C. & Roncoroni, A. (1953) Reflex 
and direct cardiopulmonary effects of 5-0H-Tryptamine (Serotonin). 
Their possible role in pulmonary embolism and coronary thrombosis. Am. 
J. Physiol., 173, 379-386. 
Connor, H.E., Peniuk, W., Humphrey, P.P.A. & Perren, M.J. (1986) 
5-Carboxamidotryptamine is a selective agonist at 5-HT receptors 
mediating vasodilatation and tachycardia in anaesthetised cats. Br. J. 
Pharmac., 87, 417-426. 
Copeland, I.W. & Bentley, G.A. (1985) A possible central action of 
prazosin and ketanserin to cause hypotension. J. Cardiovasc. Pharmac., 
7, 822-825. 
Dawes, G.S. & Pastier, P.N. (1950) Reflex actions of some isothiourea 
derivatives on circulation and respiration. Br. J. Pharmac., 5, 323-334. 
Dawes, G.S. & Mott, J.C. (1950) Circulatory and respiratory reflexes 
caused by aromatic guanidines. Br. J. Pharmac., 5, 65-76. 
Dhasmana, K.M., De Boer, H.J., Banerjee, A.K. & Saxena, P.R. (1988) 
Analysis of the tachycardic response to 5-hydroxytryptamine in the 
spinal guinea pig. Eur. J. Pharmac., 145, 67-73. 
Docherty, J.R. (1988) Investigations of cardiovascular 
5-hydroxytryptamine receptor subtypes in the rat. 
Naunyn-Schmiedeberg's Arch. Pharmac., 337, 1-8. 
Donatsch, P., Engel, G., Richardson, B.P. & Stadler, P. (1984) 
res 205-930: A highly selective and potent antagonist at peripheral 
neuronal5-hydroxytryptamine (5-HT) receptors. Br. J. Pharmac., 81, 34P. 
Doods, H.N., Boddeke, H.W.G.M., Kalkman, H.O., Hoyer, D., Mathy, M-J. & 
van Zwieten, P.A. (1988) Central 5-HT1A receptors and the mechanism 
of the central hypotensive effect of(+) 8-0H-DPAT, DP-5-CT, R 28935 
and urapidil. J. Cardiovasc. Pharmac., 11, 432-437. 
Eglen, R.M. & Whiting, R.L. (1989) Comparison of the positive 
chronotropic responses to 5-hydroxytryptamine with 13-adrenoceptor 
agonists on the guinea pig atria in vitro. J. Cardiovasc. Pharmac., 13, 
45-51. 
Pastier, P.N., McDowall, M.A. & Waal, H. (1959) Pharmacological 
properties of phenyldiguanide and other amidine derivatives in relation 
to those of 5-hydroxytryptamine. Br. J. Pharmac., 14, 527-535. 
Feniuk, W. & Humphrey, P.P.A. (1979) The mechanism of 
5-hydroxytryptamine-induced pressor responses in ganglion-blocked 
anaesthetized dogs. Br. J. Pharmac., 66, 81P. 
Feniuk, W., Hare, J. & Humphrey, P.P.A. (1981) An analysis of the 
mechanism of 5-hydroxytryptamine-induced vasopressor responses in 
ganglion-blocked anaesthetized dogs. J. Pharm. Pharmac., 33, 155-160. 
Fillion, G.M.B., Lluch, S. & Uvnas, B. (1971) Release of noradrenalin 
from the dog heart in situ after intravenous and intracoronary 
administration of 5-hydroxytryptamine. Acta Physiol. Scand., 83, 
115-123. 
Fozard, J.R. & Mwaluko, G.M.P. (1976) Mechanism of the indirect 
sympathomimetic effect of 5-hydroxytryptamine on the isolated heart of 
the rabbit. Br. J. Pharmac., 57, 115-125. 
25 
Fozard, J.R. & Mobarok Ali, A.T.M. (1978) Receptors for 
5-hydroxytryptamine on the sympathetic nerves of the rabbit heart. 
Naunyn Schmied. Arch. Pharmac., 301, 223-235. 
Fozard, J.R. & Host, M. (1982) Selective inhibitio'n of the Bezold-Jarisch 
effect of 5-HT in the rat by antagonists at neuronal 5-HT receptors. 
Br. J. Pharmac., 77, 520P. 
Fozard, J.R. (1983) Selective blockade of 5-hydroxytryptamine neuronal 
receptors by benzoic acid esters of tropin. Br. J. Pharmac., 80, 511P. 
Fozard, J.R. (1983) MDL 72222: A potent and highly selective antagonist 
at neuronal 5-hydroxytryptamine receptors. Br. J. Pharmac., 80, 466P. 
Fozard, J.R. (1984) MDL 72222: a potent and highly selective antagonist 
at neuronal 5-hydroxytryptamine receptors. Naunyn Schmied. Arch. 
Pharmac., 326, 36-44. 
Fozard, J.R., Humphreys, A., Round, A. & Wallis, D.I. (1985) Further 
studies on the actions of MDL 72222 on responses to 5-HT in rabbit 
nodose (NG) and superior cervical (SCG) ganglia. Br. J. Pharmac., 85, 
309P. 
Fozard, J.R., Mir, A.K. & Middlemiss, D.N. (1987) Cardiovascular response 
to 8-hydroxy-2-(di-n-propylamino) tetralin (8-0H-DPAT) in the rat: site 
of action and pharmacological analysis. J. Cardiovasc. Pharmac., 9, 328-
347. 
Goethert, M., Schlicker, E. & Kollecker, P. (1986) Receptor-mediated 
effects of serotonin and 5-methoxytryptamine on noradrenaline release 
in the rat vena cava and in the heart of the pithed rat. 
Naunyn-Schmied. Arch. Pharmac., 332, 124-130. 
Gonzalez, R. & Garcia, M. (1977) Sobre et mecanisme de accion de la 
serotonina en la auricula aislada de hamster. I. Serotonina: amina de 
accion mixta. Acta Physiol. Lat. Am., 27, 239-247. 
Gonzalez, R. & Garcia, M. (1978) Lack of a-adrenergic component in the 
chronotropic action of serotonin on isolated atrium of hamster. Pol. J. 
Pharmac., 30, 425-429. 
Gradin, K., Pettersson, A., Hjorth, S., Hedner, T., Arvidsson, L.E. & 
Persson, B. (1985a) Cardiovascular effects in the Sprague-Dawley rat of 
8-hydroxy-2(di-N-propylamino) tetralin, a selective 5-hydroxytryptamine 
receptor agonist. J. Pharm. Pharmac., 37, 263-265. 
Gradin, K., Pettersson, A., Hedner, T. & Persson, B. (1985b) Acute 
administration of 8-hydroxy-2-(di -n-propylamino) tetralin (8-0H-DPAT), 
a selective 5-HT receptor agonist, causes a biphasic blood pressure 
response and a bradycardia in the normotensive Sprague-Dawley rat and 
in the spontaneously hypertensive rat. J. Neural. Transm., 62, 305-319. 
Grimson, B.S., Robinson, S.C., Danford, E.T., Tindall, G.T. & Greenfield, 
J.C. (1969) Effects of serotonin on internal and external carotid artery 
blood flow in the baboon. Am. J. Physiol., 216, 50-55. 
Hageman, G.R., Urthaler, F. & James, T.N. (1977) Cyproheptadine 
blockade of a cardiogenic hypertensive chemoreflex. Proc. Soc. Exp. 
Biol. Med., 154, 578-581. 
Hageman, G.R., Urthaler, F., Schwatzell, R.H. & James, T.N. (1980) 
Analysis of sympathetic discharges during cardiogenic hypertensive 
chemoreflex. Am. J. Physiol., 238, H61-H65. 
26 
Harris, P., Fritts, H.W. & Cournand, A. (1960) Some circulatory effects 
of 5-hydroxytryptamine in man. Circulation, 21, 1134-1139. 
Higashi, H. & Nishi, S. (1982) 5-Hydroxytryptamine receptors of visceral 
primary afferent neurones on rabbit nodose ganglia. J. Physiol. 
(London), 323, 543-567. 
Higgins, T.J.C., Allsopp, D. & Bailey, P.J. (1981) Mechanisms of 
stimulation of rat cardiac muscle by 5-hydroxytryptamine. Biochem. 
Pharmac., 30, 2703-2707. 
Hollander, W., Michelson, A.L. & Wilkins, R.W. (1957) Setotonin and 
Antiserotonins. I. Their circulatory, respiratory and renal effects in 
man. Circulation, 16, 246-255. 
Hoyer, D. (1988) Functional correlates of serotonin 5-HTi recognition 
sites. J. Receptor. Res., 8, 59-81. 
Ireland, S.J. & Tyers, M.B. (1987) Pharmacological characterization of 
5-hydroxytryptamine-induced depolarization of the rat isolated vagus 
nerve. Br. J. Pharmac., 90, 229-238. 
Jacob, J. & Poite-Bevierre, M. (1960) Actions de la serotonine et de la 
benzyl-1-dimethyl-2,5,serotonine sur le coeur isole de lapin. Arch. Int. 
Pharmacodyn. Ther., 127, 11-26. 
Jacob, J. & Fillion, G. (1967) Actions du d-propranolol, de la 
reserpinisation et d'antagonistes de la serotonine sur 1es tachycardies 
provoquees par la serotonine, par la noradrenaline et par stimulation 
des nerfs cardioaccelerateurs chez le chien. J. Physiol. (Paris), 59, 
434-435. 
Jacobs, L & Comroe, J.H. (1971) Reflex apnea, bradycardia, and 
hypotension produced by serotonin and phenyldiguanide acting on the 
nodose ganglia of the cat. Circ. Res., 29, 145-155. 
James, T.N. (1964) The chronotropic action of serotonin studied by direct 
perfusion of the sinus node. J. Pharmac. Exp. Ther., 146, 209-214. 
James, T.N., Isobe, J.H. & Urthaler, F. (1975) Analysis of components in a 
cardiogenic hypertensive chemoreflex. Circulation, 52, 179-192. 
Kaumann, A.J. (1985) Two classes of myocardial 5-hydroxytryptamine 
receptors that are neither 5-HTi nor 6-HT2. J. Cardiovasc. Pharmac., 7 
Suppl. 7, 876-878. 
Kirby, G.C. & McQueen, D.S. (1984) Effects of the antagonists MDL 72222 
and ketanserin on responses of cat carotid body chemoreceptors to 
5-hydroxytryptamine. Br. J. Pharmac., 83, 259-269. 
Kimura, T. & Satoh, S. (1983) Presynaptic inhibition of cardiac 
sympathetic transmission in dogs. Clin. & Exp. Pharmac. & Physiol., 10, 
535-542. 
Kottegoda, S.R. & Mott, J.C. (1955) Cardiovascular and respiratory 
actions of 5-hydroxytryptamine in the cat. Br. J. Pharmac., 10, 66-72. 
Krstic, M.K. & Katusic, Z. (1982) Divergent effects of cyproheptadine 
and R 50656, a 5-HT2 antagonist, on the cardiovascular response to 
5-hydroxytryptamine in rats. Eur. J. Pharmac., 85, 225-227. 
LeMessurier, D.H., Schwartz, C.J. & Whelan, R.F. (1959) Cardiovascular 
effects of intravenous infusions of 5-hydroxytryptamine in man. Br. J. 
Pharmac., 14, 246-250. 
27 
Levy, J. & Michel-Ber, E. (1956) Contribution a l' action pharmacologique 
exercee par la serotonine sur quelques organes isoles (intestin et 
oreillette). J. Physiol. (Paris), 48, 1051-1081. 
MacCanon, D.M. & Horvath, S.M. (1954) Some effects of serotonin in 
pentobarbital anaesthetized dogs. Am. J. Physiol., 179, 131-134. 
Magistretti, M. & Valzelli, L. (1955) Boll. Soc. Ita!. Bioi. sper., 31, 
1035-1037. 
Main, B.W., Smith, T. & Kurz, K.D. (1984) Cardiovascular activity of 
8-hydroxy-2-(di-n-propylamino)-tetralin (8-0H-DPAT) in SHR. Fed. 
Proceed., 43, 556. 
Martin, G.E. & Lis, E.V. (1985) Hypotensive action of 
8-hydroxy-2-(di-N-propylamino) tetralin (8-0H-DPAT) in spontaneous 
hypertensive rats. Arch. Int. Pharmacodyn., 273, 251-261. 
Maxwell, G.M., Castillo, C.A., Clifford, J.E., Crumpton, C.W. & Rowe, 
G.G. (1959) Effects of serotonin (5-hydroxytryptamine) on the systemic 
and coronary vascular bed of the dog. Am. J. Physiol., 197, 736-738. 
McCall, R.B., Patel, B.N. & Harris, L.T. (1987) Effects of serotonin1 and 
serotoninz receptor agonists and antagonists on blood pressure, heart 
rate and sympathetic nerve activity. J. Pharm. Exp. Ther., 242, 
1152-1159. 
McCawley, E.L., Leveque, P.E. & Dick, H.L.H. (1952) Certain actions of 
serotonin (5-hydroxytryptamine-creatinine sulfate) on cardiac rythm. 
J. Pharmac. Exp. Ther., 106, 406. 
Mohr, B., Born, A.H., Kaumann, A.J. & Thaemer, V. (1987) Reflex 
inhibition of efferent renal sympathetic nerve activity by 
5-hydroxytryptamine and nicotine is elicited by different epicardial 
receptors. Pfl iigers Arch., 40 9, 145-151. 
Noble, J.G. & Nanson, E.M. (1959) An investigation of the effects of 
5-hydroxytryptamine (serotonin) on the cardiovascular system of the 
dog. Ann. Neurosurg., 150, 846-853. 
Paintal, A.S. (1964) Effects of drugs on vertebrate mechanoreceptors. 
Pharmac. Rev., 16, 341-380. 
Paintal, A.S. (1973) Vagal sensory receptors and their reflex effects. 
Physiol. Rev., 53, 159-227. 
Parks, V.J., Sandison, A.G., Skinner, S.L. & Whelan, R.F. (1960) The 
stimulation of respiration by 5-hydroxytryptamine in man. J. Physiol. 
(London), 151, 342-351. 
Phillips, C.A., Mylecharane, E.J., Markus, J.K. & Shaw, J. (1985) 
Hypotensive actions of ketanserin in dogs: involvement of a centrally 
mediated inhibition of sympathetic vascular tone. Eur. J. Pharmac., 111, 
319-327. 
Ramage, A. (1985a) Effects of ritanserin and cinanserin on the 
cardiovascular system of the cat. Br. J. Pharmac., 86, 598P. 
Ramage, A. (1985b) The effects of ketanserin, methysergide and LY 53857 
on sympathetic nerve activity. Eur. J. Pharmac., 113, 295-303. 
Ramage, A.G. & Fozard, J.R. (1987) Evidence that the putative 5-HTtA 
receptor agonist 8-0H-DPAT and ipsapirone have a central hypotensive 
action that differs from that of clonidine in anaesthetized cats. Eur. J. 
Pharmac., 138, 179-191. 
28 
Reid, G. (1952) Circulatory effects of 5-hydroxytryptamine. J. Physiol. 
(London), 118, 435-453. 
Richardson, B.P., Engel, G., Donatsch, P. & Stadler, P.A. (1985) 
Identification of serotonin M-receptor subtypes and their specific 
blockade by a new class of drugs. Nature, 316, 126-131. 
Riccioppo Neto, F. (1978) The depolarizing action of 5-HT on mammalian 
non-myelinated nerve fibers. Eur. J. Pharmac., 49, 351-356. 
Saito, A., Kimura, s. & Goto, K. (1986) Calcitonin gene-related peptide 
as potential neurotransmitter in guinea pig right atrium. Am. J. Physiol., 
250, H693-H698. 
Sakai, K. & Akima, M. (1979) An analysis of the stimulant eff.acts of 
5-hydroxytryptamine on isolated, blood-perfused rat heart. Eur. J. 
Pharmac., 55, 421-424. 
Saxena, P.R. ( 1988) Further characterization of 5-hydroxytryptamine1-like 
receptors mediating tachycardia in the cat: No apparent relationship to 
known subtypes of the 5-hydroxytryptaminel-binding sites. Drug 
Develop. Res., 13, 245-258. 
Saxena, P.R. & Lawang, A. (1985) A comparison of cardiovascular and 
smooth muscle effects of 5-HT and 5-carboxamidotryptamine, a selective 
agonist of 5-HTl receptors. Arch. Int. Pharmacodyn., 277, 235-252. 
Saxena, P.R. Mylecharane, E.J. & Heiligers, J. (1985) Analysis of the 
heart rate effects of 5-hydroxytryptamine in the cat; mediation of 
tachycardia by 5-HTl-like receptors. Naunyn Schmied. Arch. Pharmac., 
330, 121-129. 
Schneider, J.A. & Yonkman, F.F. (1953) Action of serotonin on vagal 
afferent impulses in the cat. Am. J. Physiol., 174, 127-134. 
Tadepalli, A.S., Ho, K.W. & Buckley, J.P. (1979) Enhancement of reflex 
vagal bradycardia following intracerebroventricular administration of 
methysergide in cats. Eur. J. Pharmac., 59, 85-93. 
Trendelenburg, U. (1960) The action of histamine and 
5-hydroxytryptamine on isolated mammalian atria. J. Pharm. Exp. Ther., 
130, 450-460. 
Urthaler, F., Hageman, G.R. & James, T.N. (1978) Hemodynamic 
components of a cardiogenic hypertensive chemoreflex in dogs. Circ. 
Res., 42, 135-142. 
Vyden, J.K., Gold, H., Bernstein, H. & Corday, E. (1967) Effects of 
5-hydroxytryptamine (Serotonin) on regional circulations. Circulation, 
Sup pl. II, 35, II -258. 
Walter, M., Lemoine, H. & Kaumann, A.J. (1984) Stimulant and blocking 
effects of optical isomers of pindolol on the sinoatrial node and trachea 
of guinea pig. Role of (3-adrenoceptor subtypes in the dissociation 
between blockade and stimulation. Naunyn Schmied. Arch. Pharmac., 327, 
159-175. 
Weidmann, H. & Cerletti, A. (1957) Untersuchungen ueber die 
pressorische Wirkung des 5-Hydroxytryptamin (Serotonin). Arch. Int. 
?harmacodyn., 111, 98-107. 
Wouters, W., Tulp, M.Th.M. & Bevan, P. (1988) Flesinoxan lowers blood 
pressure and heart rate in cats via 5-HTlA receptors. Eur. J. Pharmac., 
149, 213-223. 
29 
Wright, C.E. & Angus, J.A. (1983) Role of serotonin type 2 (5-HTz) 
receptors in the Bezold-Jarisch reflex in the conscious rabbit. 
Proceedings IUPS, Vol. 15, XXIX Congres, Sydney, Australia. 
Wright, C.E. & Angus, J.A. (1989) 5-Carboxamidotryptamine elicits 5-HTz 
and 5-HT3 receptor-mediated cardiovascular responses in the conscious 
rabbit: evidence for 5-HT release from platelets. J. Cardiovasc. 
Pharmac., 13, 557-564. 
Zakusov, V.V. (1962) Principles of pharmacological influence on coronary 
chemoreflexes. Arch. Int. Pharmacodyn., 140, 646-654. 
Zucker, I.H. & Cornish, K.G. (1980) Reflex cardiovascular and respiratory 
effects of serotonin in conscious and anaesthetized dogs. Circ. Res., 47, 
509-515. 
van Zwieten, P.A., Mathy, M.J., Boddeke, H.W.G.M. & Doods, H.N. (1987) 
Central hypotensive activity of ketanserin in cats. J. Cardiovasc. 
Pharmac., 10 (Suppl. 3), 854-858. 

31 
Chapter 4 
REFLEX INHIBITION OF EFFERENT RENAL SYMPATHETIC NERVE 
ACTIVITY BY 5-HYDROXYTRYPTAMINE AND NICOTINE IS ELICITED 
BY DIFFERENT EPICARDIAL RECEPTORS. 
B. Mohr, A.H. Born, A.J. Kaumann & V. Thamer. 
Pflugers Arch. 409, 145-151, 1987 

Pfliigers Arch (1987) 409:145-151 
33 
Eu~Joomal 
of Physiology 
© Springer-Verlag 1987 
Reflex inhibition of efferent renal sympathetic nerve activity 
by 5-hydroxytryptamine and nicotine 
is elicited by different epicardial receptors* 
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Abstract. Intrapericardial administration of 5-hydroxy-
tryptamine (5-HT) induced reflex effects consisting in an 
inhibition of renal sympathetic nerve activity (RSNA), 
bradycardia and a fall in blood pressure. Nicotine caused 
the same reflex effects as 5-HT. The reflex effects of both 5-
HT and nicotine were abolished by vagotomy. MDL 72222, 
an antagonist at 5-HT M-receptors, abolished or attenuated 
the decreases in RSNA, heart rate and blood pressure in-
duced by 5-HT, leaving the reflex effects of nicotine 
unchanged. In the absence of MDL 72222 the reflex 
bradycardia partially concealed a positive chronotropic re-
sponse to 5-HT. Mter blockade of the bradycardia response 
by MDL 72222, 5-HT elicited a significant tachycardia, 
which was not altered by propranolol and phentolamine, 
but was prevented by phenoxybenzamine. 5-HT probably 
reaches the sinoatrial node and activates 5-HT receptors 
that mediate directly the increase in heart rate. The nicotine 
receptor antagonist hexamethonium selectively abolished or 
attenuated the reflex effects of nicotine without interfering 
with those of 5-HT. We conclude that 5-HT and nicotine 
elicit similar reflex effects in epicardial vagal nerve endings 
by stimulation of M-receptors or nicotine receptors, respec-
tively. 
Key words: Renal nerve activity - Heart rate - 5~ 
Hydroxytryptamine - Nicotine - MDL 72222 - Hexa-
methonium 
Introduction 
The cardiovascular changes that follow an intravenous injec-
tion of 5-hydroxytryptamine (5-HT) can be regarded as net 
result of direct and reflex effects on heart and blood vessels. 
In most species the response to 5-HT is triphasic: an initial 
depressor effect, a short lasting pressor effect and fmally 
a prolonged depressor effect (Douglas 1965). The initial 
component is due to a reflex bradycardia (Comroe et a!. 
1953; Mott and Paintal 1953; Schneider and Yonkman 
1954); the second component is probably related to the 
sum of positive inotropic effects, tachycardia and arterial 
• This study was supported in part by grant SFB 30 Kardiologie 
of the Deutsche Forschungsgerneinschaft 
•• Present address: ICI Pharmaceuticals Division, Mereside 
Alderley Park, Macclesfield, Cheshire SK10 4TG, UK 
Offprint requests to: V. Thiimer 
constriction; the late component is due to arterial vasodila-
tion (Kalkman et a!. 1983). 
The changes in blood pressure and heart rate which are 
· reflexly mediated may result from excitation of sensory vagal 
afferents in different organs, e.g. type J pulmonary receptors 
(Paintal1955), cardiac receptors (Zakusov 1962) and carotid 
body chemoreceptors (Black et a!. 1972; Kirby and 
McQueen 1984). Injection of 5-HT into the blood stream 
may additionally induce a depressor response mediated by 
stimulation of 5-HT receptors in the central nervous system 
(Takahashi 1985). The purpose of the present work was to 
analyse the reflex changes elicited by exclusive stimulation of 
epicardial sensory afferents by 5-HT. To avoid the complex 
mosaic of effects due to activation of multiple mechanism by 
i. v. administration, we administered 5-HT intrapericardially 
(i.pc.). To investigate whether an inhibition of efferent sym-
pathetic nerve activiry is part of the reflex effects, as de-
scribed for nicotine (Oberg and Thoren 1973), we measured 
renal sympathetic nerve activity (RSNA) during i.pc. admin-
istration of5-HT. MDL 72222 blocks the reflex bradycardia 
of 5-HT in the rat (Fozard 1984) by competing with 5-
HT forM-receptors (Gaddum and Picarelli 1957; recently 
reclassified as 5-HT3-receptors by Bradley et al.1986) on the 
afferent vagal fibres. Hexamethonium prevents the action 
of nicotine on nonmedullated vagal fibres (Volle and Koelle 
1975). 
In order to find out whether the reflex effects of 5-HT 
a.nd nicotine are induced through nonspecific or specific 
epicardial receptors we used the M-receptor antagonist 
MDL 72222 (1o:H, 3o:,5o:H-tropan-3-yl-3,5-dichloroben-
zoate) and the nicotine receptor antagonist hexamethonium. 
The results show that 5-HT causes the Bezold-Jarisch reflex 
and a decrease of RSNA through epicardial M-receptors 
located on afferent vagal fibers. 
Methods 
The experiments were performed on 29 cats weighing 1.9-
4.9 kg anaesthetized with chloralose (60 mgfkg i.v.). A 
tracheal cannula was inserted and the cats were ventilated 
artificially with air supplemented with oxygen. The arterial 
pC02 and pH were measured periodically and the values 
were maintained within the physiological range by adjusting 
either the tidal volume or the respiratory frequency. The 
arterial p02 exceeded 100 mm Hg. The arterial pC02 was 
maintained between 25 and 30 mm Hg and pH between 7.35 
and 7.45. Body temperature was kept between 37° C and 
39° C by external heating. 
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Fig. 1. Effect of intrapericardial administration of 5-HT on blood 
pressure (BP), heart rate (HR) and renal sympathetic nerve activity 
(RSNA) before and after vagotomy 
Surgical procedure. After a leftsided thoracotomy the 
pericardium was opened. For administration of drugs a 
silastic catheter was introduced into the pericardia! sac and 
sutured to the pericardium in such a way that its tip lay over 
the apical portion of the left ventricular surface. 
Haemodynamic measurements. Blood pressure was measured 
in a femoral artery through a catheter connected to a 
Statham P23 Gb transducer. Heart rate was measured with 
a cardiotachometer (Gould, Oxnard, CA, USA) which was 
triggered by the arterial pressure wave. 
Recording of nerve activity. A branch of the renal sympa-
thetic nerve was dissected free from the surrounding tissue 
. and cut distally. The nerve was covered with mineral oil and 
placed on bipolar platinum electrodes. Nerve activity was 
recorded as previously described by Vogt and Thiimer 
(1980). 
Experimental protocol. The protocol was started 30 min after 
completing the surgical preparation. 
For stimulation of epicardial receptors 5-HT or nicotine 
were injected i.pc. The drugs were diluted in 0.9% NaCl at 
room temperature and the injected volume was always 1 mi. 
Injection of 1 ml of0.9% NaCl at room temperature did not 
elicit reflex changes. In six preliminary experiments we found 
that no tachyphylaxis occurred following repeated adminis-
tration of 5-HT and nicotine and the reproducibility of each 
type of stimulation was good. 
We used doses of 5-HT and nicotine which produced a 
decrease of at least 30% in either heart rate or RSNA. Two 
minutes after administration of 5-HT or nicotine i. pc. the 
drugs were washed out with 20 ml 0.9% NaCl warmed to 
37° C. The interval between two injections was 30 min. The 
antagonists MDL 72222 and hexamethonium were applied 
i.pc. 2 min before application of 5-HT or nicotine. The 
dose of MDL 72222 was increased (0.1-10 llgfkg) until it 
reduced or abolished the reflex effects of 5-HT. 30 min later 
this blocking dose of MDL 72222 was injected i.pc. again 
and its effect on the reflex changes of nicotine investigated. 
In another series of experiments the dose of hexamethonium 
was increased (10-40 llgfkg) until the reflex effects of 
nicotine were abolished or greatly diminished. After 30 min 
this blocking dose of hexamethonium was applied i.pc. again 
and its effect on the reflex effects of 5-HT was studied. 
Statistical analysis. Data are given as mean values ± stan-
dard error of the mean. Student's t-test for paired observa-
Table 1. Intrapericardial doses of 5-HT needed to elicit a decrease 
of at least 30% in either heart rate or RSNA and the corresponding 
intrapericardial doses of MDL 72222, which blocked the reflex 
No. of Dose of5-HT Dose of MDL 72222 
animal (llgfkg) (Jlgfkg) 
1 20 1 
2 30 0.1 
3 60 1 
4 60 1 
5 70 1 
6 80 0.1 
7 80 0.5 
8 80 1 
9 80 10 
10 100 1 
11 130 1 
12 200 0.5 
13 300 1 
In cats 14-19 the blocking agent was hexamethonium and results 
are shown in Fig. 6 
tion was used to assess the significance of differences of 
mean vahies. 
Results 
Effects of 5-HT 
5-HT was administered i.pc. in 29 cats, which showed a 
variable sensitivity for 5-HT: in 10 of the 29 cats 5-HT failed 
to produce reflex effects to doses up to 300 llgfkg. It cannot 
be excluded that higher doses would have initiated a reflex. 
Nevertheless in alii 0 cats pronounced reflex responses could 
be elicited when 5-HT was injected i.v. in doses from 15 to 
300 llgfkg. 
In the remaining 19 cats 3 different types of reflex effects 
were observed: a decrease in RSNA, bradycardia and a fall 
in blood pressure (Figs. 1-3 and 6). The dose of 5-HT 
required to cause at least a 30% decrease in heart rate or 
RSNA varied from 20 to 300 llgfkg. To assure that the 
observed reflex effects were mediated via vagal afferent 
fibres, vagotomy was performed in 6 animals. After this 
procedure the 5-HT-induced decreases in RSNA, heart rate 
and blood pressure were abolished and 5-HT caused 
tachycardia (Fig. 1, Table 2). 
In 3 of the vagotomized cats propranolol (0.5 mgfkg) 
and phentolamine (1 mgfkg) were administered jointly i.v. 
This lowered mean arterial blood pressure from 
108 ± 22 mm Hg to 70 ± 25 mm Hg and decreased heart 
rate, but the 5-HT-induced increase in heart rate persisted 
(Table 2). 
In the other 3 vagotomized cats i.v. administration of 
phenoxybenzarnine ( 5 mgfkg) led to a fall in mean arterial 
blood pressure from 150 ± 15 mm Hg to 77 ± 6 mm Hg, 
while heart rate increased (Table 2). The pretreatment with 
phenoxybenzarnine abolished the 5-HT mediated tachy-
cardia (Table 2). 
Effects of nicotine 
Nicotine in a dose of 10 or 20 11g/kg consistently elicited 
decreases of RSNA, heart rate and blood pressure in each 
animal (Figs. 4, 5). 
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Fig.2 
Reversible blockade of the reflex 
effect of5-HT by MDL 72222. (BP) 
arterial pressure; (HR) heart rate; 
(RSNA) renal sympathetic nerve 
activity 
c 1 n c I n c I n 
Selective blockade of the reflex effects of 5-HT 
by MDL 72222. (MAP) mean arterial pressure, 
(HR) heart rate, (RSNA) renal sympathetic nerve 
activity. C control; I average value for the period 
of 1 to 15 s after the administration of 5-HT; 
n = 13 *o<OOS <SC n ~tSEM II average value for the period of 16 to 30 s after 
the administration of 5-HT; n = number of cats 0 p < 0.05 vs sam~ period before MOL 72222 
Blockade by MDL 72222 of the reflex effects of 5-HT 
I.pc. administration of MDL 72222 did not change RSNA, 
heart rate and blood pressure, but greatly diminished or 
abolished the response in RSNA, heart rate and blood pres-
sure to 5-HT (Figs. 2, 3). With the exception of one exper-
iment (cat no. 9 in Table 1) we found that 1 11g/kg MDL 
72222 was sufficient to block the reflex effects of 5-HT; 
sometimes a blockade could be obtained with even lower 
dosages (Table 1). The inhibitory effect of MDL 72222 was 
reversible; after washing the pericardia! sac with 0.9% NaCl 
the reflex could be induced again with 5-HT. Reversibility 
of blockade was even observed when the concentration of 
MDL 72222 was unusually high (Fig. 2). 
The response in heart rate to 5-HT was biphasic in the 
absence of MDL 72222; following the bradycardia there was 
a trend to a positive chronotropic response. Heart rate fell 
from 215 ± 6 to a minimum of 125 ± 14 beats/min and 
reached a value of 227 ± 6 beats/min after 2 min. This late 
tachycardia became significant when the bradycardia was 
abolished by MDL 72222; heart rate significantly increased 
from 210 ± 7 to 235 ± 4 beats/min after 2 min (p < 0.05, 
n = 13). 
Lack of effect of MDL 72222 on the nicotine-induced reflex 
The dose ofMDL 72222, (0.1-10 !lgfkg) which blocked the 
reflex effects of 5-HT did not alter the reflex response to 
nicotiUe (Fig. 4). 
Effect of hexamethonium on the reflex effects of nicotine 
Lpc. administration of hexamethonium did not cause signifi-
cant changes in RSNA, heart rate and blood pressure. A 
dose of 10 to 40 11gfkg hexamethonium greatly diminished 
the nicotine-induced bradycardia, decrease in RSNA and 
fall in blood pressure (Fig. 5). 
Hexamethonium does not block the 5-HT induced reflex 
The dose of hexamethonium, which diminished the reflex 
response to nicotine did not change the fall in heart rate and 
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of Fig. 3 
Table2 
Effect of vagotomy and combinations witb 
propranolol, phentolamine and phenoxy-
benzamine on tbe positive chronotropic 
response to 5-HT 
Before 5-HT 
2 min after 5-HT 
Before 5-HT 
2 min after 5-HT 
blood pressure and the inhibition of RSNA induced by 5-
HT(Fig. 6). 
Discussion 
Our experiments demonstrate that 5-HT can induce pro-
nounced reflex effects by stimulation of epicardial receptors. 
The reflex response includes a bradycardia as well as an 
inhibition of RSNA and a fall in blood pressure. All 3 
responses were abolished by vagotomy, indicating that the 
decrease in RSNA is also mediated by excitation of sensory 
vagal afferents, as already known for the bradycardia and 
early hypotension elicited by i.v. administration of 5-HT 
(Cornroe eta!. 1953; Schneider and Yonknian 1954; Kotte-
goda and Mott 1955). 
We assume that sympathetic inhibition is not restricted 
to the renal bed because: (1) the reflex pattern of other 
chemical agents like nicotine includes a strong vasodilata-
tion in the skeletal muscle (6berg and Thoren 1973) and (2) 
Kottegoda and Mott (1955) described an increase in blood 
n Heart rate (beats/min) 
Control Vagotomy Vagotomy+ 
0.5 mgfkg i.v. propranolol + 
1 mg/kg i. v. phentolamine 
218± 14 217± 9 185± 9 
248± 8 248 ± 11 230±25 
n Heart rate (beats/min) 
Control Vagotomy Vagotomy+ 
5 mg/kg i.v. phenoxybenzamine 
217 ± 16 227± 9 250 ± 18 
235±46 262± 11 245 ± 15 
flow in the eat's hind limb ilfter i.v. injection of 5-HT, which 
persisted after administration of atropine but was abolished 
by vagotomy. We also found that ip.c. 5-HT reduced efferent 
nerve activity in cardiac nerves (Born et a!. 1985). These 
fmdings suggest that sympathetic inhibition as well as 
bradycardia contribute to the early fall in blood pressure 
induced by 5-HT. 
Page (1952) .and Cornroe et a!. (1953) observed a con-
siderable variability in the sensitivity of cats to 5-HT injected 
i.v. Our data also show that the sensitivity of cats to 5-HT 
administered i.pc. was very variable: in 10 of 29 cats no 
reflex effects could be induced, while the reniaining 19 cats 
required doses from 20 to 300 11g/kg to show clear reflex 
responses. In all the cats without reflex response to 5-HT 
i.pc., marked reflex responses were obtained when 5-HTwas 
administered i.v. A general lack of receptors sensitive to 
5-HT is therefore unlikely. 
One explanation for the variable sensitivity for 5-HT 
might be a quite different number and distribution of 5-
HT receptors on the epicardial surface of individual cats. 
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Although we know the total dose of 5-HT injected i.pc., 
variability in actual 5-HT concentrations due to differences 
in the quantity of pericardia! fluid in the respective heart 
regions is possible. These factors could also account for 
the variability of the reflex responses. These explanations, 
however, appear unlikely because cats should have shown 
the same variability in sensitivity to the blocking agent MDL 
72222 and this was not observed. Another explanation could 
be an interaction of a vagal depressor response and a coun-
teracting sympathetic reflex. Reimann and Weaver (1980) 
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reported that epicardial application of bradykinin, which is 
able to stimulate vagal as well as sympathetic afferent fibers, 
leads to variable reflex responses in cats. They observed 
excitatory responses, inhibitory responses or no changes in 
blood pressure and RSNA, whereas the response was always 
inhibitory after thoracic sympathectomy and always ex-
citatory after vagotomy. Therefore they assumed that the 
varying responses of individual cats depended on the relative 
density of sympathetic and vagal receptors accessible to 
the chemical or the relative excitability of the two afferent 
38 
groups. The same could be true for 5-HT because this sub-
stance does not ouly stimulate vagal afferent fibres but also 
cardiac afferent sympathetic fibres (Uchida et aL 1969). 
However, the participation of afferent sympathetic fibres 
appears unlikely for 2 reasons: ( 1) we never saw an excitatory 
response in the intact animal and (2) even after vagotomy 
none of the six cats showed an increase in blood pressure 
and RSNA. Zimpfer eta!. (1981) described a depression of 
chemoreceptor reflex responses with the anaesthetic 
IX-chioralose in dogs. Although there was no difference re-
garding doses of IX-chloralose among cats in our experiments, 
a different sensitivity to IX-chloralose leading to varying re-
flex responses might be an explanation for the variability in 
the sensitivity to 5-HT _ 
To block the reflex effects of 5-HT we used the 5-HT 
antagonist MDL 72222, which has been shown to block 
selectively: (1) the excitatory action of 5-HT on sympathetic 
nerve terminals of the rabbit heart (Fozard and Gittos 1983), 
(2) the rapid response of cat carotid body chemoreceptors to 
5-HT (Kirby and McQueen 1984) and (3) the 5-HT induced 
depolarization in the nodose ganglion and the superior 
cervical ganglion of the rabbit (Azarni et a!. 1985). F ozard 
(1984) also reported a marked attenuation by MDL 72222 
of the heart rate and blood pressure response of the rat to 
i.v. 5-HT. 
We were able to prevent the reflex effects of 5-HT by 
MDL 72222, whereas the reflex effects of nicotine were 
unchanged. This evidence is compatible with a selective 
blockade of vagal 5-HT receptors of the M-type (Gaddum 
and Picarelli 1957; Fozzard 1984; Richardson et aL 1985) 
by MDL 72222. 
MDL 72222 selectively inhibited the positive chrono-
tropic response to 5-HT in the isolated rabbit heart (Fozard 
1984). In contrast, we found in the cat that marginal 
tachycardia developed with 5-HT, which became more pro-
nounced when the bradycardic response to 5-HT was 
blocked by MDL 72222 or vagotomy. Therefore, MDL 
72222 is not an antagonist at the receptor site responsible 
for the tachycardia in the cat. This is in agreement with 
the earlier fmdings of Trendelenburg (1960), who showed 
striking differences in the mechanism by which 5-HT induces 
a positive chronotropic response in the isolated atrium of 
rabbit and cat. 
In the rabbit 5-HT seems to act by a release of 
noradrenaline from sympathetic nerve endings because the 
effects were prevented by reserpine pretreatment, whereas 
in the cat reserpine had no specific effects against 5-HT. This 
indicates that the positive chronotropic action of 5-HT in 
the cat is not mediated by endogenous catecholarnines. In 
analogy to these experiments on isolated tissues we were not 
able to block the 5-HT mediated tachycardia in the cat by 
the IX-receptor antagonist phentolamine and the P-receptor 
antagonist propranoloL Kaumann (1983, 1985a, b) has 
shown that the positive chronotropic effects of 5-HT on 
isolated kitten atria are irreversibly blocked by phenoxy-
benzarnine. We confirmed this in vivo in three experiments 
in vagotomized cats where 5-HT did not induce an increase 
in heart rate after administration of phenoxybenzarnine. 
The nature of myocardial 5-HT receptors is not com-
pletely understood. 5-HT has a relatively low affinity for cat 
sinoatrial receptors (Kaumann 1983, 1985a, b) suggesting 
involvement of 5-HT 2-receptors. However concentrations 
of ketanserin saturating 5-HT 2-receptors do not antagonize 
the positive chronotropic effects of 5-HT in kitten atria, 
ruling out their 5-HT ,-nature. 
Surprisingly, some drugs with high affmity for 5-HT 1-
receptors also do not antagonize the positive chronotropic 
effects of 5-HT in kitten atria. Thus it has been concluded 
that sinoatrial 5-HT receptors of kitten heart are neither 5-
HT1 nor 5-HT2 (Kaumann 1985a, 1986). 
The nicotinic antagonist hexamethonium selectively 
blocked the reflex effects of nicotine, but did not change the 
responses in heart rate, RSNA and blood pressure to 5-
HT. Hexamethonium applied i.pc. did not change control 
conditions in heart rate, blood pressure and RSNA. The 
dosage was too low to block transmission in sympathetic 
ganglia if absorption would have occurred, but it might have 
blocked transmission in parasympathetic ganglia, which are 
situated in the subepicardial region. This is unlikely for 
2 reasons: (1) heart rate did not rise after application of 
hexamethonium and (2) the bradycardia induced by 5-HT 
was unchanged after application 'of hexamethonium. 
We conclude that reflex bradycardia and reflex decrease 
ofRSNA can be elicited on epicardial sensory vagal afferents 
by specific activation ofM-receptors with 5-HT or of nico-
tinic receptors with nicotine. 
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5-Hydroxytryptamine-induced tachycardia in the pig: 
possible involvement of a new type of 
5-hydroxytryptamine receptor 
A.H. Born, * D.J. Duncker, 1 P.R. Saxena & * P.D. Verdouw 
Department of Pharmacology and *Laboratory for Experimental Cardiology (Thorax Centre), Erasmus 
University Rotterdam, P.O. Box 1738,3000 DR Rotterdam, The Netherlands 
1 The mechanism of 5-hydroxytryptamine (5-HT)-induced tachycardia is species-dependent and is 
mediated directly or indirectly either by '5-HT1-Iike' (cat), 5-HT2 (rat, dog) or 5-HT3 (rabbit) recep-
tors, or by an action similar to tyramine (guinea-pig). The present investigation is devoted to the 
analysis of the positive chronotropic effect of 5-HT in the pentobarbitone-anaesthetized pig. 
2 Intravenous bolus injections of 5-HT (3, 10 and 30 pgkg- 1) in pigs resulted in dose-dependent 
increases in heart rate of 24 ± 2, 38 ± 3 and 51 ± 3 beats min_,, respectively (n = 39). Topical 
application of a high concentration of 5-HT (150pgkg- 1 in 5ml) on the right atrium was also 
followed by tachycardia (38 ± 6 beats min- 1, n = 4). 
3 A number of drugs which antagonize responses mediated by different 5-HT receptors - phe-
noxybenzamine, methiothepin, metergoline, methysergide and mesulergine ('5-HT,-Iike' and 5-HT2 
receptors), ketanserin, cyproheptadine, pizotifen and mianserin (5-HT 2 receptors), and MDL 72222 
and ICS 205-930 (5-HT 3 receptors)- did not attenuate the chronotropic responses to 5-HT. 
4 The 5-HT-induced tachycardia was also not affected by antagonists at ex- and P-adrenoceptors, 
muscarinic, nicotinic, histamine and dopamine receptors, and calcium channels. 
5 Selective inhibitors of 5-HT-uptake, indalpine and fluvoxamine, themselves increased porcine 
heart rate and facilitated 5-HT-induced tachycardia both in magnitude and in duration. 
6 A number of putative selective agonists at '5-HT 1-like' receptors or their possible subtypes (5-
carboxamidotryptamine (5-CT), 8-hydroxy-2-(di-N,N-n-propylamino) tetralin (8-0H-DPAT), BEA 
1654 and RU 24969), or at 5-HT 3 receptors (2-methyl-5-HT), elicited no or only a weak tachy-
cardiac response in the pig. RU 24969, but not 8-0H-DPAT, seemed to potentiate the responses to 
5-HT, whereas 5-CT slightly inhibited these responses. 
7 It was concluded that the tachycardia induced by 5-HT in the pig does not involve the receptors 
for some common neurotransmitter substances but may be mediated by a new 5-HT receptor type 
that is clearly different from '5-HT1-Iike', 5-HT2 or 5-HT3 receptors. 
Introduction 
Intravenous bolus injections of 5-hydroxytryptamine 
(5-HT) result in a transient decrease in heart rate 
(Page, 1958) due to a chemoreceptor reflex (von 
Bezold-Jarisch reflex) initiated by the stimulation of 
receptors on sensory vagal afferent fibres (Paintal, 
1973). In the rat (Fozard, 1984; Richardson et al., 
1985) and the cat (Saxena et al., 1985a) the brady-
cardiac effect has been shown to be mediated by 
5-HT 3 receptors (for nomenclature of 5-HT recep-
tors, see Bradley et al., 1986; Saxena et al., 1986b). 
1 Author for correspondence. 
5-HT can also increase heart rate in a variety of 
non-mammalian and mammalian species, including 
man (Page, 1958; Hollander et al., 1957; LeMessu-
rier et al., 1959). The tachycardiac action of 5-HT 
has been analysed in some species and it involves 
several different mechanisms (frendelenburg, 1960; 
Saxena, 1986). In the cat 5-HT-induced tachycardia 
is mediated by myocardial '5-HT1-Iike' receptors (Saxena et al., 1985a; Connor et al., 1986), and in the 
rat (Saxena & Lawang, 1985; Gothert et al., 1986) 
and the dog (Feniuk et al., 1981) 5-HT2 receptors, 
,present on the myocardium and adrenal medulla, 
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respectively, seem to be involved. The third 5-HT 
receptor type characterized so far (5-HT 3 receptor), 
located on the postganglionic cardiac sympathetic 
fibres, mediates the effects of 5-HT in the rabbit 
(F ozard, 1984) while, in the guinea-pig, tachycardia 
has been attributed to P-adrenoceptors (Eglen et al~ 
1985), probably activated by catecholamines released 
via a tyramine-like action (De Boer et aL, 1986; 
Dhasmana et aL, 1988). High concentrations of 5-HT 
can also cause tachycardia by such a mechanism in 
the rat (Gothert et al~ 1986) and in the hamster 
(Gonzalez Alvarez & Garcia Rodriguez, 1971). 
In the present experiments the increase in heart 
rate caused by 5-HT in the pig has been investigated 
and the results reveal the involvement of a mecha-
nism which is different from those proposed so far 
(see above). Preliminary results of this investigation 
were communicated to the British Pharmacology 
Society (Duncker et al., 1985). 
Metbocls 
General 
After an overnight fast, 42 young Yorkshire pigs (25-
30 kg, 12-16weeks old) were initially sedated with 
120mg (i.m.) azaperone and 12().-150mg (i.v.) meto-
midate. After the animals had been intubated, they 
were connected to a respirator for intermittent posi-
tive pressure ventilation with a mixture (1 : 2) of 
oxygen and nitrous oxide. The anaesthesia was 
maintained with a continuous infusion of pentobar-
bitone sodium (15-20mgkg- 1 h- 1, i.v.). Aortic 
blood pressure was recorded with a Statham pres-
sure transducer via a cannula inserted into the left 
femoral artery. All drugs were injected into the left 
femoral or jugular vein cannulated for this purpose. 
The animal's temperature was maintained around 
37oc by using an electric blanket and arterial blood 
gasses and pH were kept within the normal limits 
(Po2 > 90mmHg; Pco2 3().-40mmHg; pH7.35-7.45) 
by adjusting respiratory rate and tidal volume or by 
infusing 4.2% sodium bicarbonate solution. 
Experimental protocol 
After the animals had been in a stable haemo-
dynamic condition for at least 30min, bolus injec-
tions of 5-HT (3, 10 and 30pgkg-', i.v.) were given 
at intervals of 1().-15min. Subsequently, one of the 
several antagonist drugs (for names, doses and 
number of experiments, see the Drug and Results 
sections), used to analyse the positive chronotropic 
effects of 5-HT, was slowly administered over two 
minutes. About 10min later, the responses to the 
three doses of 5-HT were elicited again. In initial 
experiments it was noticed that several drugs, in 
doses sufficient for the purpose for which they were 
employed, did not modify the effects of 5-HT. There-
fore, in order to restrict the number of animals to be 
used for this investigation, it was decided to use 
more than one such drug, rather than several doses 
of a particular drug, in any single experiment. The 
order of their use was varied and a total of 30 
animals was used for the above purpose. Further-
more, in 3 animals the reproducibility of the 5-HT-
induced tachycardia was checked after a period of 
2h. 
In 13 animals (12 new and 1 from the above 
group) the effect of some drugs thought to be selec-
tive agonists at different 5-HT receptors was studied. 
Lastly, after the above experiments had been com-
pleted, on 4 occasions 5-HT was administered locally 
on the surface of the right atrium. 
Data presentation and analysis 
All data in the text and tables, unless otherwise 
stated, are presented as mean ± s.e. mean. The peak 
change in heart rate by the different doses of 5-HT 
(and other putative 5-HT receptor agonists) were 
recorded. The mean ± s.e. mean increases in heart 
rate by the three doses of 5-HT just before and after 
a particular antagonist drug were compared by use 
of Duncan's new multiple range test, once an 
analysis of variance (randomized block design) 
revealed that the samples represented different popu-
lations (Saxena, 1985). A P value of 0.05 or less (two-
tailed) was considered statistically significant. 
Drugs 
The following drugs used in this study were kindly 
supplied by the sources mentioned: atropine sul-
phate (Pharmacy Department, Erasmus University 
Rotterdam, Rotterdam, The Netherlands), 5-
carboxamidotryptamine maleate (5-CT; Dr W. 
Feniuk, Glaxo, Ware, U.K.), cimetidine hydro-
chloride (Smith Kline & French, Welwyn Garden 
City, U.K.), cyproheptadine hydrochloride (Merck, 
Sharpe and Dohme, Haarlem, The Netherlands), fiu-
voxamine maleate (Dr W. Wouters, Duphar, Weesp, 
The Netherlands); haloperidol base (Janssen Phar-
maceutica, Beerse, Belgium), histamine phosphate 
(Pharmacy Departlnent, Erasmus University Rot-
terdam, Rotterdam, The Netherlands), 8-hydroxy-2-
(di-N,N-n-propylamino)tetralin (8-0H-DPAT; Dr 
J.R. Fozard, Merrell Dow Research Institute, Stras-
bourg, France), indalpine base (Dr A. Uzan, Phar-
muka Laboratories, Gennevilliers, France), 
isoprenaline sulphate (Pharmacy Departlnent, 
Erasmus University Rotterdam, Rotterdam, The 
Netherlands), ketanserin tartrate (Dr· J.M. Van 
Neuten, Janssen Phannaceutica, Beerse, Belgium), 
mepyramine maleate (Rhone-Poulenc, Paris, 
France), noradrenaline bitartrate (Pharmacy Depart-
ment, Erasmus University Rotterdam, Rotterdam, 
The Netherlands), mesulergine hydrochloride (Dr G. 
Engel, Sandoz, Basle, Switzerland), metergoline base 
(Farmatalia Carlo Erba, Torino, Italy), methiothepin 
methane-sulphonate (Hoffman La Roche, Mijdrecht, 
The Netherlands), 5-methoxy-3-(1,2,3,6-tetrahydro-4-
pyridinyi-1H-indole succinate (RU 24969; Roussel 
Laboratories, Hoevelaken, The Netherlands), 2-
methyl-5-hydroxytryptamine maleate (2-methyl-5-
HT; Dr W. Feniuk, · Glaxo, Ware, U.K.), 
methysergide hydrogen maleate (Sandoz, Basle, 
Switzerland), mianserin hydrochloride (Organon, 
Oss, The Netherlands), pizotifen maleate (Sandoz, 
Basle, Switzerland), phentolamine hydrochloride 
(Ciba-Geigy, Basle, Switzerland), phenoxybenzamine 
hydrochloride (dibenzyline; Smith Kline & French, 
Philadelphia, U.SA.), propranolol hydrochloride 
(Imperial Chemical Industries, Rotterdam, The 
Netherlands), lotH,3ot,5otH-tropan-3yl-3,5-dichloro-
benzoate (MDL 72222; Dr J.R. Fozard, Merrell 
Dow Research Institute, Strasbourg, France), (3ot-
tropanyl)-1H-indole-3-carboxylic acid ester (ICS 
205-930; Dr G. Engel, Ludwigshafen, F.R.G.). Other 
drugs were purchased: 1,1-dimethyl-4-phenyl-
piperazinium iodide (DMPP; Sigma, St. Louis, 
U.SA.), 5-hydroxytryptamine creatinine sulphate 
(5-HT; Merck, Darmstadt, F.R.G.) and hexa-
methonium bromide (Fluka, Buchs, Switzerland). 
The doses mentioned in the text refer to the salts of 
substances except in the case of 5-HT and 5-CT, 
where they refer to the base. All drugs were dissolved 
in saline before injection; fresh solutions were pre-
pared for each experiment. 
Results 
Effects of 5-HT 
Intravenous bolus InJections of 5-HT (3, 10 and 
30Jlgkg- 1 ) were given in a total of39pigs where the 
baseline values of heart rate and mean arterial blood 
pressure were, respectively, 90 ± 3 beats min- 1 and 
78 ± 2 mmHg. None of the three doses of 5-HT pro-
duced consistent changes in arterial pressure and, 
therefore, they were not quantified further. Brady-
cardia due to the Bezold-Jarisch reflex, as is usual in 
several species, was also absent, probably due to the 
level of anaesthesia. These doses of 5-HT, however, 
induced dose-dependent increases in heart rate of 
24 ± 2, 38 ± 2 and 51± 3 beats min-•, respectively 
(n = 39). In 3 animals the reproducibility of the 
tachycardiac effects of 5-HT was tested; the increase 
in heart rate by the three doses of 5-HT were, respec-
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tively, 29 ± 2, 45 ± 2 and 65 ± 4 beatsmin- 1 and 
after an interval of 2 h: 27 ± 3, 38 ± 2 and 59 ± 2 
beats min -•. 
Topical application of a high concentration of 
5-HT (150Jlgkg- 1 in 5ml) on the right atrium was 
followed by an· increase in heart rate of 38 ± 6 
beatsmin- 1 from a basal value of 91 ± 5 beats 
min_, in 4 pigs. 
Tachycardiac effects of 5-HT after some antagonist 
drugs 
To study the involvement of the three types of 5-HT 
receptors the effects of non-selective ('5-HT 1-like' 
and 5-HT2 : phenoxybenzamine, methiothepin, 
metergoline, methysergide and mesulergine) and sel-
ective ( 5-HT 2 : ketanserin, cyproheptadine, pizotifen 
and mianserin; 5-HT3 : MDL 72222 and ICS 205-
930) 5-HT receptor antagonists were studied. None 
of these drugs (except MDL 72222 against the lowest 
dose of 5-HT) reduced the magnitude of tachycardia 
induced by 5-HT. One such experiment involving 
MDL 72222, cyproheptadine and methysorgide is 
shown in Figure 1, while the summary of all the data 
is presented in Table 1. It may be noted that, iLstead 
of an antagonism, phenoxybenzamine (highest dose 
of 5-HT) and cyproheptadine seemed to facilitate the 
chronotropic effects of 5-HT. 
Since none of the above 5-HT antagonists was 
capable ofreducing the 5-HT-induced tachycardia, a 
number of other commonly used antagonist drugs 
were investigated. Table 2 shows that the antagonists 
at adrenoceptors, cholinoceptors, histamine and 
dopamine receptors and at voltage-dependent 
calcium channels did not modify the responses to the 
three doses (3, 10 and 30 Jlgkg- 1) of5-HT. The effec-
tiveness of phentolamine, propanolol, hexa-
methonium and mepyramine was confirmed by 
blockade of, respectively, the noradrenaline 
(1 Jlg kg- 1 )-induced pressor effect, and isoprenaline 
(O.lJLgkg- 1)-, DMPP (20Jlgkg- 1)- and histamine 
(3 Jlg kg- 1)-induced tachycardia; the responses 
before and after the antagonists involved were 
respectively: noradrenaline, 36 ± 7 and 
18 ± 4mmHg (n = 4); isoprenaline: 48 ± 2 and 
1 ± 1 beats min-• (n = 3); DMPP, 54± 17 and 
3 ± 2 beats min -• (n = 4) and histamine, 15 ± 7 and 
1 ± 1 beats min -• (n = 4). The hypotensive response 
to histamine was also antagonized by mepyramine 
(-18±2mmHg before and -2±0mmHg after 
mepyramine). Cimetidine did not antagonize the 
tachycardia caused by histamine indicating that, as 
in the cat (Owen, 1977), the histamine-induced tachy-
cardia in the pig is mediated by histamine H 1 recep-
tors, probably on the adrenal medulla. The 
hypertensive response to noradrenaline remaining 
after phentolamine was apparently due to an 
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Figure 1 The effects of 5-hydroxytryptamine (5-HT; 3, 10 and 30pgkg- 1) on heart rate in an anaesthetized pig 
before (a) and after successive administration of MDL 72222 (0.3mgkg- 1) (b), cyproheptadine (O.Smgk:g- 1) (c) and 
methysergide (O.Smgkg- 1) (d). Note that 5-HT caused a dose-dependent tachycardia which was not antagonized by 
these drugs. 
Table 1 Effects of antagonists at different 5-hydroxytryptamine (5-Hl) receptors on the 5-HT-induoed increases in 
heart rate (beats min- 1) in the pig 
Antagonist 
Phenoxybenzamine 
Methiothepin 
Metergoline 
Methysergide 
Mesulergine 
Ketanserin 
Cyproheptadine 
Pizotifen 
Mianserin 
MDL 72222 
ICS 205-930 
Dose 
(mgk:g- 1) 
1.0 
0.5 
0.5 
0.5 
0.3 
0.5 
0.5 
0.5 
0.5 
0.3 
0.3 
• P < 0.05, after vs before. 
n 
3 
6 
5 
6 
3 
4 
5 
5 
5 
4 
3 
5-HT 
3pgkg- 1 
Before After 
38 ± 13 44± 10 
22±3 21±4 
29±2 22±3 
26±3 28±3 
25±1 26±1 
20±4 18 ±4 
17±3 23±3· 
29±2 26±2 
24±2 23±2 
28±4 22±5· 
29±2 21±3 
5-HT 5-HT 
10pgkg-1 30pgkg- 1 
Before After Before After 
46 ± 10 55± 12 44±11 60±10* 
40±5 39±4 53±5 53±3 
49±3 46±6 63±4 63±6 
50±4 49±3 63±5 63±3 
40±2 45±2 52±4 56±4 
42±8 41 ±7 58±7 57±7 
40±3 45±4* 54±3 60±4* 
49±3 45±2 61 ± 5 56 ±4 
45±1 44±3 59±3 54±4 
45±4 45±5 60±5 58±6 
43 ±4 41 ±2 54±6 56±1 
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T!'hJe 2 Effects of some common antagonists on the S-hydroxytryptamine (S-HT)-induced increases in heart rate 
(beats min - 1) in the pig 
5-HT 5-HT 5-HT 
Dose 3pgkg-1 10pgkg- 1 30pgkg-1 
Antagonist (mgkg- 1) n Before After Before After Before After 
Phentolantine 1.0 5 26±4 24±6 42±4 38±6 58±5 51± 12 
Propranolol 0.5 5 24±4 27±4 43±3 43±4 60±4 60±3 
Atropine 0.5 
+ propranolol 0.5 3 37±4 35±4 50±5 51± 1 55±6 58±2 
Atropine 1.0 
+ hexamethonium 10.0 4 9±2 10±2 24± 11 37±7 32±7 53 ±8 
Cimetidine 1.0 4 38 ±5 33 ±3 48±5 47±4 58 ±5 56±6 
Mepyramine 1.0 4 31 ± 5 35 ±3 45±7 47-±5 55± 7 53± 5 
Haloperidol 1.0 3 31 ±4 35±2 45±5 46±3 51± 6 55±4 
Verapamil 0.1• 3 23±4 23±2 44±2 34±7 58 ±2 45±5 
"This dose was followed by an infusion of0.01mgkg- 1 min-1• 
increase in cardiac output, since it was eliminated 
after additional administration of propranolol. 
Lastly, indalpine and fiuvoxamine, which are 
known to interfere with the uptake of 5-HT by nerve 
terminals and blood platelets (Ciaasen et al., 1977; 
Le Fur & Uzan, 1977; Ashkenazi et al., 1983), were 
employed in an attempt to antagonize the tachy-
a Before 
150 
cardiac responses to 5-HT. However, after4ldminis-
tration of these drugs the positive chronotropic 
responses to bolus injections of 5-HT were not 
reduced, but, on the contrary, these responses were 
facilitated both in magnitude and in duration (see 
Figure 2 for indalpine and Table 3 for both indal-
pine and fiuvoxamine). Furthermore, the two 5-HT-
b After 
'00[ 
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50 • 3 ---t • 3 
I 
c: 
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Figure 2 The effects of S-hydroxytryptamine (S-HT; 3, 10 and 30pgkg- 1) on heart rate in an anaesthetized pig 
before (a) and after (b) administration ofindalpine (lmgkg- 1). It can be seen that heart rate increased after indal-
pine and that this drug potentiated the tachycardiac responses t~ S-HT. 
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Table 3 Effects of 5-hydroxytryptamine (5-HI)-uptake blockers on the 5-HT-induced increases iu heart rate 
(beats min- 1) iu the pig 
5-HT 5-HT 5-HT 
Dose 
(mgkg- 1) 
1.0 
l.O 
3pgkg- 1 10pgkg- 1 30pgkg- 1 
Antagonist 
lndalpiue 
Fluvoxamiue 
n 
3 
4 
Before After Before After Before After 
20 ± 3 48 ± 3* 30 ± 1 58± 3* 45±3 54±7* 
11±2 26±2* 21±2 40±8* 30±3 48±9* 
• P < 0.05, after vs before. 
Table 4 Effects of putative agonists of 5-hydroxytryptamine (5-Hl) receptors on the 5-HT-induced increases iu 
heart rate (beatsmiu- 1) iu the pig 
5-HT 5-HT 5-HT 
Dose 3pgkg-1 10pgkg- 1 30pgkg- 1 
Agonist (mgkg- 1) n Before After Before After Before After 
RU-24969 l.O 3 14±3 39±5* 13 ±3 41 ±5* 24±4 47± 8* 
8-0H-DPAT l.O 3 33 ± 13 33 ± 10 44±4 47±4 51±1 61 ± 12 
5-Cf 0.1 3 27±3 18±2* 38 ±2 28± 2* 59 ±2 43 ± 1* 
• P < 0.05, after vs before. 8-0H-DPAT = 8-hydroxy-2-(di-N,N-n-propylamiuo)tetralin and 5-Cf = 5-
carboxamidotryptamiue. 
uptake blockers caused a slowly developing increase 
in heart rate; the peak tachycardiac effects following 
indalpine and tluvoxamine were 49 ± 10 (n = 3) and 
10 ± 5 (n = 4) beatsmin- 1, respectively. 
Effects of some putative agonists of 5-HT 
The effects of intravenous injections of 5-Cf, 8-0H-
DPAT, BEA 1654, RU 24969 and 2-methyl-5-HT on 
the heart rate were also studied. Compared to 5-HT, 
60 
/ 
3 10 30 100 300 1000 3000 
Dose (1'-9 kg-1 ) 
Figure 3. Heart rate responses to a number of agonists 
at 5-hydroxytryptamiue {5-Hl) receptors: 5-
carboxamidotryptamiue {0, n = 4), 2-methyl-5-HT {1111, 
n = 3), 8-hydroxy-2-(di-N,N-n-propylarnino)tetralin (6, 
n = 3), RU-24969 (0, n = 4) and BEA 1654 (A, n = 3). 
Compared to 5-HT ( 8, n = 39), these agents elicited 
either no or only a slight increase in heart rate. The 
values of heart rates before administration of different 
doses of agonists varied between 74 ± S and 
96 ± 13beatsmiu-1 and did not differ significantly. 
none of these drugs had any profound effect on 
porcine heart rate (Figure 3~ In experiments with 
RU 24969, 8-0H-DPAT and 5-CT the effect of the 
highest dose of each compound was also studied on 
the heart rate responses to 5-HT. The tachycardia 
caused by 3, 10 and 30pgkg- 1 of 5-HT was poten-
tiated after administration of RU 24696 (1 mgkg- 1), 
remained unchanged after 8-0H-DPAT (1mgkg- 1) 
and was slightly inhibited by 5-Cf (0.1 mg kg - 1) (see 
Table4). 
Discussion 
Consideration of known 5-HT receptors 
Until recently 5-HT receptors had been classified on 
the basis of antagonism by dibenzyline 
(phenoxybenzamine) and morphine as 'D' and 'M' 
receptors, respectively (Gaddum & Picarelli, 1957), 
or on the basis of high binding affinity for [ 3H]-5-
HT and [ 3H]-spiroperidol as 5-HT 1 and 5-HT 2 , 
respectively (Peroutka & Snyder, 1979). However, 
neither of these classifications, though correct within 
themselves, adequately covered the pharmacological 
actions of 5-HT. Being aware of this drawback and 
prompted by the recent availability of more selective 
drug tools, Bradley et al. (1986) subdivided 5-HT 
receptors into three distinct groups named as 
'5-HT1-like', 5-HT2 and 5-HT3 • They advocated 
5-Cf ('5-HT1-like') and 2-methyl-5-HT (5-HT3) as 
selective agonists, and methiothepin and methyser-
gide ('5-HT1-like'), ketanserin and cyproheptadine (5-HT 2), and MDL 72222 and ICS 205-930 (5-HT 3) 
as antagonists. It is to be noted that while the 
antagonists for 5-HT2 and 5-HT3 are selective, the 
drugs antagonizing '5-HT clike' receptors, being 
even more effective against the responses mediated 
via 5-HT2 receptors, are not. The above agonist-
antagonist criteria are clearly fulfilled with respect to 
5-HT-induced tachycardia in the cat (5-Cf in doses 
of 0.1 to 1pgkg-• mimics, and methiothepin and 
methysergide, but not ketanserin and cypro-
heptadine, antagonize) (Saxena et al., 1985a; Connor 
et al., 1986), the rat (5-CT does not mimic and, 
ketanserin and cyproheptadine antagonize) (Saxena 
& Lawang, 1985) and the rabbit (2-methyl-5-HT 
mimics, and MDL 72222 and ICS 205-930 
antagonize) (Fozard, 1984; Richardson et al., 1985). 
However, in the present investigation in the anaes-
thetized pig, it was noticed that the above drugs 
neither mimicked nor antagonized the tachycardiac 
responses to 5-HT. Therefore, it can be concluded 
that the positive chronotropic effects of this amine in 
the pig are not mediated by either the '5-HT 1-like', 
5-HT 2 or 5-HT 3 receptors. 
Bradley et al. (1986) have pointed out that the 
receptor category denoted as '5-HT 1-like', being 
devoid of a selective antagonist, is not yet fully char-
acterized but that it appears to be heterogeneous. 
However, neither the relationship of '5-HT,-Iike' 
receptors with the 5-HT 1 binding sub-sites is clear 
nor the selectivity of drugs for the subclasses is as yet 
entirely satisfactory. Richardson & Engel (1986) have 
nevertheless attempted to subclassify '5-HT 1-like' 
receptors into three subclasses, namely 5-HT lA 
(agonists; 8-0H-DPAT and 5-Cf; antagonists: spi-
roperidol and methiothepin), 5-HT 18 (agonist: 5-Cf; 
antagonists: 21-009 and methiothepin) and 5-HT 1c (agonist: ( + )-S-oc-methyl-5-HT; antagonists; mesu-
lergine and methiothepin). Although not all of these 
drugs could be used in this investigation, the ineffec-
tiveness of 8-0H-DPAT, 5-Cf, mesulergine and 
methiothepin does not allow the effect of 5-HT on 
the porcine heart to be classified into any of the 
above putative, though not yet convincingly charac-
terized, subclasses. The above conclusion is further 
supported by the finding that some more drugs 
which have affinities for 5-HT binding sites - phe-
noxybenzamine and metergoline (5-HT, and 5-HT2 ; 
Peroutka & Snyder, 1979; Leysen et al., 1981), pizo-
tifen (5-HT2 ; Leysen et al., 1981; Hoyer et al., 1985), 
BEA 1654 (5-HT,A; Verdouw et al., 1985; Middle-
miss, unpublished), RU 24969 (5-HT,A and 5-HT18; 
Hoyer et al., 1985) and mianserin (5-HT 2 and 
5-HT 16 Hoyer et al., 1985) - were all ineffective in 
our experiments. 
Lastly, it has to be remarked that the doses of the 
compounds used were equal to or greater than those 
found effective in our earlier experiments concerning 
analyses of functional 5-HT receptors (see Saxena & 
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Verdouw, 1982; 1984; 1985; Saxena et al., 1985a,b; 
1986a; Saxena & Lawang, 1985; Verdouw et al., 
1984; 1985). These doses also appear to be sufficient 
on the basis of their estimated affinity constants (see 
Hoyer et al., 1985; Richardson & Engel, 1986). 
Consideration ofnon-5-HT ~chanisms 
Since the chronotropic response to 5-HT could not 
be classified into any of the above categories, some 
common non-5-HT mechanisms were considered. 
The involvement of baroreceptors was ruled out by 
the fact that the changes in blood pressure were 
inconsistent and that instillation of 5-HT, though 
admittedly in a high concentration, on the right 
atrium also raised heart rate. Moreover, tachy-
cardiac responses of similar magnitude were 
obtained in animals after complete ganglion 
(hexamethonium+ atropine) or sympathetic and 
parasympathetic (propranolol + atropine) blockade. 
The use of atropine, hexamethonium, phentolamine 
and propranolol also precluded the involvement of 
the muscarinic and nicotinic receptors, oc- and P-
adrenoceptors and the release of catecholarnines (by 
a tyramine-like action) in the mechanism of tachy-
cardia produced by 5-HT in the pig. 
Similarly, the increase in heart rate by 5-HT in the 
pig was' not mediated by histamine H 1 and H 2 or 
dopamine receptors because the respective antago-
nists - mepyramine, cimetidine and haloperidol -
were also incapable of modifying the responses to 
5-HT. 
Does a new type of 5-HT receptor mediate 
5-HT-induced tachycardia in the pig? 
The inability to find a specific mechanism 
responsible for the positive chronotropic action can 
suggest that 5-HT may be taken up into some 
neurone to displace a neurotransmitter agent (other 
than those mentioned above: noradrenaline, acetyl-
choline, histamine and dopamine). If an unidentified 
neurotransmitter is indeed displaced and released by 
5-HT, this would involve an uptake process that is 
distinct from the one selectively inhibited (m the 
brain and blood platelets) by indalpine (Le Fur & 
Uzan, 1977; Ashkenazi et al., 1983) and fiuvoxarnine 
(Oaasen et al., 1977) since these drugs increased (not 
reduced) the magnitude and duration of 5-HT-
induced tachycardia. Though such a possibility 
cannot be entirely dismissed, it is perhaps more 
likely that the tachycardia elicited by 5-HT is medi-
ated by a receptor type which is different from those 
characterized so far, i.e. '5-HT,-Iike', 5-HT2 or 
5-HT 3 receptors (Bradley et al., 1986; Saxena et al., 
1986b). This 5-HT receptor, apparently not much 
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dependent on extracellular calcium as indicated by 
the ineffectiveness of verapamil, may resemble the 
one that mediates either the positive inotropic effect 
of 5-HT in the kitten isolated papillary muscle 
(Kaumann, 1985; 1986) or the slow depolarization of 
myenteric type II/ AH neurones in the guinea-pig 
small intestine (Mawe et al~ 1986). In the kitten iso-
lated papillary muscle the responses to 5-HT, unlike 
that in the kitten isolated atria (Kaumann, 1985; 
1986) or the cat heart in vivo (Saxena et al., 1985a; 
Connor et al., 1986), are neither mimicked by 5-CT 
nor antagonized by methysergide or phenoxybenza-
mine. Similarly, the above 5-HT receptor in the gut 
is insensitive to ICS 205-930 or lysergide, but is 
antagonized by dipeptides of 5-hydroxytryptophan 
and excited by hydroxylated indalpines (Mawe et al., 
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Chapter 6: ARTERIOVENOUS ANASTOMOTIC BLOOD FLOW IN THE 
PORCINE CAROTID CIRCULATION 
1. Anatomical localization, 
Arteriovenous anastomoses form direct connections between the large 
arterioles and venules, thereby bypassing the capillary bed. Using 
radioactive microspheres it has been shown that in the carotid circulation 
of the anaesthetized pig the entrapment of microspheres increases with 
microsphere size in the ears and the skin, whereas in the brain, muscles, 
tongue, bones, eyes, fat and salivary glands no enlarged entrapment is 
observed, suggestive for the presence of relatively small arteriovenous 
anastomoses in the ears and skin (Saxena & Verdouw, 1985a). However, 
using the largest microspheres (diameter: 35 pm), the arteriovenous shunt 
flow was only reduced by 16 % compared to the shunt flow measured with 
15 pm microspheres, showing that the majority of arteriovenous shunt 
flow occurs through relatively large arteriovenous anastomoses. The 
localization of these blood vessels is still not clarified, but they are most 
likely located in the ears, the skin, the tongue, the lips and the nasal 
mucosa. From studies in other species (Hales, 1974; Marcus et al., 1976; 
Fan et al., 1979) it is known that only a small amount of 15 pm 
microspheres can be retrieved in cerebral venous blood, showing that the 
blood flow through arteriovenous anastomoses in the brain is probably 
very low. Since the dura mater is draining on the same venous system, 
blood flow through arteriovenous anastomoses in this tissue is probably 
very low. 
2. Innervation 
In conscious pigs arteriovenous blood flow is very low at an ambient 
temperature of 20°C (Verdouw et al., unpublished results), but during 
anaesthesia arteriovenous blood flow increases, resulting in a shunting of 
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70-80 % of the total carotid blood flow. This could be explained by a 
reduction in sympathetic outflow to the blood vessels, resulting in a 
decrease in vascular tone. However, electrical stimulation of the 
cervical sympathetic nervous system did not reduce the arteriovenous 
anastomotic blood flow (Verdouw et al., 1984a). Furthermore, intracarotid 
infusions of noradrenaline were also ineffective. Only intracarotid bolus 
injections of noradrenaline or clonidine caused a temporary decrease in 
shunt flow, which could be antagonized with phentolamine, whereas 5-HT 
caused a marked decrease in shunt flow (Saxena & Verdouw, 1982), 
indicating that the low potency of noradrenaline cannot be explained by 
an action of the anaesthesia on the vascular smooth muscle cells. 
3. Physiological role 
Arteriovenous anastomoses play an important role in thermoregulation. 
Thermoregulatory responses are under control of the hypothalamus, which 
receives information about temperature changes in the periphery from 
thermoreceptors in the skin and spinal cord, which is integrated with 
information from central thermoreceptors located in the hypothalamus 
itself. An increa~e in body temperature above a certain set-point will 
result in a scala of heat loss responses: blood is redistributed from the 
core of the body to the periphery; sweating (but not in the pig), followed 
by evaporation; panting; behavioural changes: reduction in muscular 
activity, resting in the shadow, saliva spreading on the fur. 
An increase in arteriovenous anastomotic blood flow in the hind limb 
occurs during spinal heating in sheep (Hales et al., 1982), whereas spinal 
cooling results in a decrease in shunt flow. In this species adrenergic 
pathways play a role in this mechanism, which is mainly mediated by 
a-adrenergic receptors. 
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4. Pathophysiology. 
In 1969 Heyck demonstrated in 7 patients that the arteriovenous oxygen 
saturation difference between arterial and jugular venous blood decreases 
during migraine attacks. In 6 patients he repeated these measurements 
after the relief of the attack (either spontaneously or after 
dihydroergotamine treatment) and found that the arteriovenous oxygen 
saturation difference returned to normal (Heyck, 1969). It is not clear 
from this study during which phase of the migraine attack the blood 
samples were collected, nor from which type of migraine (e.g. classic or 
common migraine) the patients were suffering. Initially, Heyck explained 
his results by an opening of arteriovenous anastomoses, but later he 
emphasized that other factors can also influence the arteriovenous oxygen 
saturation difference (Heyck, 1981). Several factors (alone or in 
combination) can explain Heyck's results: 
a) opening of arteriovenous anastomoses, allowing arterial blood to go 
directly into the venous system. 
b) an increase in capillary blood flow, exceeding the metabolic 
requirements. 
c) a reduction in oxygen consumption by the cranial tissues without a 
reduction in perfusion. 
d) disturbance in the process of COz and Oz exchange. 
4.1. Opening of arteriovenous anastomoses 
Opening of arteriovenous anastomoses can explain the decrease in 
arteriovenous oxygen saturation difference, since the arterial blood is 
allowed to enter the venous system, without the exchange of oxygen and 
carbondioxide in the capillary bed. An identical theory has been 
postulated by Fontaine (1957), who reported higher oxygen saturation 
values in venous samples from the limbs of patients with varicose veins 
than in blood samples from healthy control subjects. Injections of 
radioactive iodine albumine aggregrates (Lindemayer et al., 1972) or 
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radioactive technetium labelled, 25 11m albumin microspheres (Hehne et 
al., 1974) into the femoral artery, failed to reveal evidence of 
arteriovenous shunting. This clearly shows that a decrease in 
arteriovenous oxygen saturation difference does not necessarily need to 
be caused by an increase in arteriovenous shunt flow, but can be caused 
by other factors like disturbance of the oxygen -carbondioxide exchange, 
which might occur during 'sterile inflammation' of blood vessels. In 
other clinical situations opening of arteriovenous anastomoses also 
occurs. Cervical sympathectomy causes ipsilateral miosis, ptosis, 
conjunctival hyperaemia and reddening of the skin, caused by a massive 
dilatation of arteriovenous anastomoses and to a lesser extent by 
dilatation of arterioles, but does not induce migraine. In contrast, 
cervical sympathectomy has been used successfully in the past for the 
treatment of patients with severe migraine attacks (Dandy, 1931). 
Furthermore, opening of arteriovenous anastomoses during heat stress 
does not necesarily cause migraine or headache. 
As long as perfusion pressure remains unchanged, opening of 
arteriovenous anastomoses without simultaneous dilatation of the 
arterioles will lead to a reduction of capillary blood flow. The local rise 
in venous blood pressure could even lead to stoppage of capillary blood 
flow and ischemia. However, simultaneous relaxation of the arterioles 
could prevent these effects. Both relaxation of arterioles and opening of 
arteriovenous anastomoses could therefore explain the pulsatile character 
of the migraine headache. In the past it has been suggested that 
ischemia might be the cause of the painful sensations. However, from 
skin transplantation experience it is known that the metabolic needs of 
the skin are extremely low. When ischemia would be the cause of the 
pain, one would expect that the pain should not occur only in the 
temporal area, but also in the lips, ears, tongue and nose, where both 
arteriovenous anastomoses and afferent pain fibers are abundantly present. 
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4.2 Increase in capillary blood flow 
Since many patients have a pale face during the migraine attack, Heyck 
assumed that no increase in capillary blood flow occured. However, 
changes in skin flow do not necessarily reflect changes in blood flow to 
other tissues like muscles, tongue, fat, eyes, bones, salivary glands and 
the brain as has been demonstrated in the anaesthetized pig using 
radioactive microspheres (e.g. Duncker et al., 1986). An increase in 
capillary blood flow can occur by vasodilatation by changes in 
parasympathetic and/or sympathetic nerve activity, by circulating 
vasoactive substances, by the release of vasoactive substances from the 
endothelium, or by changes in autoregulatory mechanisms. Therefore, 
the increased oxygen saturation of jugular venous blood during the 
migraine attack, as described by Heyck, can also be explained by an 
increase in capillary blood flow in certain tissues, exceeding the metabolic 
needs of the tissue. 
4.3 Reduction of oxygen consumption 
No data on oxygen consumption and carbondioxide production in cranial 
tissues of migraine sufferers are available yet. In the future, these 
biochemical processes might be studied using positron emission 
tomography. 
4.4 Disturbances in carbondioxide-oxygen exchange. 
Increased permeability of the vascular wall in certain cranial vascular 
beds will result in oedema and infiltration of plasma proteins and other 
constituants (sterile inflammation ?) , which might reduce the 
carbondioxide-ox~gen exchange between the tissue and the blood, 
resulting in an increased oxygen saturation of jugular venous blood. 
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However, despite the fact that the role of arteriovenous anastomoses in 
migraine is still unclear, it is evident that some drugs that are active in 
the treatment of migraine (like methysergide, dihydroergotamine, 
ergotamine, isomepthene, GR43175) reduce cranial arteriovenous 
anastomotic blood flow in anaesthetized animals like the cat, dog and pig 
(see Saxena, 1987; Perren et al., 1989). 
Due to the technique used, it is difficult to define, whether these drugs 
act directly on the arteriovenous anastomoses or that they act on 
certain large arterioles which are located between the small arteries and 
the arteriovenous anastomoses. Therefore, it is better to speak about 
reduction in arteriovenous blood flow instead of constriction of 
arteriovenous anastomoses. 
The fact that drugs that reduce arteriovenous anastomotic blood flow are 
also effective in migraine does not necessarily imply that there is a 
causal relationship. The receptors, which are mediating the reduction in 
shunt flow, might be also involved in the therapeutic effect of these 
antimigraine drugs, but could be located on other anatomical structures. 
5. 5-HT receptors in the cranial circulation of the pig. 
Intracarotid administration of 5-HT decreases arteriovenous anastomotic 
blood flow, whereas arteriolar blood flow increases, especially to the 
skin, which becomes bright red (Saxena & Verdouw, 1982). These effects 
are mimicked by 5-carboxamidotryptamine, which has a high affinity for 
5-HTl-like receptors. The 5-HTz antagonists ketanserin and WAL 1307 
did not cause important changes in these responses to 5-HT (Verdouw et 
al., 1984b; Saxena et al., 1986). Furthermore cyproheptadine did not 
modify the effects of 5-carboxamidotryptamine (Saxena & Verdouw, 
1985b). Methysergide and BEA 1654, compounds with a high affinity for 
5-HTl binding sites, did not cause a large increase in arteriolar blood 
flow, as seen during 5-HT or 5-carboxamidotryptamine infusions, 
suggestive for a heterogeneity of the 5-HT1-like receptors in the carotid 
vascular bed. 
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In earlier studies of our group the circulating blood volume was enlarged 
by infusion of plasma-expanders and saline, resulting in carotid blood flow 
values exceeding 200 ml min-1 (Saxena & Verdouw, 1982;1984;1985a;1 985t, 
Verdouw et al., 1984a; 1984b; 1985). Since cardiac output in anaesthetized 
pig is in the range of 2 - 2.5 1 min-1 and vertebral blood flow is also 
supplying the head, about 20-25 % of the cardiac output would perfuse 
the cranial structures, which must be considered as very high: Therefore, 
in the following studies it was decided not to follow this procedure, 
which resulted in much lower carotid blood flows (80 - 120 ml min-1), 
which are more in the range described by Buckley et al. (1979). 
Furthermore, the risk of binding of drugs to the plasma expander could 
be avoided. 
From the earlier experiments it was clear that 5-HT might act on 5-HTl-
like receptors. Therefore, the effects of the 5-HTs receptor antagonist 
MDL 72222 and the 5-HT1-like and 5-HTz receptor antagonist 
methiothepin on the 5-HT-induced changes in carotid blood flow and its 
distribution were determined (Chapter 8). 
In order to study the involvement of the putative 5-HT1A and 5-HTlB 
receptors, 8-0H-DPAT, ipsapirone (TVX Q7821) and RU 24969 
were tested in the carotid circulation of the pig (Chapter 9 & 1 0). 
Since ergotamine also possesses affinity for the 5-HTl binding sites, this 
compound was also tested in the carotid vascular bed of the cat and the 
pig (Chapter 11). 
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Chapter 7: 5-HT RECEPTORS IN THE CAROTID CIRCULATION 
1. Introduction. 
A possible role of 5-HT in migraine has been suggested after the 
observation that the urinary concentration of 5-hydroxy-indolacetic acid 
(5-HIAA), the main metabolite of 5-HT, was increased in some patients 
during migraine attacks (Sicuteri et al., 1961; Curran et al., 1965), 
indicating that the turnover of 5-HT was enhanced. Since 5-HT is mainly 
present in the gastrointestinal tract (GIT), the thrombocytes and the 
brain, changes in the 5-HT metabolism in these regions might explain this 
phenomenon. Changes in GIT motility frequently occur during migraine 
attacks (vomiting, diarrhea), which might be the reflection of changes in 
parasympathetic and/or sympathetic nerve activity. These motility 
changes could result in an enhanced release of 5-HT from 
enterochromaffin cells and 5-HT-containing neurons in the myenteric 
plexus. 5-HT will be released and transported by the portal circulation 
to the liver, where 5-HT will be metabolized by monoamine oxidase 
(MAO). Free serotonin that escapes this metabolic process will either be 
taken up by thrombocytes or will be transported to the lungs, which also 
rapidly inactivates the amine. Therefore it is very unlikely that 5-HT 
will have any effect on the arterial circulation after GIT release, but it 
might explain the high urinary 5-HIAA levels. However, thrombocytes 
transport 5-HT to every part of the circulation. Therefore, the release 
of 5-HT in the arterial system might have systemic effects. A decrease 
in thrombocyte 5-HT concentration has been described by many authors 
(see Anthony, 1987), which cannot be explained by a reduced 5-HT uptake 
by these cells (Anthony & Lance, 1975). However, plasma 
13-thromboglobuline levels increase during the attacks, indicating an 
increased release of substances from the thrombocytes (Gawel et al., 
1979). This release might be induced by "serotonin releasing factors" 
(Dvilansky et al., 1976; Mueck-Seler et al., 1979), which are still not 
characterized. The amount of 5-HT that is released from thrombocytes 
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can be estimated using the data of Anthony and Lance (1975). In a 
subject of 70 kg with a blood volume of 5000 ml and a thrombocyte 
concentration of 400,000 thrombocytes per ml, the total number of 
thrombocytes will be 2.109 • According to Anthony and Lance the 5-HT 
concentration of thrombocytes decreased from 514 to 384 ng per 109 
thrombocytes. Therefore 2 x (514-384) = 260 ng 5-HT will be released in 
a volume of 5000 ml: 5-HT concentration increase: 52 ng per liter = 0.3 
nM. Since it is very unlikely that all thrombocytes will release 5-HT at 
the same moment, and considering that 5-HT is also removed from the 
circulation by lungs, liver and vascular endothelium, this increase in 5-HT 
concentration will probably not occur. Only a local, massive release of 
5-HT from thrombocytes may have important vascular effects. 
2. Effect of 5-HT and related vasoactive agents on carotid blood flow in 
different species. 
2.1. Cat. 
Intravenous infusion of 5-HT reduces total carotid blood flow by a 
reduction in arteriovenous anastomotic blood flow, whereas arteriolar 
blood flow is almost unchanged. Intracarotid infusion of 5-HT also 
reduces arteriovenous shunt flow both in intact and spinal cats (Saxena & 
Verdouw, 1982). Furthermore, many studies have reported about the 
effects of ergotamine on the carotid circulation. Ergotamine reduces the 
number of microspheres detected in the jugular vein (Johnston & Saxena, 
1978), and reduces carotid blood flow and arteriovenous shunt flow 
(Spierings & Saxena, 1980). Dihydroergotamine mimicks the effect of 
ergotamine, whereas methysergide is ineffective (Spierings & Saxena, 
1980). Indalpine, a selective inhibitor of 5-hydroxytryptamine, reduces 
the number of microspheres in jugular venous blood, indicating a decrease 
in arteriovenous shunting, probably induced by the increased 5-HT levels 
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in the blood (Saxena & Tangri, 1983). GR43175, a selective 5-HT1-like 
receptor agonist, also reduces arteriovenous shunting in the circulation 
(Perren et al., 1989). 
2.2. Rabbit 
In anaesthetized rabbits, intra-atrial infusion of 5-HT 
(10 p.g kg-1 min-1 ) induces an increase on both extracerebral and 
cerebral blood flow despite a fall in blood pressure. In conscious 
animals, intravenous infusion of 5-HT also results in an increase in 
extracerebral and cerebral blood flow, whereas blood pressure remains 
unchanged (Saxena et al., 1977). Intravenous injection of methysergide 
in anaesthetized rabbits clearly reduces arteriovenous shunting in the 
circulation. Therefore, the subsequent response to 5-HT is markedly 
inhibited (Forsyth & Saxena, 1978). 
2.3. Dog 
Intravenous infusion of 5-HT in anaesthetized dogs causes an initial 
increase in carotid blood flow, followed by a decrease, which is related to 
the simultaneous blood pressure changes. However, carotid resistance is 
mildly decreased (Vyden et al., 1974). In cervical vagosympathectomized 
dogs intracarotid bolus injection of 5-HT causes a decrease in carotid 
blood flow, without any effect on blood pressure. Since the internal 
carotid artery and the occipital artery were ligated, the decrease in 
carotid blood flow can be related to a decrease in external carotid blood 
flow. In the same animal model ergotamine also reduces external carotid 
blood flow. After increasing doses of ergotamine the original 
5-HT-induced decrease in blood flow is converted into an increase in 
blood flow (Saxena & de Vlaam-Schluter, 1974). Using radioactive 
microspheres it has been demonstrated that the ergotamine-induced 
decrease in external carotid blood flow is mainly caused by an reduction 
in arteriovenous anastomotic blood flow, which cannot be prevented by 
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pretreatment with phentolamine and/or pizotifen, excluding the 
involvement of a-adrenoceptors, 5-HTz and histamine1 receptors. 
Methysergide also reduces total and internal carotid blood flow by an 
increase in arterial resistance (Saxena, 197 4). In isolated, internal and 
external carotid arteries it has been demonstrated that 5-HT causes a 
potent vasoconstriction in the internal carotid artery, whereas the 
external carotid artery only shows a minimal response (Chiba et al., 1978). 
However, intracarotid infusion of 5-HT causes an increase in external 
carotid blood flow in dogs with an ligated internal carotid artery, 
whereas this infusion causes a decrease in carotid blood flow in dogs with 
a ligated external carotid artery. Methysergide is able to block both 
effects. However, the a-adrenoceptor antagonist zolertine, the ganglion 
blocking agent chlorisondamine and the vasodilator diazoxide only block 
the external carotid artery response (Vidrio & Hong, 1975). 
2.4. Monkey 
Intracarotid infusions of 5-HT induce a dose-dependent reduction in 
internal and external carotid blood flow in the Macaca nemestrinas 
(Spira et al., 1978). In the same species the effects of methysergide, 
pizotifen and ergotamine have been tested (Mylecharane et al., 1978). 
Methysergide causes a transient increase in resistance in both external 
and internal carotid resistance, but complete recovery is obtained after 10 
minutes. 
The 5-HT-induced increase in external and internal carotid resistance is 
reduced after methysergide. Pizotifen has no effect by itself, but during 
intracarotid infusion of 5-HT the increase in external carotid resistance is 
enhanced, whereas the increase in internal carotid blood flow is 
attenuated. Ergotamine produces a long-lasting, marked increase in 
external carotid resistance, but a rather mild increase in internal carotid 
resistance. The effects of 5-HT on both vascular beds are therefore 
reduced. 
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In the baboon (African papiopapiogera) the effect of intracarotid 5-HT 
infusion has also been studied (Grimson et al., 1969). Total carotid 
blood flow was measured during clamping of the external carotid artery 
(measurement of internal carotid blood flow) or during clamping of the 
internal carotid artery (measurement of the internal carotid blood flow). 
5-HT causes a decrease in internal carotid blood flow, whereas the amine 
induces an increase in external carotid blood flow. In both type of 
experiments no significant changes in blood pressure were observed. 
It has been generally accepted that vascular alterations occur during 
migraine attacks. Therefore, we decided to characterize the actions of 
5-HT on the carotid circulation of the anaesthetized pig. 
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Effects of MDL 72222 and methiothepin 
on carotid vascular responses to 5-hydroxytryptamine in the pig: 
Evidence for the presence of "5-hydroxytryptamine1-like" receptors 
Pramod R. Saxena', Dirk J. Duncker 2 , Anton H. Born', Jan Heiligers 1, and Pieter D. Verdoow2 
1 Departments of Pharmacology and 2 Experimental Cardiology (Thorax Center). Erasmus University Rotterdam, 
P.O. Box 1738. NL-3000 DR Rotterdam, The Netherlands 
Summary. The present study concerns the effects of MDL 
72222 (0.5 mg · kg-•, i.v.), a 5-hydroxytryptamine3 (5-HT3) 
receptor antagonist, and methiothepin (1.0 mg ·kg-', i.v.), 
an antagonist of both 5-HT2 and "5-HT1-Iike" receptors, 
on the responses to local infusions of 5-HT (2.0 Jlg 
· kg- 1 • min- 1) on the total common carotid artery blood 
flow and its complete distribution in anaesthetized pigs. 
As reported earlier, more than 80% of the carotid blood 
bypassed the capillary circulation via cranial arteriovenous 
anastomoses, while approximately 15% and 2% was dis-
tributed to the extracerebral structures and brain, respec-
tively. The total carotid blood flow did not change or was 
moderately reduced by 5-HT, but the amine consistently 
caused a 85% reduction in arteriovenous anastomotic blood 
flow and a 5-fold increase in blood flow to the extracerebral 
tissues, mainly the skin and ears. The colour of the skin and 
ears changed to bright pink. Complete recovery from the 
effects of5-HTwas observed once the infusion was stopped. 
MDL 72222 and methiothepin did not themselves affect 
carotid haemodynamics. The responses to 5-HT were not 
modified by MDL 72222 except that the reduction of the 
total carotid blood flow by 5-HT was augmented. In 
contrast, methiothepin almost completely abolished both 
the reduction of arteriovenous anastomotic blood flow and 
the increase in tissue blood flow following 5-HT-infusion. 
The colour of the skin and ears also did not become pink. 
In conjunction with our earlier findings that the constriction 
of arteriovenous anastomoses and the dilatation of arterioles 
caused by 5-HT within the carotid territory of the pig are not 
attenuated by 5-HT 2 receptor antagonists (cyproheptadine, 
methysergide, ketanserin and WAL 1307), and are mimicked 
by agonists at ''5-HT1-Iike" receptors (5-carboxamidotrypt-
amine and BEA 1654), our results clearly establish that these 
responses are mediated by "5-HT 1-like" receptors. 
Key words: Arteriovenous anastomoses - Blood flow -
Carotid artery - 5-Hydroxytryptamine - 5-Hydroxytrypt-
amine, receptors - MDL 72222 - Methiothepin - Re-
gional blood flow - Serotonin - Skin blood flow 
Introduction 
Early studies using electromagnetic blood flow probes 
showed that drugs like mianserin, methysergide, cypro-
Send offprint requests to P. R. Saxena at the above address 
heptadine or pizotifen, which effectively block the 5-hydroxy-
tryptamine2 (5-HT 2 ) receptor-mediated constriction 
of the isolated segments of the carotid and other "large" 
conducting arteries (see Miiller-Schweinitzer and Weidmann 
1978; Cohen et aL 1983; Miiller-Schweinitzer and Engel 
1983), do not effectively antagonize the vasoconstrictor 
effect of 5-HT in the total carotid vascular bed in vivo 
(Saxena et aL 1971; Saxena 1972; Saxena and de Vlaam-
Schluter 1974; Spira et aL 1976; Mylecharane et aL 1978). 
Subsequently, studies where the entire distribution of 
common carotid artery blood flow was followed with radio-
active microspheres revealed that 5-HT, as a result of a 
constriction of arteriovenous anastomoses and a dilatation 
of arterioles (particularly in the skin and ears), causes a 
redistribution of carotid blood flow in favour of the nutrient 
(capillary) compartment at the expense of the non-nutrient 
(arteriovenous anastomotic) compartment, irrespective of 
whether the total carotid artery blood flow decreases, re-
mains unchanged or increases (Saxena 1978; Saxena and 
Verdouw 1982). The constriction of arteriovenous anasto-
moses and dilatation of arterioles within the carotid territory 
seem to involve mainly "atypical", possibly "5-HT,-like", 
receptors since the effects of 5-HT are (i) only poorly antago-
nized (arteriovenous anastomoses) or even enhanced 
(arterioles) by selective 5-HT 2 receptor antagonists, 
cyproheptadine (Saxena and Verdouw 1982), low dose 
(0.3 mg · kg -•) methysergide (Saxena and Verdouw 1984), 
and ketanserin and WAL 1307 (Verdouw et aL 1984b), and 
(ii) mimicked by 5-carboxamidotryptamine (5-CT) (Saxena 
and Verdouw 1985a) and BEA 1654 (Verdouw et aL 1985), 
both of which have a selective affinity for 5-HT 1 recognition 
sites and are considered as putative 5-HT 1 receptor agonists 
(Feniuk et aL 1981, 1984; Engel et aL 1983; Saxena and 
Lawang 1985; Verdouw et aL 1985; Charlton et aL 1986). 
For a more definitive characterization of "5-HT1-Iike" re-
ceptors, Bradley et aL (1986) have suggested that a response 
should, in addition to the above two criteria, be unaffected 
by antagonists of 5-HT3 ("M') receptors, like MDL 72222 
(Fozard 1984) or ICS 205-930 (Richardson et aL 1985) and 
be amenable to blockade by high doses of, for example, 
methiothepin (metitepine) or methysergide which, though 
having a higher affinity for 5-HT 2 recognition sites, also 
show appreciable affinity for 5-HT 1 recognition sites 
(Peroutka and Snyder 1979; Leysen et aL 1981 ). In this 
investigation, therefore, we have now studied the effects of 
MDL 72222 and methiothepin on the responses to local 
infusions of 5-HT on the carotid arteriovenous anastomoses 
and arterioles in the anaesthetized pig. 
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Materials and methods 
Exper~ent~l set-up. After an overnight fast, young 
Yorkshirep1gs (body weight: 16-29 kg, age: 12-16weeks) 
~ere sedated_with 1~0 mg (i.m.) azaperone and 120-150 mg 
(1. v.) metonudate, mtubated and connected to a respirator 
for intermittent positive pressure ventilation with a mixture 
(1: 2) of oxygen and nitrous oxide. A continuous infusion of 
pentobarbitone sodium (15-20 mg · kg- 1 · h- 1, i.v.) 
completed the anaesthesia. Aortic blood pressure was re-
corded with a Statham pressure transducer via a cannula 
i~serted into the left femoral artery. Respiratory rate and 
udal_ volume were adjusted or sodium bicarbonate (8.4%) 
was mfused to keep arterial blood gases within the normal 
ranges:90 < P0 , (mm Hg) < 150; 35 < Pco, (mm Hg) < 45. 
The anJma!'s temperature was maintained at around 37°C 
using an electric blanket. 
Distribution of common carotid blood flow. The common 
carotid arteries were dissected free and bilateral cervical 
vagosympathectomy was performed to avoid reflex in-
fluences on the carotid circulation. Blood flow in one of 
the common carotid arteries was measured with a suitable 
precalibrated blood flow probe connected to a sine wave 
electromagnetic blood flow meter (Skalar, Delft, The 
Netherlands). T~o 0.5 mm (external diameter) needles, 
connected to swtable polyethylene tubing, were inserted 
directly into the main artery for intracarotid infusions of 5-
HT and microsphere injections. The distribution of carotid 
blood flow into nutrient (tissue; capillary) and non-nutrient 
(arteriovenous anastomotic) fractions was determined with 
~e radioactive microsphere method using 15 ± 1 (S.D.) J.1l1l 
~~ameter spheres, labelled with 141Ce, 113Sn, 103Ru, 46Sc or 
Nb (NEN Company, Dreieich, FRG). For each measure-
ment a suspension of microspheres, labelled with one of the 
nuclides, was ultrasonicated and injected in 0.5 m1 saline 
over a 15-20 s period. To facilitate uniform mixing, the 
spheres were injected against the direction of tlie blood flow. 
At the end of each experiment the animal was killed with 
an overdose of pentobarbitone sodium. The various tissues 
o~ the right and left half of the head, neck muscles, heart, 
kidneys and lungs were dissected out, weighed and placed 
in vials. The radioactivity in the vials was counted for 5-
10 min in a y-scintillation counter (Packard model 5986) eq~pped with a multichannel pulse height analyser (Conrac) 
usmg suitable windows for discriminating the different 
isotopes. The microsphere and other data were processed by 
a PDP-11/70 computer using a set of specially developed 
programmes (Saxena et al. 1980). The amount of carotid 
blood distributed to the individual tissues (Q'!'r•!'') of the 
head was calculated by: Qti•[cuJ (ml · nun 0 = (! .. ,/ 
I,.,) x Q.,., where/,;,. and J,., are, respectively, the radioactiv-
ity ( c ·min- 1) in a particular tissue and that detected in 
all tissues collectively, and Q.u is carotid blood flow 
(~ · min- 1). ~ince we ensured complete entrapment of 
nucrospheres 1~ th': ~llll:gs by the absence of significant 
amoun~s of radioaciiV!ty m the heart and kidneys, the values 
deterrmned for the lungs represent the arteriovenous 
anastomotic part of the carotid circulation (for details, see 
Saxena and Verdouw 1982). 
Experimental procedure. In all experiments the baseline val-
ues were determined after the preparation had been stable 
for at least 45 min after completion of the surgical proce-
dure. The measurements consisted of the recording of heart 
rate, mean arterial blood pressure and common carotid 
artery blood now, while a batch ofmicrospheres (100,000-
150,000) was mjected for the determination of tissue and 
anastomotic blood flow. All measurements were repeated 
foll?~g a 10 min intracarotid infusion of 2.0 11g · kg- 1 
· mm 5-HT and after a recovery period of 20 min. Sub-
sequently, 1.0 mg · kg- 1 methiothepin (n = 6) or 
0.5 ~g · kg- 1 MDL 72222 (n = 4) was slowly injected via 
an 1.v. catheter. After 10-20 min, when arterial pressure 
and heart rate were stable, another 10 min infusion of 
2.0 11g · kg- 1 • min- 1 5-HTwasgivenandallmeasurements 
were repeated before and after the infusion. 
Statistical analysis. The significance of the differences be-
tween the variables was evaluated by Duncan's new multiple 
range test, once an analysis of variance (randomized block 
design) had revealed that the samples represented different 
populations (Steel and Torrie 1980). For comparing the 
~ffects of 5-HT before and after the antagonists, the changes 
mduce~ ~y 5-HT were first calculated before subjecting data 
to stallsllcal analysis. Statistical significance was accepted 
at P < 0.05 (two-tailed). All data are expressed as means 
±SEM. 
Drugs. Apart from anaesthetics, the drugs used in this study 
were: 5-hydroxytryptamine creatinine sulphate (Janssen 
Chimica, B~rse, Belgium), methiothepin maleate (courtesy: 
Dr. P. J. PiJper, Hoffman La Roche B.V., Mijdrecht, The 
Netherlands) and 1o:H, 3o:,5o:H-tropan-3-yl-3,5-dichJoro-
benzoate (MDL 72222; courtesy: Dr. J. R. Fozard, Merrell 
Dow Research Institute, Strasbourg, France). The doses 
of 5-HT and MDL 72222 are in terms of the base and sub-
stance, respectively, while that of methiothepin refers to 
the salt. 
Results 
Systemic haemodynamics 
In Table 1 are swnrnarized the values of mean arterial blood 
pressure and hea..rt rate recorded during the experiments. 
The administration ofmethiothepin (1.0 mg · kg- 1) resulted 
Ta~le_l; Effects of intra.carotid infusions of 5-HT (2.0 I'& · kg- 1 
· mm ) on mean artenal blood pressure (MAP) and heart rate 
(FIR) in anaesthetized pigs before and after MDL 72222 
0.5mg · kg- 1 (n=4) ormethiothepin, 1 mg · kg-• (n= 6) ' 
Base- 5-HT Reco- Anta- 5-HTafter 
line very gonist antagonist 
MAP(mmHg) 
Methio-
thepin 87± 91± 83± 5 77±4 86±4 
MDL72222 104± 100± 95± 4 88±2 86±4 
HR (beats· min- 1) 
Methio-
thepin 114± 7 115± 7 95± 5 88±4* 96±4*•,••• 
MDL 72222 113±11 115±11 99±12 93±9 92+7 
• P "': 0.05 vs recovery; •• P < 0.05 vs antagonist (MDL 72222 or 
met~othepm);_ ••• the 5-HT-indueed change after antagonist was 
stgmficantly different (P < 0.05) from the 5-HT-indueed change 
before the antagonist 
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Fig. I. Changes induced by intracarotid infusions of5-HT (2.0 11g ·kg-'· min- 1) in the total carotid blood flow and its distribution into 
non-nutrient (arteriovenous anastomotic; AVA) and nutrient (extracerebral and cerebral) parts in 4 pigs. MDL 72222 (0.5 mg · kg- 1, i.v.) 
did not affect carotid haemodynamics or modify the responses to 5-HT other than potentiating the reduction of the total carotid blood 
flow and, therefore, reducing extracerebral vasodilatation. • P < 0.05 vs baseline; •• P < 0.05 vs MDL 72222; ••• 5-HT-induced change 
after MDL 72222 was significantly different (P < 0.05) from the 5-HT-induced change before MDL 72222 
in a small decrease in heart rate, but arterial blood pressure 
remained unchanged. MDL 72222 (0.5 mg · kg- 1) caused 
no effect. Infusions of 5-HT did not have major effects on 
these variables; only a moderate tachycardia was noticed 
with 5-HT after methiothepin. 
Carotid haemodynamics 
Effect of MDL 72222 on the responses to 5-HT. A large 
part ( > 80%) of carotid blood flow was distributed via 
arteriovenous anastomoses. Intracarotid infusions of 5-HT 
(2.0 ).lg ·kg-'· min- 1) decreased the arteriovenous anasto-
motic fraction, but increased the fraction distributed to the 
extracerebral structures; the cerebral fraction, which was 
less than 2% of carotid blood flow, did not change (Fig. 1). 
The decrease in the arteriovenous anastomotic blood flow 
was more than the increase in blood flow to the extracerebral 
structures. Complete recovery from the effects of 5-HT was 
noticed within 20 min of stopping the infusion. MDL 72222 
(0.5 mg · kg_,), which by itself did not affect the total ca-
rotid blood flow or its fractionation, failed to modify the 
effects of 5-HT on the distribution (%) of carotid bl"od 
flow. However, as there was an exaggerated decrease in the 
total carotid blood flow by 5-HT after MDL 72222, the 
enhancement of extracerebral blood flow by 5-HT was 
somewhat less (Fig. 1 ). 
The increase in blood flow to the extracerebral tissues 
after 5-HT was mainly in the skin and ears (Fig. 2) which 
became bright pink in colour. After MDL 72222 the 5-HT-
induced increase in the blood flow to the tissues, in terms of 
percent distribution, was similar but the absolute 
(rnl · min -l) increase in the blood flow to the skin and ears 
was less, probably due to a more marked diminution of the 
total carotid blood flow (Fig. 1). However, the remaining 
increase in the skin and ear blood flow was of such a 
magnitude that the colour change was still indistinguishable 
from that after the control 5-HT infusions. 
Effect ofmethiothepin on the responses to 5-HT. The effects 
of methiothepin on the carotid vascular responses to 5-HT 
are shown in Figs. 3 and 4. In this series, the infusion of 5-
HT did not affect the total carotid blood flow. Nevertheless, 
the arteriovenous anastomotic blood flow was decreased 
and the extracerebral blood flow was increased by 5-HT. 
Administration of methiothepin did not itself have any in-
fluence on the total carotid blood flow or its distribution. 
The drug, however, strongly reduced the effects of 5-HT on 
both the arteriovenous anastomotic and extracerebral tissue 
blood flows. The change in the colour of the head skin 
and ears, normally observed during infusions of 5-HT, was 
conspicuously absent when the amine was infused after 
methiothepin administration. 
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Fig. 2. Changes induced by intracarotid infusions of 5-HT (2.0 )lg · kg- 1 • min-') in the distnbution of carotid blood to extracerebral 
tissues in 4 pigs. MDL 72222 (0.5 mg · kg-•, i.v.) itself did not cause any change in tissue blood flows or their responses to 5-HT except 
that skin and ear blood flows increased less and the bone fraction increased more when compared to control 5-HT-infusion. • P < 0.05 vs 
baseline; •• P < 0.05 vs MDL 72222; ••• 5-HT-induced change after MDL 72222 was significantly different (P < 0.05) from the 5-HT-
induced change before MDL 72222 
Discussion 
This study confirmed our earlier observations that in an-
aesthetized pigs with bilateral cervical vagosympathectomy 
80-85% of the co=on carotid artery blood flow is 
shunted via arteriovenous anastomoses and that 5-HT is 
able to reduce the anastomotic blood flow to very low levels 
(Saxena and Verdouw 1982, 1984; Verdouw et aL 1984b). 
The carotid arteriovenous anastomoses have been located 
in the head skin and ears (Saxena and Verdouw 1985b) and 
it is in these tissues that 5-HT prominently increases blood 
flow, reduces the difference in blood flow measured with 10 
and 35 J.llTI microspheres and causes colour change from 
light pink to characteristic bright pink (Saxena and Verdouw 
1982, 1984, 1985b; Verdouw et aL 1984b; present results). 
The dilatation of porcine skin vessels is in agreement with the 
vasodilatation reported in the human skin (Maricq 1972). In 
the dog, however, Dobbins et aL (1983) have reported that 
5-HT increases arterial perfusion pressure in the forelimb 
skin vasculature. The results of our study suggest that the 
increase in the perfusion pressure observed by these authors 
may be due to the constriction of arteriovenous anastomoses 
(and not arterioles) by 5-HT. This suggestion is reinforced 
by the fact that the effects of 5-HT were selectively blocked 
by methysergide but not by cyproheptadine (Dobbins et 
aL 1983), thus indicating the involvement of "5-HT 1-like" 
receptors. 
Barring some exceptions, for example the dog auricular 
and basilar arteries where a part of the contractile response 
to ·5-HT may be mediated via "5-HT 1-like" receptors (Apperley et a!. 1980; Peroutka et aL 1983), isolated 
segments of "large" conducting arteries contract mainly in 
response to the activation of 5-HT2 receptors since the 
effects of 5-HT are susceptible to ketanserin, pizotifen, 
methysergide or cyproheptadine (Apperley et al.1976; Black 
et aL 1981; Van Nueten eta!. 1981; Cohen eta!. 1983; 
M iiller-Schweinitzer and Engel1983; Blackshear et a!. 1985; 
Clancy and Maayani 1985). In addition, 5-HT 2 receptors 
apparently also mediate the constriction of arterioles (resis-
tance vessels) in the pig carotid (Saxena and Verdouw 1982, 
1984; Verdouw et aL 1984b), and the rat mesenteric 
(McLennan and Taylor 1984) circulations as indicated by 
unmasking andjor facilitation of 5-HT-induced vaso-
dilatatory responses by 5-HT 2 receptor antagonists. 
The constriction of arteriovenous anastomoses and the 
dilatation of "small" resistance vessels (arterioles) elicited 
by 5-HT in the carotid vascular bed are resistant to antago-
nism by a number of 5-HT 2 receptor antagonists (Saxena 
and Verdouw 1982, 1984; Verdouw eta!. 1984b). Further-
more, it has also been shown that two agonists of ''5-HT ,-
like" rec~ptors, 5-CT (Feniuk eta!. 1981, 1984, 1985; Engel 
eta!. 1983; Saxena eta!. 1985b; Saxena and Lawang 1985) 
and BEA 1654 (Verdouw eta!. 1985), mimick the effects of 
5-HT, and their effects are not modified by ketanserin and/ 
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Fig.3 
Changes induced by intracarotid in-
fusions of 5-HT (2.0 11g · kg- 1 
· ntin _,) in the total carotid blood flow 
and its distribution into non-nutrient 
(arteriovenous anastomotic; AVA) and 
nutrient ( extracerebral and cerebral) 
parts in 6 pigs. Methiothepin 
(1.0 mg ·kg-', i.v.) did not affect ca-
rotid haemodynamics~ but it almost 
completely antagonized the reduc-
tion of AVA and cerebral blood flow 
and the increase in the extracerebral 
tissue blood flow. • P < 0.05 vs ~ 
baseline; •• P < 0.05 vs 
methiothepin; ••• 5-HT-induced 
change after methiothepin was sig-
nificantly different (P < 0.05) from the 
5-HT-induced change before methio-
thepin 
~ c"'1"'h- r:b 
Tongue Bones Eyes 
Fig.4. Changes induced by intracarotid infusions of 5-HT (2.0 11g · kg- 1 • min- 1) in the distribution of carotid blood to extracerebral 
tissues in 6 pigs. Methiothepin (1.0 mg · kg- 1, i.v.) itself did not cause any change in tissue blood flo"s, but it effectively antagonized the 
increase in the skin and ear blood flows by 5-HT. • P < 0.05 vs baseline; •• P < 0.05 vs methiothepin; ••• 5-HT-induced change after 
methiothepin was significantly different (P < 0.05) from the 5-HT-induced change before methiothepin 
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or phentolamine (Saxena and Verdouw 1985a; Verdouw et 
aL 1985). In the present investigation, we provide further 
evidence for the involvement of "5-HT 1-like" receptors in 
mediating arteriovenous anastomotic constriction and 
arteriolar dilatation. MDL 72222, a 5-HT 3 receptor antago-
nist (Fozard 1984), was ineffective whereas methiothepin 
was quite effective in antagonizing the above effects, and the 
accompanying colour changes, caused by 5-HT. In contrast 
to ketanserin, cyproheptadine and WAL 1307, all of which 
have a high affinity for 5-HT 2 recognition sites but not for 
5-HT 1 recognition sites, methiothepin also has a noticeable 
affinity for the latter (see Peroutka and Snyder 1979; Leysen 
et aL 1981; Verdouw et al. 1985). Adlnittedly, methiothepin 
exhibits a-adrenoceptor blocking properties, but such a 
mechanism can be discounted in the antagonism of the ca-
rotid vascular responses to 5-HT. Thus, we have earlier 
observed that the effects of 5-HT are not amenable to 
blockade to drugs (ketanserin, WAL 1307 and phentol-
amine) which can block a-adrenoceptors (Verdouw et a!. 
1984b; Saxena, Verdouw and Heiligers, unpublished). 
Moreover, in the carotid circulation of the pig, noradren-
aline is not an effective constrictor agent (Verdouw et a!. 
1984a). 
Although we have now conclusively demonstrated that 
"5-HT 1-like" receptors mediate carotid arteriovenous 
anastomotic constriction and arteriolar dilatation, we 
cannot categorically state whether or not these two re-
sponses to 5-HT are coupled with each other, i.e. the reduc-
tion in arteriovenous anastomotic blood flow results form 
"steal" as a consequence of dilatation in the nutrient vascular 
channels or vice versa. However, a comparison of data 
obtained with two calcium channel antagonists, nimodipine 
and nifedipine, in the pig carotid circulation suggests that 
5-HT does actively constrict arteriovenous anastomoses. In 
the face of a 5.5-fold increase in nutrient vascular 
conductance, the calcium channel antagonists reduced ar-
teriovenous anastomotic conductance by about 40% 
(Duncker et al. 1986), whereas in association with a smaller 
increase (3- to 4.5-fold) in nutrient conductance, 5-HT 
decreases arteriovenous anastomotic conductance much 
more prolninently (by 70-80%); see Saxena and Verdouw 
1982 and present results. We also do not yet know if the "5-
HT 1-like" receptors demonstrated in the pig carotid circula-
tion are associated with any one of the three sub-types of 5-
HT 1 recognition sites (Pedigo eta!. 1981; Pazos et al. 1984). 
The agonist activity of methysergide in the carotid circula-
tion (Saxena 1974; Saxena and Verdouw 1984) suggests that 
the carotid vascular "5-HT 1-like" receptors may resemble 
those present in the dog saphenous vein (Apperley et al. 
1980; Feniuk et al. 1981, 1985), but may de different from 
those, for example, demonstrated in the cat heart (Saxena 
eta!. 1985b). 
Apart from the now well-established presence of the 5-
HT 1 and 5-HT 2 receptors, the porcine carotid vascular bed 
may have yet another type of 5-HT receptor. In the present 
experiments, before the antagonist treatment, 5-HT either 
decreased (MDL 72222 series) or had no effect 
(methiothepin series) on the total carotid blood flow. How-
ever, as described earlier with the 5-HT-induced contraction 
of the cat urinary bladder (Saxena et al. 1985a), MDL 72222 
conspicuously potentiated the 5-HT 2 receptor-mediated ca-
rotid vasoconstrictor response. This indicates that 5-HT 3 
receptors may be mediating vascular smooth muscle relaxa-
tion by a local neuronal action. 
Lastly, the characterization of the 5-HT receptors in the 
different segments of the carotid vascular bed explains the 
weak antagonist action of 5-HT 2 receptor antagonists 
against the increase in the total carotid vascular resistance 
elicited by bolus injections of 5-HT (Saxena et a!. 1971 ; 
Saxena 1972; Spira et al. 1976; Mylecharane et al. 1978).1t 
is now obvious that the antagonism will depend upon the 
relative recruitment of "5-HT 1-like" and 5-HT 2 receptors in 
the overall response to 5-HT in the carotid vascular bed. 
This fact also helps explain why divergent results can be 
obtained in in vitro and in vivo studies dealing with 5-HT 
and its antagonists. 
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Carotid haemodynamics in pigs during infusions of 
8-0H-DPAT: reduction in arteriovenous shunting is 
mediated by 5-HT1-like receptors 
Anton H. Born, *Pieter D. Verdouw & 1Pramod R. Saxena 
Department ofPharmocology and '"Laboratory for Experimental Cardiology (Thorax Centre), Erasmus 
University Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands 
1 The effects of intracarotid infusions of 8-hydroxy-2-[di-n-propyl-amino]-tetralin (8-0H-DPAT) 
on heart rate, blood pressure and carotid blood flow and its distribution were studied in anaes-
thetized pigs by use of radioactive microspheres of 15 Jlii1 diameter. 
2 Control experiments with physiological saline showed that systemic and carotid haemo-
dynamics remain essentially unchanged during the experimental period. In contrast to results 
obtained in rat, cat and dog experiments, 8-0H-DPAT did not decrease arterial blood pressure. 
3 8-0H-DPAT, which has a high affinity and is selective for the 5-HT1A recognition site, caused a 
dose-related ·decrease in arteriovenous anastomotic (non-nutrient) blood flow, resulting in a 
decrease in carotid blood flow. At the highest dose used, a small increase in arteriolar (nutrient) 
blood flow was observed. 
4 The decrease in arteriovenous anastomotic and carotid blood flow induced by 8-0H-DPAT was 
not significantly modified by pretreatment with the 5-HT 2 receptor antagonist ketanserin 
(0.5mgkg- 1), but was markedly reduced by pretreatment with methiothepin (1mgkg- 1), which 
blocks both the 5-HT 1-like and 5-HT 2 receptors. 
S It is concluded that the effects of 8-0H-DPAT on arteriovenous anastomotic blood flow are 
mediated by 5-HT 1-like receptors. These receptors, however, cannot yet be classified as belonging to 
5-HT 1A receptor subtype. Since a number of antimigraine drugs reduce arteriovenous shunting, it is 
tempting to suggest that 8-0H-DPAT may have similar clinical efficacy. 
Introduction 
Intracarotid administration of 5-hydroxytryptamine 
(5-HT) in the anaesthetized pig decreases arterio-
venous anastomotic (non-nutrient) blood flow but 
increases arteriolar (nutrient) blood flow. The 
increase in arteriolar blood flow is especially marked 
in the ears and skin which change to bright red 
colour (Saxena & Verdouw, 1982). These effects of 
5-HT are antagonized by methiothepin, which 
blocks both 5-HT1-like and 5-HT2 receptors, but 
not by the 5-HT2 receptor antagonist ketanserin or 
the 5-HT 3 receptor antagonist MDL 72222 
(V erdouw et al., 1984). Furthermore, the effects of 
5-HT are mimicked by 5-carboxamidotryptamine 
(Saxena & Verdouw, 1985). Therefore, according to 
the recent criteria for the classification of functional 
1 Author for correspondence. 
5-HT receptors (Bradley et al., 1986), 5-HT clike 
receptors mediate the constriction of arteriovenous 
anastomoses as well as the dilatation of arterioles 
(Saxena et al., 1986). 
The 5-HT c like receptors in the carotid circulation 
appear to be heterogeneous. Methysergide (Saxena 
& Verdouw, 1984) and BEA 1654 (Verdouw et al., 
1985), whic' t have affinity for 5-HT 1-like binding 
sites, reduc.e arteriovenous shunting but, unlike 
5-HT (Saxena & Verdouw, 1982) or 5-
carboxamidotryptamine (Saxena & Verdouw, 1985), 
only slightly increase arteriolar blood flow. More 
recently, another 5-HT1-like receptor agonist, GR 
43175, has been described. This compound lacks 
5-HT 1-like receptor-mediated vascular and intestinal 
smooth muscle relaxant actions, but contracts dog 
saphenous vein and inhibits noradrenaline release 
© The Macmillan Press Ltd 1989 
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from sympathetic nerve terminals (Humphrey et al., 
1988). GR 43175 also reduces arteriovenous anasto-
motic blood fiow without affecting arteriolat blood 
fiow in the eatotid circulation of the cat (F eniuk et 
al., 1987). 
The subdivision of functional 5-HT receptors into 
5-HT,-Iike, 5-HT2 and 5-HT3 receptors has been 
partially based on results from radioligand binding 
studies. Peroutka &. Snyder (1979) demonstrated 
that two distinct 5-HT recognition sites exist in the 
central nervous system. The sites labelled by 
[ 3H]-5-HT were designated as 5-HT ,-'receptors' and 
those labelled by eHJ-spiperone were called 
5-HT2-'receptors'; the former have been further sub-
divided into 5-HT,A> 5-HT18 , 5-HT1c and 5-HTm 
recognition sites (Pedigo et aL, 1981; Pazos & Pala-
cios, 1985; Heuring & Peroutka, 1987). In contrast 
to the good agreement between 5-HT2 recognition 
sites and functional 5-HT 2 receptors, it is still 
uncleat whether the subtypes of the 5-HT 1 recogni-
tion site correspond to 5-HT .-J,ike receptors, which 
undoubtedly, are heterogeneous (Bradley et al~ 1986; 
Humphrey & Richatdson, 1988). The batrier here is 
the lack of sufficiently selective compounds. to dis-
criminate unequivocally between the different 5-HT 1 
recognition site subtypes. One possible exception 
appeats to be the 5-HT tA recognition site where 
8-0H-DPAT displays a high affinity and about 1000 
fold selectivity compared to the other subtypes of 
5-HT 1 recognition sites (Middlemiss & Fozard, 
1983; Hoyer et al., 1985; Heuring & Peroutka, 1987). 
Therefore, in an attempt to characterize further the 
5-HT 1-like receptors in the porcine eatotid circula-
tion we studied the effects of 8-0H-DPAT on 
carotid blood fiow and its distribution in the anaes-
thetized pig. 
.Methods 
General 
After an overnight fast young Yorkshire pigs (body 
weight: 19-29kg) were sedated with 120mg (i.m.) 
azaperone and 120-150mg (i.v.) metomidate, intu-
bated and connected to a respirator for intermittent 
positive pressure ventilation with a mixture (1: 2) of 
oxygen and nitrous oxide. A continuous infusion of 
pentobarbitone sodium (20-26mgkg- 1 h- 1, i.v.) 
completed the anaesthesia. Respiratory rate and 
tidal volume were adjusted to keep arterial blood 
gases and pH within normal limits (pH, 7.35-7.45; 
Po2 , 90-lSOmmHg; Pro2 , 35-45mmHg). Aortic 
blood pressure was recorded with a Statham pres-
sure transducer (P23 ID) connected to a cannula 
inserted into the right femoral artery. The common 
eatotid arteries were dissected free and a bilateral 
cervical vagosympathectomy was performed to 
reduce refiex influences on the carotid circulation. 
Blood fiow in one of the common catotid arteries 
was measured with a precalibrated fiow probe (2.5 or 
3 mm, i.d.) connected to a sine-wave electromagnetic 
blood fiow meter (Transfiow 601-system, Skalat, 
Delft, The Netherlands). After removing its hub, a 
0.5 mm (external diameter) needle, connected to suit-
able polyethylene tubing, was inserted into this 
common catotid artery for the administration of 
microspheres and drugs. The animals were insulated 
with a blanket to maintain body temperature at 37-
380C. 
Distribution of common carotid blood flow 
The distribution of common catotid blood fiow was 
determined with the radioactive microsphere method 
using 15 ± 1 (s.d.) JLID. diameter spheres labelled with 
either 141Ce, 113Sn, 103Ru, 95Nb or 46Sc (NEN 
Company, Dreieich, Federal Republic of Germany). 
For each measurement a suspension ofrnicrospheres, 
labelled with one of the nuclides, was mechanically 
agitated and injected against the direction of the 
eatotid blood fiow to facilitate uniform mixing with 
the blood. At the end of the experiment the animal 
was killed and the heart, kidneys, lungs and the 
various tissues of the head were dissected out, 
weighed and placed in vials. The radioactivity in 
these vials was counted for 5-lOmin in a y-
scintillation counter (Packard, Minaxi Autogamma 
5000) equipped with a multichannel analyzer using 
suitable windows for discriminating the different iso-
topes. The amount of eatotid blood fiow distributed 
to the individual tissues (Qti,!ca•J was calculated as 
described eatlier (Saxena et al.; 1980; Saxena & 
Verdouw, 1982) by: Q,;.1 • .,1 (mlmin- 1) = (I,.Jl~oJ 
x Q1 • .,1, where Itis and Ito, ate, respectively, the 
radioactivity (c.p.m.) in a particular tissue and that 
detected in all tissues, and Q1 • .,1 is eatotid blood fiow (mlmin- 1). Because there was complete trapping of 
rnicrospheres passing through the cranial circulation 
in the capillaries of the lungs (no significant amounts 
of radioactivity were detected in the heatt or 
kidneys), the values determined for the lungs provide 
an index of the atteriovenous anastomotic fraction of 
the common eatotid arterial blood fiow (see John-
ston & Saxena, 1978; Saxena & Verdouw, 1982). 
Experimental protocol 
Four series of experiments (n = 6 each) were per-
formed. In the first series the effects of 4 consecutive 
intraeatotid infusions of physiological saline on 
eatotid blood flow and its distribution were deter-
mined. In the following series, the effects of intra-
eatotid infusions of 8-0H-DPAT on carotid blood 
CAROTID HAEMODYNAMICS AND 8-0H-DPAT 83 
flow distribution were assessed in untreated animals 
(Series 2) and in animals that were pretreated with 
either 0.5 mg kg - 1 ketanserin (Series 3) or 1 mg kg - 1 
methiothepin (Series 4) administered at a rate of 
lmlmin-• during a period of 10min, followed by a 
10min period of intracarotid infusion of physiologi-
cal saline. 
In all experiments the baseline values were deter-
mined after the preparation had been stable for at 
least 45 min after completion of the surgical pro-
cedure. The measurements consisted of the recording 
of the electrocardiogram, arterial blood pressure and 
common carotid blood flow, while a batch of micro-
spheres (100,000-150,000) was injected for the deter-
mination of tissue (arteriolar) and arteriovenous 
anastomotic blood flows. Subsequently, in Series 2-4 
the measurements were repeated after consecutive 
10min intracarotid infusions of 8-0H-DPAT, 0.3, 
1.0, 3.0 and 10.0 pg kg- 1 min- 1 at the rate of 
1 ml min-'. always given in this order. In the first 
series, in which only physiological saline was infused, 
an identical protocol was followed. 
Statistical analysis 
The significance of the differences between variables 
was evaluated by Duncan's new multiple range test, 
once an analysis of variance (randomized block 
design) had revealed that the samples represented 
different populations (Steel & Torrie, 1980). Sta-
tistical significance was accepted at P < 0.05 (two-
tailed). All data are expressed as means ± s.e.mean. 
Drugs 
Apart from the anaesthetics, the drugs used in this 
study were: 8-0H-DPAT (8-hydroxy-2-[di-n-propyl-
amino]-tetralin (courtesy of Dr. J. Traber, Tropon-
werke, Cologne, Federal Republic of Germany), 
ketanserin tartrate (courtesy of Dr J.M. Van Nueten, 
Janssen Pharmaceutica, Beerse, Belgium) and 
methiothepin maleate (courtesy of Dr P J. Pijper, 
Hoffman La Roche B.V., Mijdrecht, The 
Netherlands). The doses of 8-0H-DPAT are in terms 
of the base, whereas those of ketanserin and methio-
thepin refer to the salt. 
Results 
Physiological saline experiments 
The effects of four consecutive infusions of physio-
logical saline on heart rate, mean arterial blood pres-
sure, carotid blood flow and its distribution are 
summarized in Table 1. Heart rate and blood pres-
sure showed a tendency to decrease, but a sta-
tistically significant change was only observed in 
heart rate after the last saline infusion. Total carotid 
blood flow and arteriovenous anastomotic blood 
flow tended to increase, but the· changes were not 
statistically significant. Nutrient (arteriolar) blood 
flow remained unaffected. 
8-0H-DPAT experiments 
Systemic haemodynamics The values for heart rate, 
mean arterial blood pressure and carotid blood flow 
before and after the infusion of either ketanserin or 
methiothepin are shown in Table 2. Both mean 
arterial blood pressure and heart rate decreased after 
intracarotid infcsion of ketanserin (0.5 mg kg- 1 ), 
whereas after methiothepin infusion (1 mgkg- 1) only 
mean arterial blood pressure was lowered. Carotid 
blood flow was not changed significantly by infusion 
of either antagonist. In Table 3 are summarized the 
values of mean arterial blood pressure and heart rate 
recorded during the intracarotid infusions of 8-0H-
DPAT. 8-0H-DPAT did not affect mean arterial 
blood pressure, but decreased heart rate in both 
Table 1 Mean arterial blood pressure, heart rate and carotid blood flow and its distributiOn during four consecu-
tive infusions of physiological saline 
Saline infusions 
Baseline First Second Third Fourth 
MAP 97 ± 12 92 ± 11 91 ± 11 88 ± 11 87 ± 11 
HR 109 ± 13 109 ± 12 105 ± 12 102 ± 11 99 ± to• 
CBF 108 ± 17 108 ± 20 115 ± 20 123 ± 22 124 ± 23 
AVA 87 ± 18 89 ±20 95 ± 21 100 ± 23 102 ± 24 
Nutrient 20±3 19 ±2 20± 3 22±3 22± 3 
Saline was infused for !Omin periods at a rate of 1mlmin-1 (n.= 6). Abbreviations and units: MAP, mean arterial 
blood pressure (mmHg); HR, heart rate (beats min- 1); CBF, total carotid blood flow (mlmin- 1); AVA, arterio-
venous anastomotic blood flow (ml min -• ); Nutrient, arteriolar blood flow (ml min -• ). 
• Significantly different (P < 0.05) from the baseline value. 
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Table :Z Mean arterial blood pressure, heart rate and carotid blood flow before and after ketanserin and methio-
thepin 
Immediately after IOmin after 
Antagonist antagonist antagonist 
pretreatment Baseline infosion infosion 
MAP Ketanserin 94±7 85 ±7* 84± 7* 
Methiothepin 98± 10 86 ± w•· 80±7* 
HR Ketanscrin 114±8 107±6 100 ± 5* 
Methiothepin 100±8 97±8 96±8 
CBF Ketanserin 125 ± 14 111 ± 14 112±13 
Methiothepin 102±8 105 ± 11 97±9 
Ketanscrin (0.5mgkg" 1 ; n = 6) or methiothepin (1mg/kg" 1 ; n = 6) was infused into the carotid artery at a rate of 
1 m1 min -• during a period of 10min. Thereafter an infusion of physiological saline (1 mlmin " 1) was given. Abbre-
viations and units: MAP, mean arterial blood pressure (mmHg); HR, heart rate (beats min" 1); CBF, carotid blood 
flow(mlmin- 1). 
• Significantly different (P < 0.05) from the baseline value. 
untreated and ketanserin- or methiothepin-pre-
treated animals during intracarotid infusions of the 
three highest doses (1, 3 and 10pgkg" 1). 
Carotid blood flow and its distribution The effects of 
intracarotid infusions of 8-0H-DPAT on carotid 
blood flow and its fractionation over non-nutrient, 
arteriovenous anastomotic blood flow and nutrient, 
arteriolar blood flow ate shown in Figure 1. As was 
the case in the experiments with physiological saline, 
a large fraction (70%) of the total carotid blood flow 
was diverted through the arteriovenous anastomoses 
in untreated as well as in ketanserin- or 
methiothepin-pretreated animals before the infusions 
of 8-0H-DPAT were started. In the untreated and 
ketanserin-pretreated animal, 8-0H-DPAT infusions 
induced a dose-dependent decrease in total carotid 
blood flow,' which was directly related to a decrease 
m arteriovenous anastomotic blood flow. Only at 
the highest dose tested did arteriolar blood flow 
show an increase in the untreated animals, whereas 
in the ketanserin-pretreated animals arteriolar blood 
flow tended to decrease. In the methiothepin-
pretreated animals the effects of 8-0H-DPAT infu-
sions on total carotid and arteriovenous anastomotic 
blood flow were markedly reduced. Furthermore, a 
small but dose-related decrease in arteriolar blood 
flow was observed. 
Analysis of regional carotid blood flow distribu-
tion showed that 8-0H-DPAT infusion at the 
highest dose caused an increase in blood flow to the 
skin, ears, tongue, bones and bram in the untreated 
animals (Figure 2). No changes in colour of the skin 
and eats, as seen with 5-HT and 5-
carboxamidotryptamine (Saxena & Verdouw, 1982; 
1985), were observed during the experiments. In the 
group pretreated with ketanserin, blood flow to the 
skin and eats increased at the highest dose of 8-0H-
Table 3 Effect of intracarotid infusions of 8-hydroxy-2[di-n-propyl-amino]tetralin (8-0H-DPAT) on mean arterial 
blood pressure and heart rate 
Antagonist 8-0H-DPAT (pgkg-•min- 1) 
pretreatment 0 0.3 1.0 3.0 10.0 
MAP None 79 ±7 78 ±7 76±6 76± 7 75 ± 6 
Ketanscrin 84±7 84±8 84± 8 84± 8 85 ± 8 
Methiothepin 80± 7 80±7 78± 7 74±5 74±6 
HR None 109 ± 7 104±6 99± s• 93 ±4* 88±3* 
Ketanserin 100±5 96± 6 92±5* 90±4* 85±2* 
Methiothepin 96± 8 94±8 90±8* 86 ± 6* 82 ± s• 
8-0H-DPAT was infused in 10min periods at a rate of 1mlmin" 1 in untreated (n = 6), ketanserin (O.Smgkg- 1 ; 
n = 6) or methiothepin (lmgkg" 1 ; n = 6) pretreated animals. Abbreviations and units: MAP, mean arterial blood 
pressure (mmHg); HR, heart rate (beats min" 1). 
• Significantly different (P < 0.05) from the value before the administration of 8-0H-DPAT. 
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Figure I Total carotid blood flow, arteriovenous anas-
tomotic (A VA) blood flow and arteriolar (nutrient) 
blood flow in untreated (control) and Jcetanserin 
(0.5mglcg- 1) or methiotbepin (1 mglcg- 1 ) pretreated 
pigs (n = 6 each) before and after intracarotid infusions 
of increasing doses of 8-hydroxy-2-[di-n-propyl-
amino]tetralin (8-0H-DPAT). • P < 0.05 vs baseline. 
DPAT, but blood fiow to the tongue, bones and 
brain remained unchanged, while that to the skeletal 
muscles and eyes was reduced. Pretreatment with 
methiothepin prevented the 8-0H-DPAT-induced 
increase in blood fiow to the skin, ears, tongue and 
brain, whereas blood fiow to the muscles, bones and 
eyes decreased. 
Discussion 
Validity of the experimental model 
Our experiments, in which four consecutive intra-
carotid infusions of physiological saline were given 
to the anaesthetized pig, clearly show that no appre-
ciable changes occur in either systemic or carotid 
haemodynamics over a period of about 40-60min. 
Similarly, we have previously shown that within 
minutes of stopping the infusions of 5-HT, which is 
quickly metabolised, the distribution of carotid 
blood fiow is restored to that observed during the 
baseline period (Saxena & Verdouw, 1982; 1984; 
Verdouw et al., 1984). Therefore, we can conclude 
that no time-dependent changes or changes due to 
the injection of microspheres themselves are seen in 
carotid haemodynamics during the experimental 
period in the animal model used here. 
Effects of8-0H-DPAT 
In contrast to the rat (Gradin et al., 1985; Martin & 
Lis, 1985; Fozard et al., 1987), cat (Ramage & 
Fozard, 1987; McCall et al., 1987; Doods et al~ 
1988) and dog (Di Francesco et al., 1988), 8-0H-
DPAT did not lower blood pressure in the anaes-
thetized pig. Whether this is caused by differences in 
species, anaesthesia or the level of baseline arterial 
blood pressure, remains unclear. The decrease in 
heart rate observed in our experiments cannot be 
unequivocally attributed to an action of 8-0H-
DPAT, since this was also observed in experiments 
in which only physiological saline was infused. The 
use of nitrous oxide as an anaesthetic might be an 
explanation for this phenomenon. Nitrous oxide is 
reported to reduce heart rate and cardiac output 
with systemic arterial blood pressure being main-
tained by increased total peripheral resistance (Eisele 
& Smith, 1972). 
Intracarotid infusion of 8-0H-DPAT, which is a 
selective agonist at 5-HT IA receptors (Middlemiss & 
Fozard, 1983; Hoyer et al., 1985), caused a dose-
related decrease in carotid blood fiow in the anaes-
thetized pig. This effect on carotid blood fiow, 
unrelated to changes in mean arterial blood pressure, 
was associated with a selective decrease in the 
arteriovenous anastomotic fraction. Pretreatment 
with methiothepin, but not with ketanserin, con-
siderably reduced the effects of 8-0H-DPAT, indi-
cating that 8-0H-DPAT was acting on 5-HT1-like 
receptors. 
The increase in tissue blood fiow to the skin and 
ears observed during the infusion of the highest dose 
of 8-0H-DPAT is probably also mediated by 
5-HT clike receptors since this effect was antago-
nized by methiothepin but not be ketanserin. 
However, it should be noted that like methysergide 
and BEA 1654 (Saxena & Verdouw, 1984; Verdouw 
eta!~ 1985) and GR 43175 (Feniuk et al., 1987), but 
in contrast to 5-HT and 5-carboxamidotryptamine 
(Saxena & Verdouw, 1982, 1985), the effect of 8-0H-
DPAT on total nutrient (arteriolar) blood fiow 
was not marked. Compatible with this difference, 
intracarotid infusions of 5-HT and 5-
carboxamidotryptamine changed the colour of the 
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Figure l The distribution of carotid blood ll.ow to various cranial tissues in untreated (control), ketanscrin 
(O.Smgkg- 1) or metbiothepin (lmgkg- 1) pretreated pigs (n = 6 each) before and after intracarotid infusions of 
increasing doses ofS-hydroxy-2-[di-n-propyl-amino]tetralin (8-0H-DPAT). • P < 0.05 vs baseline. 
skin and ears to bright red {Saxena & Verdouw, 
1982; 1985), but infusions of 8-0H-DPAT did not. 
The above findings are suggestive of heterogeneity of 
the 5-HT 1-like receptors mediating the constriction 
of -arteriovenous anastomoses and the dilatation of 
arterioles in the carotid vascular bed. 
The selectivity of 8-0H-DPAT for the 5-HT1A 
recognition sites (Middlemiss & Fozard, 1983; 
Hoyer et aL, 1985) obviously tempts one to suggest 
that the 5-HT 1-like receptors mediating the 
reduction of arteriovenous blood flow belong to the 
S-HT1A subtype. However, it is still unclear whether 
this is so, since no selective antagonists for the 
putative 5-HT 1A receptor are as yet available. More-
over, in initial experiments, ipsapirone, which also 
has a high alfmity for the 5-HT 1A recognition site (Peroutka, 1986; Traber & Glaser, 1987) and reduces 
blood pressure in anaesthetized cats by an agonist 
action on putative 5-HT lA receptors in the brain 
(Ramage & Fozard, 1987), was found to be inactive 
in our experimental model (Bom et a/., 1988). It 
remains possible that the inactivity of ipsapirone is 
due to a low efficacy of the drug at the putative 
5-HT lA receptors or to some differences in 5-HT 1 
recognition sites in the brain and in the carotid cir-
culation. 
Lastly we would like to draw some attention to 
the possible clinical relevance of the main finding of 
this study, i.e. the constriction of arteriovenous anas-
tomoses by 8-0H-DPAT. It should be recalled that 
dilatation of arteriovenous anastomoses has been 
suggested to form part of the pathophysiology of 
migraine headache {Heyck, 1969; Saxena, 1978; 
1987). Indeed, a number of proven and effective anti-
migraine drugs, including ergotamine, methysergide 
and isometheptene {Johnston & Saxena, 1978; Spier-
ings & Saxena, 1980a,b; Saxena & Verdouw, 1984; 
Saxena, 1987), constrict arteriovenous anastomoses. 
Also, GR 43175, the newly developed agonist at 
5-HT1-like receptors {Humphrey et al., 1988), 
reduces arteriovenous anastomotic blood flow 
{Feniuk et al., 1987) and has shown promise in the 
treatment of acute attacks of migraine {Doenicke et 
aL, 1988). It is therefore possible that 8-0H-DPAT 
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may also have an antimigraine action. However, we 
do not know how the behavioural effects of 8-0H-
DPAT described in animals (fricklebank, 1985) 
would manifest in man. 
In conclusion the present study demonstrates that 
8-0H-DPAT, which has a high affinity and is selec-
tive for 5-HT tA recognition sites, decreases common 
carotid arterial blood flow in the pig by selectively 
reducing arteriovenous anastomotic blood flow. 
Since methiothepin, but not ketanserin, antagonized 
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The 5-HT1-like receptor mediating reduction of porcine carotid 
arteriovenous shunting by RU 24969 is not related to either the 5-HT1A 
or the 5-HT IB subtype 
Anton H. Born\ Carlos M. Villalon\ Pieter D. Verdouw 2 and Prantod R. Saxena 1 
1 Department of Pharmacology and 2 Laboratory for Experimental Cardiology (Thorax Centre), Faculty of Medicine and Health Sciences, 
Erasmus University Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands 
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Using the radioactive microsphere technique in anaesthetized pigs, we studied the systemic and carotid 
haemodynamic effects of intracarotid infusions (0.3, 1, 3 and 10 l'gfkg ·min) of 5-methoxy-3-(1,2,3,6-tetrahydro-4-
pyridinyl)-1H-indole succinate (RU 24969), a drug with high affinity for 5-HT1A and 5-HT18 recognition sites. Unlike 
in the rat, R U 24969 did not elicit hypotension in the pig. Instead, the two highest doses of the drug caused a slight 
increase in blood pressure. RU 24969 reduced common carotid artery blood flow by decreasing the non-nutrient, 
arteriovenous anastomotic blood flow; the nutrient, arteriolar blood flow was inildly increased. The decrease in 
common carotid and arteriovenous anastomotic blood flow was only slightly attenuated in animals pretreated with the 
5-HT2 receptor antagonist, ketanserin (0.5 mgjkg i.a.), but was markedly reduced in animals pretreated with the 
5-HT1-like and 5-HT2 receptor antagonist, methiothepin (1.0 mgjkg i.a.). However, these responses were not modified 
after pretreatment with the putative 5-HT1A and 5-HT18 receptor antagonist, (±)-pindolol (4.0 mgjkg i.v.). The slight 
increase in arteriolar blood flow was attenuated in the animals pretreated with either ketanserin, methiothepin or 
( ± )-pindolol. It is concluded that the RU 24969-induced reduction in common carotid and arteriovenous anastomotic 
blood flow is mediated mainly by 5-HT1-like receptors, which do not seem to correspond to either the 5-HT1A or 
5-HT18 receptor subtypes. 
Arteriovenous anastomoses; Carotid blood flow; 5-Hydroxytryptarnine (5-HT, serotonin); 5-HT receptors; 5-HT1-Iike 
receptors; Migraine; RU 24969 
1. Introduction 
Intracarotid infusion of 5-hydroxytryptamine 
(5-HT) into anaesthetized pigs causes a reduction 
in cephalic arteriovenous anastomotic blood flow 
and an increase in arteriolar blood flow (Saxena 
and Verdouw, 1982). According to the classifi-
Correspondence to: P.R. Saxena, Department of Pharmacol-
ogy, Faculty of Medicine and Health Sciences, Erasmus Uni-
versity Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, The 
Netherlands. 
cation of Bradley et al. (1986), these effects are 
mediated mainly by 5-HTclike receptors, since 
the effects are strongly antagonizied by 
methiothepin, which blocks both 5-HT1-like and 
5-HT2 receptors, but only slightly by tile 5-HT2 
receptor antagonist, ketanserin, or tile 5-HT3 re-
ceptor antagonist, MDL 72222 (Verdouw et al., 
1984; Saxena et al., 1986). Furthermore, 5-carbox-
arnidotryptarnine, which has a high affinity for tile 
5-HT1A> 5-HT18 and 5-HTm recognition sites 
(Hoyer, 1988), mimics tile effects of 5-HT (Saxena 
and Verdouw, 1985). 
In subsequent studies, we reported that 8-0H-
DPAT, which has a high affinity for tile 5•HT1A 
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recogrutlon site (Middlemiss and Fozard, 1983; 
Hoyer et al., 1985; Hoyer, 1988), reduced arterio-
venous anastomotic blood flow without increasing 
arteriolar blood flow (Born et al., 1989b). How-
ever, it is still unclear whether 5-HT1A recognition 
sites correspond to the 5-HTclike receptor 
mediating the decrease in arteriovenous anasto-
motic shunting, because ipsapirone, another com-
pound with high affinity for the 5-HT1A recogni-
tion site (Traber and Glaser, 1987), was found to 
be ineffective (Born et al., 1988). Both 5-HT and 
5-carboxamidotryptamine increase arteriolar blood 
flow, especially to the skin which becomes bright 
red; this effect is not observed during infusions of 
either 8-0H-DPAT or ipsapirone, thus it is un-
likely that the 5-HT1A receptor is involved. Never-
theless, in order to further study the possible 
involvement of 5-HT1A andjor 5-HT18 receptors 
in the distribution of nutrient and non-nutrient 
cephalic blood flow, we have investigated the 
carotid vascular effects of RU 24969 in the 
anaesthetized pig. RU 24969 has a high affinity 
for both 5-HT1A and 5-HT18 recognition sites in 
rat and bovine brain tissue, and to a lesser extent 
for the 5-HT2 recognition site (Hoyer et al., 1985; 
Peroutka, 1986; Hoyer, 1988). 
2. Material and methods 
2.1. ··Experimental set-up 
Fasted young Yorkshire pigs (n = 24; body 
weight: 18-37 kg) were sedated with azaperone 
(120 mg i.m.) and metomidate (120-150 mg i.v.), 
intubated and artificially ventilated with a mixture 
(1 : 2) of oxygen and nitrous oxide. A continuous 
infusion of pentobarbitone sodium (15-30 mgjkg 
· h i.v.) completed the anaesthesia. The respiratory 
rate and tidal volume were adjusted to keep arterial 
blood gases and pH within normal limits (pH: 
7.35-7.45; Pa02 : 90-150 mmHg; PaC02 : 35-45 
mm Hg). The right femoral artery and vein were 
cannulated for the measurement of aortic blood 
pressure (Statham transducer, model P23 ID) and 
infusions of (±)-pindolol, respectively. The heart 
rate was derived from the pressure signals. Both 
common carotid arteries were dissected free and a 
bilateral cervical vagosympathectomy was per-
formed. The blood flow in one of the common 
carotid arteries was measured with a precalibrated 
electromagnetic flow probe (2.25-2.50 mm internal 
diameter; Transflow 601-system, Skalar, Delft, The 
Netherlands). A hub-less 0.5 mm (external diame-
ter) needle, connected to suitable polyethylene 
tubing, was inserted into this common carotid 
artery for the administration of microspheres, RU 
24969, ketanserin and methiothepin. The aninlals 
were packed in a thermo-insuluating blanket to 
maintain the body temperature between 37-38°C. 
2.2. Distribution of common carotid artery blood 
flow 
The distribution of common carotid artery 
blood flow was determined with 15 ± 1 (S.D.) JLID 
diameter microspheres labelled with either 141 Ce, 
113Sn, 103Ru, 95 Nb or 46Sc (NEN Company, 
Dreieich, West Germany). For each measurement 
a suspension of microspheres (with 1-1.5 X 105 
spheres), labelled with one of the nuclide, was 
mechanically agitated and injected into the carotid 
artery against the direction of blood flow to 
facilitate uniform mixing. At the end of the 
experiments the aninlals were killed and the heart, 
kidneys, lungs and the various cranial tissues were 
dissected out, weighed and placed in vials. The 
radioactivity in these vials was counted for 5-10 
min in a y-scintillation counter (Packard, Minaxi 
Autogarnma 5000) using suitable windows for dis-
criminating the different isotopes. The ratio be-
tween the radioactivity in a particular tissue and 
the radioactivity in the sum of all tissues was 
calculated with a specially developed computer 
program (Saxena et al., 1980). By multiplying this 
ratio with the. value for the total carotid blood 
flow, determined just before the microsphere 
injection, the carotid blood flow to a particular 
tissue could be determined. Little or no radioactiv-
ity was detected in the heart or kidneys, signifying 
a nearly complete entrapment of the microspheres 
in the lungs. Therefore, the amount of radioactiv-
ity in the lungs was used as an index for the 
arteriovenous anastomotic part o{ the common 
carotid artery blood flow. 
2.3. Experimental protocol 
After a post-surgical stabilization period of 45 
min, the animals were divided into four groups 
and received either physiological saline, ketanserin 
(0.05 mgjkg ·min) and methiothepin (0.1 mgjkg · 
min) at a rate of 1.0 ml/min for a period of 10 
min (total dose 0.5 and 1.0 mgjkg i.a.; respec-
tively) or ( ± )-pindolol (0.2 mgjkg ·min) at a rate 
of 1.0 ml/min for a period of 20 min (total dose 
4.0 mgjkg i.v.). This was followed by an infusion 
of physiological saline at the same flow rate for a 
period of 10 min. Then, baseline measurements of 
heart rate, mean arterial blood pressure, common 
carotid artery blood flow and its distribution were 
made. These measurements were repeated after 
the intracarotid administration of RU 24969 (0.3, 
1.0, 3.0 and 10.0 JLgfkg · min) at 10 min intervals. 
2.4. Statistical analysis 
The significance of the differences between the 
variables was evaluated with Duncan's new multi-
ple range test, once an analysis of variance (ran-
domized block design) had revealed that the sam-
ples represented different populations (Steel and 
Torrie, 1980). Statistical significance was accepted 
at P < 0.05 (two-tailed). All data are expressed as 
means ± S.E.M. 
TABLE 1 
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2.5. Drugs 
Apart from the anaesthetics, the drugs used in 
this study were: ketanserin tartrate (gift: Dr. J.M. 
Van Nueten, Janssen Pharmaceutica, Beerse, Bel-
gium), methiothepin maleate (gift: Dr. P.J. Pijper, 
Hoffman La Roche B.V., Mijdrecht, The Nether-
lands), (±)-pindolol (gut: Sandoz B.V., Uden, 
The Netherlands) and 5-methoxy-3-(1,2,3,6-tetra-
hydro-4-pyridinyl)1H-indole succinate (RU 24969; 
gift: Roussel Laboratories, Hoevelaken, The 
Netherlands). With the exception of (±)-pindolol 
(which was dissolved in ethanol 30% with physio-
logical saline), all drugs were dissolved in physio-
logical saline. The doses of ketanserin, meth-
iothepin and RU 24969 refer to the salts. 
3. Results 
3.1. Systemic haemodynamics 
The effects of intracarotid infusions of physio-
logical saline, ketanserin (total dose: 0.5 mgjkg), 
methiothepin (total dose: 1.0 mgjkg), (±)-pindo-
lol (total dose: 4.0 mgjkg) and increasing doses of 
RU 24969 (0.3, 1.0, 3.0 and 10.0 JLg/kg ·min) on 
the mean arterial blood pressure and heart rate are 
summarized in table 1. The heart rate was lowered 
by ketanserin, whereas the mean arterial blood 
Effect of intracarotid infusion of physiological saline (n = 6), ketanserin (0.5 mgjkg; n = 6), methiothepin (1.0 mgjkg; n = 6) or 
(±)-pindolol (4.0 mgjkg; n = 6) and subsequent doses of RU 24969 on heart rate and mean arterial blood pressure in pigs. 
Pretreat- Baseline Pretreat· RU 24969 (l'g/kg·min) 
mentgroup ment 0.3 1.0 3.0 10.0 
Heart rate (beats/min) 
Saline 96± 5 94± 4 92± 4 87±3b 82± 3b 79± 3b 
Ketanserin 98± 5 87± 4 4 84± 3 81±3b 78± 2b 76± 2b 
Methiothepin 106± 4 102± 7 102± 8 99±8 95± 7b 91± 6b 
( ± )-Pindolol 122±10 125± 6 130± 7 131±7 128± 8 129± 8 
Mean arterial blood pressure (mm Hg) 
Saline 66± 7 65± 6 71± 8 74±8 75± 9 75±10 
Ketanserin 80± 7 72± 7 71± 8 76±5 80± 7 b 82± 8 b 
Methiothepin 83± 3 75± 3 72± 5 74±4 76± 5 75± 7 
(± )-Pindolol 92± 9 104±10 a 100± 10 104±9 103±10 101± 9 
a p < 0.05 vs. baseline; b p < 0.05 vs. pretreatment. 
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pressure was increased after pretreatment with 
( ± )-pindolol. Furthermore, the heart rate de-
creased during the intracarotid infusion of increas-
ing doses of RU 24969 in saline-, ketanserin- and 
methiothepin-pretreated animals, an effect which 
has also been observed during repeated infusions 
of physiological saline (Born et al., 1989b). The 
heart rate remained essentially unchanged during 
the experimental period in the animals pretreated 
with ( ± )-pindolol. The mean arterial blood pres-
sure was increased by the two highest doses of RU 
24969 only in the an1mals pretreated with 
ketanserin. 
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3.2. Carotid haemodynamics 
The effects of intracarotid infusions of RU 
24969 on the total carotid blood flow and its 
distribution over non-nutrient, arteriovenous 
anastomotic blood flow and nutrient, arteriolar 
blood flow are shown in fig. L Irrespective of the 
pretreatment a large fraction (70%) of the total 
carotid blood flow was diverted through the ce-
phalic arteriovenous anastomoses. In the saline-
pretreated animals increasing doses of RU 24969 
caused a marked decrease in arteriovenous blood 
flow and a less pronounced increase in arteriolar 
i gi·.3g AU 24969 (119/kg.min) 10.0 
Methiothepin Pindolol 
Fig. 1. Effect of intracarotid infusion of RU 24969 (0.3, 1.0, 3.0 and 10 JLgfkg·min) on the total carotid artery blood flow and in its 
arteriovenous anastomotic (AVA) and nutrient (tissue) fractions in groups of six pigs pretreated '"ith either physiological saline. 
ketanserin (0.5 mgjkg i.a.), methiothepin (1.0 mgjkg i.a.) or ( ±)·pindolol (4.0 mgjkg i.v.). • P < 0.05 vs: baseline. 
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Fig. 2. Effect of intracarotid infusion of RU 24969 (0.3, 1.0, 3.0 and 10 l'gjkg·min) on the total carotid conductance and in its 
·arteriovenous anastomotic (AVA) and nutrient (tissue) fractions in groups of six pigs pretreated with either physiological saline, 
ketanserin (0.5 mgjkg i.a.), methiothepin (1.0 mgjkg i.a.) or (±)-pindolol (4.0 mgjkg i.v.). * P < 0.05 vs. baseline. 
blood flow, resulting in a decrease in the total 
carotid blood flow. In animals pretreated with 
ketanserin (total dose: 0.5 mgjkg) the effects of 
RU 24969 were attenuated (more pronounced on 
the arteriolar blood flow than on the total carotid 
blood flow and its arteriovenous anastomotic part), 
whereas in the methiothepin-pretreated (total dose: 
1.0 mgjkg) animals these effects were markedly 
suppressed. In contrast, pretreatment with ( ± )-
pindolol (total dose: 4.0 mgjkg) did not modify 
the effects of RU 24969 on either the total carotid 
blood flow _or its arteriovenous anastomotic frac-
tion, although the effects of RU 24969 in the 
arteriolar (nutrient) fraction were attenuated. The 
effects of the intracarotid infusion of RU 24969 
on vascular conductance, approximated by the 
ratio of blood flow and mean arterial blood pres-
sure, showed a similar pattern (fig. 2). 
The effects of RU 24969 on the fractionation of 
nutrient, arteriolar flow are shown in figs. 3 and 4. 
RU 24969 increased the arteriolar blood flow to 
the ears, skin, tongue, salivary glands and fat, 
whereas the arteriolar blood flow to the eyes, 
muscles, brain and bones remained unchanged. 
No change in colour of the skin or ears was 
observed. The RU 24969-induced increase in 
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Fig. 3. Effect of intracarotid infusion of RU 24969 (0.3, 1.0, 3.0 and 10 p.gjkg·min) on carotid blood flow to the ears, head skin, 
tongue, eyes and head muscles in groups of six pigs pretreated with either physiological saline, ketanserin (0.5 mgjkg i.a.), 
methiothepin (1.0 mgjkg i.a.) or (±)-pindolol (4.0 mg/kg i.v.). • P < 0.05 vs. baseline. 
arteriolar blood flow to the above mentioned tis-
sues was reduced in the ketanserin-, methiothepin-
and ( ± )-pindolol-pretreated animals. 
4. Discussion 
4.1. Systemic haemodynamics 
In contrast to the hypotensive effect observed 
in ketanserin-treated rats (Doods et al., 1985), RU 
24969 did not decrease the mean arterial blood 
pressure in anaesthetized pigs. However, there was 
a tendency for the blood pressure to increase in 
the ketanserin-pretreated animals. The cause of 
this difference between rats and pigs remains un-
clear, but it must be emphasized that 8-0H-DPAT 
did not have the hypotensive action in the 
anaesthetized pig (Born et al., 1989b) that is 
observed in the rat (Doods et al., 1985; Fozard et 
al., 1987), cat (Ramage and Fozard, 1987) and dog 
(Di Francesco et al., 1988). The effects of pretreat-
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Fig. 4. Effect of intracarotid infusion of RU 24969 (03, 1.0, 3.0 and 10 JLg/kg·min) on carotid blood flow to the brain, salivary 
glands, fat and bones in groups of six pigs pretreated with either physiological saline, ketanscrin (0.5 mg/kg i.a.), methiothepin (1.0 
mgjkg i.a.) or (±)-pindolol (4.0 mgjkg i.v.). • P < 0.05 vs. baseline. 
ment with ( ± )-pindolol on the mean arterial blood 
pressure and heart rate during the experimental 
period might be explained in terms of the intrinsic 
sympathomimetic activity of this ,8-adrenoceptor 
antagonist (Scriabine and Taylor, 1984). Firstly, 
( ± )-pindolol is able to increase renin release 
(Weber et al., 1977), thereby suggesting that the 
increase in mean arterial blood pressure we 
observed could have been a consequence of ( ± )-
pin dolo! pretreatment. Secondly, nitrous oxide 
(which was used as an anaesthetic) is reported to 
reduce the heart rate and cardiac output while the 
systemic arterial blood pressure is maintained by 
an increased total peripheral resistance (Eisele and 
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Smith, 1972), which could explain the bradycardia 
observed in the saline-, ketanserin- or methiothe-
pin-pretreated animals; however, this effect was 
not observed after pretreatment with ( ± )-pindo-
lol, possibly because of its intrinsic activity on 
cardiac P-adrenoceptors, which has been described 
elsewhere (Louis et al., 1977). 
4.2. Carotid haemodynamics 
Despite the tendency of the blood pressure to 
increase, intracarotid infusion of RU 24969 caused 
a dose-related reduction in the total common 
carotid blood flow, which was directly related to a 
decrease in the non-nutrient, arteriovenous anas-
tomotic blood flow. Pretreatment with ketanserin 
slightly attenuated these effects, whereas the 
reduction in the total carotid blood flow and 
arteriovenous anastomotic blood flow was 
markedly reduced after pretreatment with 
methiothepin. Therefore, RU 24969 seems to re-
duce arteriovenous anastomotic shunting mainly 
via 5-HT1-like receptors (Saxena et al., 1986). 
However, as described previously for 5-HT (Saxena 
and Verdouw, 1982; Verdouw et al., 1984), 5-HT2 
receptors could also be involved to a lesser extent 
in the reduction of arteriovenous anastomotic 
blood flow induced by RU 24969. Indeed, it is 
known from radioligand binding studies that RU 
24969 has affinity for 5-HT2 recognition sites 
(Peroutka, 1986). 
The exact reason for the increase in arteriolar 
blood flow (to the ears, skin, tongue and salivary 
glands) induced by RU 24969, which was suscepti-
ble to ketanserin, methiothepin and ( ± )-pindolol, 
is difficult to explain. It could be secondary to the 
reduction of the arteriovenous anastomotic part of 
the carotid blood flow; however, another drug, 
indorenate, did not increase the arteriolar blood 
flow despite similarly decreasing the arteriovenous 
anastomotic blood flow (unpublished observa-
tions). Another possibility is that vasodilator sub-
stances are released from tlrrombocytes andjor 
blood vessels by a 5-HT receptor mechanism; 
Kokkas and Boeynaems (1988) have recently 
shown that 5-HT can release prostacyclin from the 
dog saphenous vein by a 5-HT2 receptor-mediated 
action. Finally, both ( + )- and (- )-pindolol have 
been reported to possess a low affinity for 5-HT2 
receptors (Hoyer, 1988); nonetheless, because of 
the fact that methiothepin as well as ( ± )-pindolol 
apparently blocked the above mentioned response, 
we cannot rule out the possibility that 5-HT1A 
andjor 5-HT18 receptors could be partly involved 
in the effects of RU 24969 on the arteriolar frac-
tion. 
4.3. Nature of 5-H~-like receptors involved in ce-
phalic arteriovenous anastomotic flow changes 
5-HTclike receptors are heterogeneous (Brad-
ley et al., 1986; Humphrey and Feniuk, 1988; 
Saxena, 1989) and it is, therefore, important to 
establish the exact nature of the 5-HTclike recep-
tor mediating the constriction of arteriovenous 
anastomoses in the carotid vascular bed. Besides 
5-HT (Saxena and Verdouw, 1982) and 5-
carboxyarnidotryptarnine (Saxena and V erdouw, 
1985), a number of other drugs having affinity for 
the 5-HT1A recognition sites (see Middlemiss and 
Fozard, 1983; Hoyer et al., 1985; Hoyer, 1988) - · 
8-0H-DPAT (Born et al., 1989b), BEA 1654 
(Verdouw et al., 1985), methysergide (Saxena and 
Verdouw, 1984) and RU 24969 (present results) -
diminish arteriovenous anastomotic blood flow in 
the pig. This could suggest that the 5-HT1-like 
receptors involved correspond to the 5-HT1A re-
cognition site. However, ipsapirone (TVX Q 7821), 
another compound with high affinity for the 5-
HT1A recognition site (Peroutka, 1986; Traber and 
Glaser, 1987), proved to be ineffective in this 
model (Born et al., 1988). Taken together, these 
fmdings imply that either the 5-HT receptors on 
carotid arteriovenous anastomoses in the pig do 
not correspond to the 5-HT1A recognition sites in 
the brain or that ipsapirone has a low efficacy at 
the 5-HT1A receptors on the carotid vessels (Born 
et al., 1989b) .. Our observation that the decrease in 
both total carotid and arteriovenous anastomotic 
blood flow induced by RU 24969 was not affected 
by ( ± )-pindolol further reveals that these carotid 
5-HTclike receptors do not belong to either the 
5-HT1A or 5-HT18 subtype. Both RU 24969 and 
(- )-pindolol have high affinity for 5-HT1A and 
5-HT18 recognition sites (Hoyer, 1988), and some 
behavioral effects of 8-0H-DPAT and RU 24969 
in the rat can be dose dependently (0.5 to 4.0 
rngjkg) blocked by (- )-pindolol (Tricklebank et 
a!., 1984; 1987). 
Furthermore, it should be noted that the 5-
HTclike receptors mediating the constriction of 
arteriovenous anastomoses and the dilatation of 
arterioles in the carotid vascular bed seem to be 
heterogeneous because 5-HT and 5-carboxarni-
dotryptamine induce these effects and change skin 
colour to bright pink (Saxena and Verdouw, 1982; 
1985), whereas rnethysergide, BEA 1654, 8-0H-
DPAT and RU 24969 (Saxena and Verdouw, 1984; 
Verdouw et a!., 1985; Born et al., 1989b; present 
results) primarily reduce arteriovenous anasto-
motic shunting. Since a change in the skin colour 
was not observed with RU 24969, a mediation by 
either 5-HT1A or 5-HT18 receptors in this phe-
nomenon is not very likely. 
4.4. Possible clinical implications 
Over the years we have shown that a number of 
drugs that are effective in the treatment of 
migraine, for example ergotamine, dihydro-
ergotamine, rnethysergide and isornetheptene (see 
Saxena, 1978; 1987), powerfully reduce cephalic 
arteriovenous anastomotic shunting, although, as 
demonstrated for ergotamine (Born et al., 1989a), 
a reduction in cephalic arteriovenous anastomotic 
blood flow does not necessiuily have to be media-
ted by 5-HT1-Iike receptors. Two new, highly se-
lective agonists at 5-HTclike receptors, AH25086 
and surnatriptan (GR43175), have recently been 
shown to constrict cephalic arteries in several 
species and to diminish feline carotid arteriovenous 
anastomotic blood flow (Feniuk et a!., 1987; 
Humphrey et a( 1989; in press; Saxena and 
Ferrari, 1989). Furthermore, these new drugs do 
not seem to cross the blood brain barrier or have 
an antinociceptive effect even after intrathecal 
administration (Humphrey et a!., 1989; in press), 
yet they are remarkably effective against acute 
migraine attacks (Brandt eta!., 1987; Doenicke et 
a!., 1988; Perrin et a!., 1989). Since RU 24969 
powerfully reduces cephalic arteriovenous anasto-
motic blood flow, the drug may also possess an 
antimigraine action. 
In conclusion, this study demonstrates that RU 
24969, which has a high affinity for 5-HT1A and 
99 
5-HT18 recogrutron sites, reduces total carotid 
blood flow in the anaesthetized pig by selectively 
affecting arteriovenous anastomotic blood flow. 
This effect of RU 24969, which was highly suscep-
tible to methiothepin but not much to ketanserin 
and which was resistant to blockade by ( ± )-
pindolol, is mediated by 5-HT1-Iike receptors that 
do not seem to belong to either the 5-HT1A or 
5-HT18 subtype. 
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Reduction of cephalic arteriovenous shunting by 
ergotamine is not mediated by 5-HT1-like or S-HT2 
receptors 
Anton H. Born, Jan P.C. Heiligers, 1Pramod R. Saxena & *Pieter D, Verdouw 
Department of Pharmacology and *Laboratory for Experimental Cardiology (Thoraxcenter), Erasmus 
University Rotterdam, P.O. Box 1738,3000 DR Rotterdam, The Netherlands 
1 The potent, antimigraine drug ergotamine has affinity for both 5-HT 1 and 5-HT 2 binding sites 
and constricts arteriovenous anastomoses. Since 5-HT also constricts arteriovenous anastomoses 
(mainly via 5-HT 1-like receptors), this study investigates the involvement of 5-HT receptors in the 
ergotamine-induced reduction of arteriovenous shunting in the carotid circulation of the cat and 
pig. 
2 In the cat, ergotamine (3, 10 and 30 Jlg kg- 1, i.v.) reduced carotid blood flow, predominantly by 
a reduction in arteriovenous anastomotic blood flow. Pretreatment with ketanserin (0.5 mg kg- 1, 
i.v.) or methiothepin (1mgkg- 1, i.v.) did not antagonize the effects of ergotamine. 
3 In the pig, ergotamine (2.5, 5, 10 and 20Jlgkg- 1, i.v.) also reduced carotid blood flow and 
arteriovenous. shunting, which was not affected by pretreatment with methiothepin (1 mgkg- 1, i.v.). 
4 These results suggest that the reduction by ergotamine in the shunting of carotid arterial blood 
via cephalic arteriovenous anastomoses is not mediated by 5-HT 1-like or 5-HT 2 receptors. 
Introduction 
Ergotamine is a potent and effective drug for the 
treatment of acute attacks of migraine headaches 
where, among other pathophysiological factors (for 
references, see Blau, 1987), an opening of arterio-
venous anastomoses has been suggested (Heyclc, 
1969; Saxena, 1978; 1987). Indeed, ergotamine 
decreases blood flow in the carotid circulation in a 
variety of species, including man (Saxena & De 
Vlaam-Schluter, 1974; Spira et a/., 1976; Puzich et 
a/., 1983). In anaesthetized cats (Johnston & Saxena, 
1978), pigs (Schamhardt et a/., 1979) and dogs 
(Saxena et a/., 1983), the decrease in carotid blood 
flow by ergotamine is almost entirely due to a 
reduction in the cephalic arteriovenous anastomotic 
('shunt') fraction. The constrictor effect of ergotamine 
on arteriovenous anastomoses in the dog is not 
antagonized by phentolamine and/or pizotifen, 
thereby excluding the involvement of oc-
adrenoceptors and histamine H 1-receptors, as well as 
the 'D' 5-hydroxytryptamine (5-HT) receptors 
(Saxena et a/., 1983) which are claimed to be 
involved in ergotamine-induced constrictions of iso-
lated extracranial arteries (Miiller-Schweinitzer & 
Weidmann, 1978; Miiller-Schweinitzer, 1986). 
1 Author for correspondence. 
The receptors for 5-HT have recently been sub-
divided into three distinct types, called 5-HT 1-like, 
5-HT2 (generally equivalent to 'D' 5-HT) and 5-HT3 
receptors (Bradley et a/., 1986; Humphrey & 
Richardson, 1988). The selective agonists at the three 
receptor types are, respectively, 5-
carboxamidotryptamine, oc-methyl-5-HT and 2-
methyl-5-HT. Ketanserin and MDL 72222 
selectively antagonize 5-HT2 and 5-HT3 receptors 
respectively, whilst methiothepin and methysergide 
are non-selective antagonists at both 5-HT 2 and 
5-HT 1-like receptors. The 5-HT 1-like receptors 
mediate the constriction of arteriovenous anasto-
moses by 5-HT in the carotid circulation of the pig, 
since this response is mimicked by 5-
carboxamidotryptamine (Saxena & Verdouw 1985a) 
and other selective 5-HT 1-like agonists such as BEA 
1654 (Verdouw eta/., 1985), AH25086 (Humphrey et 
a/., 1987) and GR43175 (Feniuk eta/~ 1987; Hump-
hrey et a/., 1988), and is blocked by methiothepin but 
not by ketanserin or MDL 72222 (Verdouw et a/., 
1984; Saxena eta/., 1986). Recent radioligand experi-
r.aents show that ergotamine possesses a high affinity 
for 5-HT 1 binding sites (Leysen & Gommeren, 1984; 
Richardson et a/., 1986). In this investigation, there-
fore, we address the question whether 5-HT 1-like 
© The Macmillan Press Ltd 1989 
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receptors mediate the ergotamine-induced con-
striction of arteriovenous anastomoses. For this 
purpose the effects of ergotamine on the carotid cir-
culation has been compared in untreated cats and 
pigs with those in animals pretreated with ketanserin 
or methiothepin. 
Methods 
Experimental set-up 
Cats The experimental set-up used in the cats has 
been described in detail (Johnston & Saxena, 1978; 
Saxena & Verdouw, 1982). Briefly, the animals 
weighing between 2.1 and 4.4 kg, were anaesthetized 
with a mixture of ex-chloralose (60mgkg- 1, ip.) and 
urethane (700 mg kg- 1, i.p.). Bilateral cervical 
vagosympathectomy was performed (to reduce reflex 
influences on the carotid circulation) and the trachea 
was cannulated and connected to a respirator for 
intermittent positive pressure ventilation. Arterial 
blood gasses were monitored and kept within 
normal limits (pH, 7.35-7.45; Pao2 , 90-150mmHg; 
Paco2 , 35-45 mmHg). Aortic blood pressure was 
measured with a Statham transducer (model P23 Ac) 
connected to a polyethylene cannula inserted in a 
femoral artery. Heart rate was derived from the pres-
sure signals. The femoral vein was cannulated for 
drug administration. Blood flow in the left common 
carotid artery was measured with electromagnetic 
flow probes (1.5-2mm i.d.; Transflow 600-system, 
Skalar, Delft, The Netherlands). A catheter was 
placed in the left lingual artery to allow retrograde 
injection of microspheres into the carotid artery. The 
body temperature was maintained around 37°C by 
use of an electric heating pad. 
.•· 
Pigs As described earlier (Saxena & Verdouw, 
1982), fasted young Yorkshire pigs (body weight: 19-
29kg) were sedated with azaperone (120mg, i.m.) 
and metomidate (120-150mg, i.v.), intubated and 
given intermittent positive pressure ventilation with 
a mixture (1: 2) of oxygen and nitrous oxide. A con-
tinuous infusion of pentobarbitone sodium (20-
26 mg kg - 1 h - 1, i. v.) completed the anaesthesia. 
Respiratory rate and tidal volume were adjusted to 
keep arterial blood gases and pH within normal 
limits (see above). The right femoral artery and vein 
were cannulated for the measurement of aortic blood 
pressure (Statham transducer, model P23 ID) and 
administration of ergotamine, respectively. Heart 
rate was derived from the pressure signals. The 
common carotid arteries were dissected free and 
both cervical vagosympathetic trunks were severed. 
Blood flow in one of the common carotid arteries 
was measured with a precalibrated flow probe (2.5-
3mm, i.d.; Transflow 601-system, Skalar, Delft). A 
hub-less 0.5mm (external diameter) needle, con-
nected to suitable polyethylene tubing, was inserted 
in this common carotid artery for the administration 
of microspheres and methiothepin (see later). The 
animals were wrapped in a thermo-insulating 
blanket to maintain body temperature between 37-
380C. 
Distribution of common carotid blood flow 
The distribution of common carotid blood flow was 
determined with the radioactive microsphere method 
using 15 ± 1 (s.d.) JlDl diameter spheres labelled with 
either 141Ce, 113Sn, 103Ru, 95Nb or 46Sc (NEN 
Company, Dreieich, West Germany). For each mea-
surement a suspension of microspheres, labelled with 
one of the nuclides, was mechanically agitated and 
injected against the direction of the carotid blood 
flow to facilitate uniform mixing with the blood. At 
the end of the experiment the animal was killed and 
the heart, kidneys, lungs and the various tissues of 
the head were dissected out, weighed and placed in 
vials. The radioactivity in these vials was counted for 
5-lOmin in a -r-scintillation counter (Packard 
Minaxi Autogarnma 5000) using suitable windows 
for discriminating the different isotopes. The amount 
of carotid blood flow distributed to the individual 
tissues (Qtls!c .. ~ was calculated as described earlier 
(Saxena et al., 1980; Saxena & Verdouw, 1982) by: 
Q,u!csrl (rnlmin- 1) = (I,.JI,.J X Q 1csrl• wh~re I,;, and 
I,., are, respectively, the radioactivity (c.p.m.) in a 
particular tissue and that detected in all tissues, and 
Q1.,.rl is carotid blood flow (rnlmin- 1). Because there 
was complete entrapment of microspheres passing 
through the cranial circulation in the capillaries of 
the lungs (no significant amounts of radioactivity 
were detected in the heart or kidneys), the values 
determined for the lungs provide an index of the 
arteriovenous anastomotic fraction of the common 
carotid blood flow (see Johnston & Saxena, 1978; 
Saxena & Verdouw, 1982). 
Experimental protocol 
Cats About 45 min after completion of the surgical 
procedures baseline measurements of heart rate, 
blood pressure and common carotid blood flow and 
its distribution (using 20,000-50,000 radioactive 
microspheres) were made. The cats were then divided 
into three groups receiving pretreatment with either 
physiological saline (0.9% NaCI, wjv) (2rnl, i.v.), 
ketanserin (0.5mgkg- 1, iv.) or methiothepin 
(lmgkg- 1, i.v.) This pretreatment was followed by 
the administration of ergotamine in cumulative 
doses (3, 10, 30pgkg-', i.v.) at intervals of 15inin. 
The systemic and carotid haemodynamic measure-
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Table 1 ·Effects of saline (n = 7), ketanserin (O.Smgkg- 1, i.v.; n = 7) or methiothepin (lmgkg-•, iv.; n = 7) and 
subsequent cumulative doses of ergot3Dline on heart rate and mean arterial blood pressure in cats 
Pretreatment Baseline 
Heart rate (beats min -•) 
Saline 181 ± 20 
Ketanserin 212 ± 8 
Methiothepin 189 ± 12 
Pretreatment 
182 ± 18 
111 ± 8* 
162 ± 9* 
Mean arterial blood pressure (mmHg) 
Saline 90 ± 7 80 ± 3 
Ketanserin 108 ± 8 71 ± 7* 
Methiothepin 95 ± 7 72 ± 7* 
* Significantly (P < 0.05) different vs baseline; 
•• Significantly (P < 0.05) different vs pretreatment. 
ments were repeated at the end of each intervention 
(pretreatment and the three ergotaniine doses). 
Pigs After a post-surgical stabilization period of 
about 45 min, the animals were divided into two 
groups recetvmg intracarotid infusions (rate: 
1 m1 min - 1 for a· period of !Omin) of either physio-
logical saline or methiothepin (total dose: 
1mgkg- 1). Ten minutes later, in all experiments 
baseline measurements of heart rate, arterial blood 
pressure, common carotid arterial blood flow and its 
distribution (with 100,000-150,000 spheres) were 
made. These measurements were repeated after the 
administration of ergotamine (2.5, 5, 10 and 
20 Jlg kg- 1 in cumulative doses) at intervals of 
l5min. 
Statistical analysis 
The significance of the differences between the vari-
ables was evaluated by Duncan's new multiple range 
test, once an analysis of variance (randomized block 
design) had revealed that the samples represented 
different populations (Steel & Torrie, 1980). Sta-
Ergotamine 
(pgkg- 1, i.v.) 
3 10 30 
154 ± 14** 135 ± 8** 129 ± 7** 
155 ± 8** 141 ± 9** 133 ± 9** 
139 ± 7** 131 ± 7** 127 ± 8** 
80±5 82±7 104 ± 7** 
80±8 .85 ± 7** 91 ±6** 
76±8 85 ± 9** 92 ± 10** 
tistical significance was accepted at P < 0.05 (twO-
tailed). All data are expressed as means ± s.e.mean. 
Drugs 
Apart from the anaesthetics, the drugs used in this 
study were: ergotamine tartrate (Gynergeen ampou-
les Sandoz B.V ~ Uden, The Netherlands), ketanserin 
tartrate (courtesy: Dr J.M. van Nueten, Janssen 
Pharmaceutica, Beerse, Belgium) and methiothepin 
maleate (courtesy: Dr P J. Pijper, Hoffmann-La 
Roche B.V., Mijdrecht, The Netherlands). The drugs 
were diluted with (ergotamine) or dissolved in 
physiological saline. The doses of ergotamine, ketan-
serin and methiothepin refer to the salts. 
Results 
Systemic haemodynamics 
In the cat experiments, pretreatment with saline did 
not change arterial blood pressure or heart rate. 
Pretreatment with ketanserin (O.Smgkg- 1 ) or 
methiothepin (1 mg kg - 1) was followed by a decrease 
Table 2 Effect of cumulative doses of ergot3Dline on heart rate and mean arterial blood pressure in untreated 
(n = 6) and methiothepin (1 mgkg- 1)-treated pigs (n = 6) 
Ergotamine 
(pgkg- 1, i.v.) 
Pretreatment Baseline 2.5 5.0 10.0 20.0 
Heart rate (beatsmin- 1) 
Saline 104 ± 10 91 ±7* 84±5* 79±5* 76±4* 
Metbiothepin 101 ± 12 96± 10 87±9* 81 ± 8* 77±7* 
Mean arterial blood pressure (mmHg) 
Saline 76±4 86±5 86± 5 86±5 80±7 
Methiothepin 79±5 83 ±5 89± 8 85 ± 10 84±11 
• Significantly different (P < 0.05) vs baseline. 
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in both variables. Irrespective of the type of pretreat-
ment, cumulative doses of ergotamine (3, 10 and 
30JLgkg- 1, i.v.) caused a decrease in heart rate, 
whereas arterial blood pressure showed a marked 
increase {Table 1). In the pig experiments ergotamine 
had no effect on mean arterial blood pressure in 
either the saline- or methiothepin-treated animals. 
Heart rate decreased dose-relatedly after ergotamine 
in both groups (Table 2). 
Carotid haemodynamics 
Cats In the saline group of animals, where saline-
treatment itself had no effect on carotid blood flow 
or its distribution, cumulative doses of ergotamine 
(3, 10 and 30JLgkg- 1, i.v.) caused a decrease in total 
carotid blood flow. This decrease was predominantly 
in the arteriovenous anastomotic fraction (non-nutri-
ent) but the nutrient (arteriolar; capillary) fraction 
was also reduced (Figure 1). Pretreatment with 
ketanserin (O.Smgkg- 1) or methiothepin (1 mgkg- 1) 
caused a decrease in total carotid blood flow which 
was similar in the arteriovenous anastomotic and 
nutrient fractions. Neither pretreatment modified the 
effects of ergotamine on total carotid and arterio-
venous anastomotic blood flows though the decrease 
in nutrient flow seemed attenuated (Figure 1). The 
decrease in the nutrient blood flow by ergotamine in 
the animals pretreated with saline was distributed 
over a number of cephalic tissues, particularly the 
ears, skin, muscles and salivary glands, but not the 
brain (data not shown). Pretreatment with ketan-
serin :educed blood flow, especially to the muscles, 
ears and skin. Methiothepin also reduced blood flow 
to the muscles and ears. Both drugs seemed to 
prevent ergotamine-induced decreases in nutrient 
blood flow, but the pre-ergotamine blood flow values 
were less after ketanserin and methiothepin when 
compared to saline (Figure 1). 
Since both potential antagonist drugs, ketanserin 
and methiothepin, decreased mean arterial blood 
pressure, the effects of these drugs on blood flow 
may be related to reduced perfusion pressure; hence 
vascular conductances within the carotid bed were 
calculated as ratios of blood flow and mean arterial 
blood pressure values. The data reveal that the 
decrease in blood flow by ketanserin and methiothe-
pin was clearly related to the drop in blood pressure, 
probably caused by vasodilatation in other vascular 
beds. Furthermore, it is observed that ergotamine-
induced decreases in vascular conductances in total 
carotid, arteriovenous anastomotic and nutrient 
beds were not much altered by either ketanserin or 
methiothepin (Figure 2). The examination of individ-
ual tissues shows that vascular conductance 
decreased with ergotamine in the saline pretreated 
animals in the ears, skin, eyes, muscles, bones and 
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Figure l Effect of ergotamine (3, 10 and 30 pgkg- 1, 
i.v.) on the total carotid blood fiow and its arterio-
venous anastomotic (AVA) and nutrient (tissue) frac-
tions in 6 cats each pretreated with either physiological 
saline, ketanserin (O.Smgkg- 1, i.v.) or methiothepin 
(l.Omgkg- 1, i.v.). Baseline, A; pretreatment, B; ergota-
mine 3pgkg- 1, C; lOpgkg- 1, D and 30pgkg-', E. 
t Significantly (P < 0.05) different vs baseline; 
• significantly (P < 0.05) different vs pretreatment. . 
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salivary giands, but not in the brain. In antagonist 
pretreated animals the effects of ergotamine were 
apparently either less or absent in several tissues; 
however, as with blood flow values, the pre-
ergotamine conductance values were lower than in 
the saline group (data not shown). 
Pigs As in the cats, ergotamine dose-dependently 
reduced common carotid blood flow in the saline-
pretreated pigs by decreasing a!1eriovenous anasto-
motic blood flow; the nutrient (arteriolar; capillary) 
fraction was unaffected. Pretreatment with methio-
thepin (1 mgkg- 1) did not much modify the effects of 
ergotamine (Figure 3). After administration of 
ergotamine, blood flow to some tissues (brain, eyes, 
fat, bones or salivary glands) did not change, but in 
others there was a tendency to increase (ears, skin 
and tongue) or decrease (muscles). The increases in 
tissue blood flow seemed to be attenuated in animals 
pretreated with methiothepin (data not shown). 
Discussion 
Shunting of microspheres 
The present results confirm the observations that a 
large fraction (cat: 35-45%; dog: 40-45%; pig: 
75-80%) of 15prn microspheres, injected into the 
carotid circulation of anaesthetized animals, is not 
trapped in the arteriolar bed of the cephalic tissues; 
these spheres pass via arteriovenous anastomoses 
and veins to the right side of the heart to be sieved 
by the pulmonary capillary bed (Johnston & Saxena; 
1978; Saxena & Verdouw, 1982; Saxena eta/., 1983). 
The simultaneous use of microspheres of four differ-
ent diameters (10, 15, 25 and 35prn) has shown that 
the large arteriovenous anastomoses in the cephalic 
circulation are mainly present in the skin and ears 
(Saxena & Verdouw, 1985b), but such 'shunt' vessels 
have also been located in the nasal mucosa 
(Anggard, 1974), tongue (Kronert et a/~ 1980), dura 
mater (Rowbotham & Little, 1965) and rete mirabile 
(Gillilan & Markesbery, 1963). The opening of 
arteriovenous anastomoses, possibly secondary to a 
decrease in blood 5-HT concentrations (Lance, 
1982), may be involved in the pathophysiology of 
migraine (see Heyck, 1969; Saxena, 1978; 1987). 
Effects of ergotamine 
Ergotamine decreased heart rate in both cats and 
pigs. In the cat the ergotamine-induced bradycardia 
is due to an agonist action on presynaptic dopamine 
receptors located on the cardiac sympathetic nerve 
terminals (Saxena & Cairo-Rawlins, 1983), but in the 
rat presynaptic IX2-adrenoceptors have been impli-
cated (Roquebert & Grenie, 1986). 
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Figure2 Effect of ergotamine (3, 10 and 30pgkg- 1 , 
iv.) on vascular conductances in the total carotid bed 
and its arteriovenous anastomotic (AVA) and nutrient 
(tissue) fractions in 6 cats each pretreated with either 
physiological saline, ketanserin (O.Smgkg-', iv.) or 
methiothepin (I.Omgkg- 1, i.v.). Baseline, A; pretreat-
ment, B; ergotantine 3pgkg- 1, C; lOpgkg- 1, D and 
30pgkg- 1, E. • Significantly (P < 0.05) different vs 
pretreatment. 
108 A..H. BOM et aL 
Total carotid 
150 
100 
I 
c AVA 
.E 
:§. 
!: 
.g 100 
-o 
0 
0 
iii 
50 
Nutrient 
50 
ABC DE 
Saline Methiothepin 
Figure 3 Effect of ergotamine (2.5, 5, 10 and 
20pgkg- 1, i.v.) on the total carotid blood flow and its 
arteriovenous anastomotic (AVA) and nutrient (tissue) 
fractions in 6 pigs each pretreated with either physio-
logical saline or methiothepin (l.Omgkg- 1, i.a.). No 
ergotamine, A; ergotamine 2.5pgkg- 1, B; 5pgkg-•, C; 
lOpgkg- 1, D and 20pgkg-•, E. • Significantly 
(P < 0.05) different vs baseline (pre-ergotantine) values. 
In both species studied, ergotamine caused a dose-
related decrease in carotid blood flow, predomi-
nantly by affecting the arteriovenous anastomotic 
fraction. Pretreatment with the 5-HT2 receptor 
antagonist ketanserin or the mixed 5-HT 1-like and 
5-HT 2 receptor antagonist methiothepin did not 
modify these effects. The doses of ketanserin 
(O.Smgkg- 1) and methiothepin chosen (1 mgkg- 1) 
were more than adequate, since they antagonize 
several cardiovascular responses mediated by 
5-HT 1-like receptors (e.g.: 5-HT-induced hypo-
tension in the rat and cat, tachycardia in the cat and 
arteriovenous anastomotic constriction and arteri-
olar dilatation in the porcine carotid bed; Saxena & 
Lawang, 1985; Saxena et al. 1985; 1986; Connor et 
al., 1986) or by 5-HT2 receptors (e.g.: 5-HT-induced 
hypertension in the rat; Saxena & Lawang, 1985). 
Therefore, despite demonstration of a high allinity 
for both 5-HT 1 and 5-HT 2 binding sites (Ley5en & 
Gommeren, 1984) and for 5-HT 2 receptors in 'large' 
conducting arteries (Miiller-Schweinitzer & Weid-
mann, 1978; Miiller-Schweinitzer, 1986), the 
reduction in the carotid blood flow following con-
striction of cephalic arteriovenous anastomoses by 
ergotamine does not appear to be mediated by either 
5-HT1-like or 5-HT2 receptors. As shown earlier in 
the dog, phentolamine and pizotifen were also 
unable to modify the responses to ergotamine, 
excluding the involvement of a:-adrenoceptors as well 
as histamine H1-receptors (Saxena et al., 1983). A 
possible mediation by 5-HT 3 receptors can not be 
ruled out from the present experiments, but neither 
5-HT 3 receptors mediate constriction of arterio-
venous anastomoses (Saxena et al., 1986) nor does 
ergotamine have an agonist action on these recep-
tors. Thus receptors involved in the ergotamine-
induced reduction of arteriovenous anastomotic 
blood flow in the carotid vascular bed are yet to be 
characterized. In this context it may be recalled that 
5-HT can act on receptors unrelated to 5-HT 1-like, 
5-HT 2 or 5-HT 3 types in isolated papillary muscle of 
kitten (Kaumann, 1985) and in the pig heart (Born et 
al., 1988) and that vasodilator dopamine receptors 
have been described on arteriovenous anastomoses 
in the canine paw pad (Bell et al~ 1978; Bell & Lang, 
1979). Whether ergotamine can act on these recep-
tors is not yet known. Another mechanism explain-
ing the action of ergotamine could be related to 
prostaglandin formation. In canine vein strips the 
constrictor response to ergotamine is in part medi-
ated by production of a prostaglandin-like substance 
(Miiller-Schweinitzer & Weidmann, 1978) and pros-
taglandin F 2• can increase vascular resistance in the 
external carotid bed of the monkey (Spira et al., 
1978). 
The vasoconstrictor action of ergotamine in some 
tissues was attenuated in both ketanserin- and 
methiothepin-pretreated animals. It may suggest that 
the vasoconstriction by ergotamine in the nutrient 
circulation may be partly mediated by a:-
adrenoceptors and/or 5-HT 2 receptors (see Saxena 
& De Vlaarn-Schluter, 1974; Miiller-Schweinitzer & 
Weidmann, 1978). 
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In conclusion this study shows that the effects of 
ergotamine on arteriovenous anastomotic blood fiow 
in cat and pig are not mediated by 5-HT clike or 
5-HT 2 receptors. The involvement of cc-
adrenoceptors and histamine H 1-receptors has been 
excluded in earlier studies. 
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Chapter 12: DISCUSSION 
1. Characterization of 5-HT receptors. 
Functional 5-HTz and 5-HTs receptors in the cardiovascular system can 
be adequately characterized using antagonists like ritanserin, ketanserin 
and cyproheptadine (5-HTz receptors) and MDL 72222 and ICS 205-930 
(5-HTs receptors). Other 5-HT receptors, which are neither 5-HTz nor 
5-HTs receptors are more difficult to characterize. From functional 
studies, showing effects of 5-HT which could not be blocked by 5-HTz or 
5-HTs receptor antagonists, the existence of 'atypical' 5-HT receptors has 
been suggested (Saxena et al., 1971; Apperley et al., 1980; Saxena & 
Verdouw, 1984; Feniuk et al.,1985). Based on the knowledge obtained 
from radioligand binding studies on cerebral membrane preparations, these 
receptors have been classified as 5-HTl-like receptors 
(Bradley et al.,1986). 5-Carboxamidotryptamine, which has a high affinity 
for 5-HTl recognition sites, proved to be a potent and selective agonist, 
mimicking the effects of 5-HT in several functional tests, like the 
5-HT-induced tachycardia in the cat (Saxena et al., 1985; Connor et al., 
1986), contraction of the dog saphenous vein (Feniuk et al., 1985) and 
reduction of arteriovenous anastomotic blood flow in the pig (Saxena & 
Verdouw, 1985). Unfortunately, no selective antagonist for the 
5-HTl-like receptor is available yet. However, methiothepin, an 
antagonist with a high affinity for both 5-HTl and 5-HTz recognition 
sites, can be used in functional tests, but other actions of methiothepin 
like a-adrenoceptor antagonism or noradrenaline uptake inhibition have to 
be considered. 
Since radioligand binding studies revealed the presence of subtypes of 
5-HTl recognition sites, many investigators studied the effects of these 
ligands in functional studies to get an impression of the efficacy of these 
compounds. However, due to the lack of selective antagonists for these 
putative subtypes of 5-HTl-like receptors, it is still not possible to 
demonstrate that the subtypes of 5-HTl binding sites in cerebral 
112 
membranes actually correspond to subtypes of functional 5-HT1 -like 
receptors in the cardiovascular system. Pindolol, which has a high 
affinity for 5-HTlA and 5-HTls recognition sites, did not antagonize the 
reduction in porcine cranial arteriovenous blood flow induced by 
RU 24969, which has affinity for the same recognition sites (Born et al., 
1989a). This shows that compounds with affinity for certain 5-HT 
recognition sites in cerebral membranes and without agonistic action on 
peripheral5-HT receptors do not necessarily behave as a 5-HT antagonist. 
Lack of antagonism by cyanopindolol has also been described for 
GR43175-induced contraction of dog saphenous vein and basilar artery 
(Humphrey et al., 1988; Connor et al., 1989). Furthermore, spiperone 
does not block the effects of 8-0H-DPAT and GR 43175 on dog saphenous 
vein and carotid vascular resistance (Perren et al., 1989). Another 
disadvantage of binding studies is the dependency on highly selective 
ligands with high affinity for a certain recognition site. For many years 
it was claimed that no 5-HTa recognition sites were present in the brain, 
until they were discovered by using better ligands. The fact, that until 
now 5-HTls recognition sites have only been found in rodents, does not 
necessarily mean that there are no 5-HTls recognition sites in the brains 
of other species ! 
Therefore, it is questionable whether binding data are useful for the 
prediction of drug effects in functional models. Binding data might be 
useful for screening of new compounds to decide which functional tests 
are the first to be done, but the 'classical' pharmacological approach 
still has to be preferred. This is clearly demonstrated in our 
experiments using ergotamine in the cranial circulation of the cat and 
the P,ig. Since it has been shown that the effects of ergotamine on 
shunt flow are not antagonized by pizotifen and/or phentolamine (Saxena 
et al., 1983) it was assumed that ergotamine was acting on 5-HTl-like 
receptors, because this compound also has a high affinity for 5-HTt 
recognition sites (Leysen & Gommeren, 1984; Richardson et al., 1986). 
However, methiothepin does not block this effect of ergotamine (Born et 
al., 1989b), which leaves us with four unanswered questions: 1) is the 
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therapeutic effect of drugs in the acute migraine attack related to their 
action on 5-HT receptors ? 2) is ergotamine acting on a receptor that is 
not a 5-HT receptor ? 3) is ergotamine acting on a subtype of 
5-HT!-like receptors that cannot be blocked by methiothepin ? 4) is 
ergotamine acting on a 5-HT receptor in the cardiovascular system, that 
is not a 5-HT!-like, 5-HTz, or 5-HTs receptor ? The first three 
questions are still difficult to answer, but there exist experimental 
evidence for the possibility suggested in the fourth question. In the 
kitten isolated papillary muscle 5-HT, but not 5-carboxamidotryptamine, 
has a positive inotropic effect that cannot be blocked by methysergide 
or phenoxybenzamine (Kaumann, 1985). In pig coronary arteries 5-HT 
inhibits the release of noradrenaline from sympathetic nerves, which is 
also resistant to 5-HT!-like, 5-HTz and 5-HTs receptor antagonists and 
which is not mimicked by 5-carboxamidotryptamine (Mo1derings et al., 
1989). However, noradrenaline release is also inhibited by 
N,N-dimethyl-5-HT, 5-aminotryptamine, tryptamine and RU 24969, a 
compound with affinity for 5-HT!A and 5-HT!B recognition sites. In the 
pig 5-HT also causes tachycardia, which is resistant to 5-HT receptor 
antagonists and antagonists at a- and 13-adrenoceptors, muscarinic, 
nicotinic, histamine and dopamine receptors, and calcium channnels (Born 
et al., 1988). 8-0H-DPAT, BEA 1654, 5-carboxamidotryptamine and 
2-methyl-5-HT are ineffective, as RU 24969, which is in contrast to the 
inhibitory effect of this compound on noradrenaline release in the pig 
coronary artery. It is still uncertain whether the above-mentioned 
effects of 5-HT are mediated by an identical 5-HT receptor or by 
different 5-HT receptors or other mechanisms. Hopefully, the 
development of new 5-HT antagonists will give an answer to this 
problem, which might lead to a reproposal for the criteria of 5-HT 
receptor classification. 
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2. Cranial arteriovenous anastomoses. 
In contrast to conscious pigs, the arteriovenous anastomotic blood flow 
in anaesthetized pigs is high (70-80 % of total carotid blood flow), 
irrespective of sympathectomy. Electrical stimulation of the cervical 
sympathetic nerves does not modify arteriovenous anastomotic shunt flow, 
indicating that the large shunt flow is not related to a central depressant 
effect of the anaesthesia on sympathetic outflow (Verdouw et al. 1 984). 
An a-adrenoceptor blocking effect of the anaesthetic agent used might be 
involved, since intracarotid infusions of noradrenaline did not have a 
marked effect on shunt flow, whereas bolus injections caused a 
short-lasting decrease in shunt flow. Furthermore, an effect of the 
anaesthesia on circulating vasoconstricting hormones (5-HT ?) cannot be 
excluded. 
3. Role of arteriovenous anastomoses in migraine. 
An increase in oxygen saturation of external jugular and frontal venous 
blood during migraine attacks has been described by Heyck (Heyck, 
1969). Treatment with dihydroergotamine returned the venous oxygen 
saturation to normal, which led to the hypothesis that opening of 
arteriovenous anastomoses might contribute to this phenomenon (Heyck, 
1981). Unfortunately, this study only includes 7 patients and for 
unknown reasons no further studies have been done on the time course of 
frontal venous oxygen saturation changes during migraine attacks and its 
relief by drugs like ergotamine, dihydroergotamine and GR43175 
(Doenicke et al., 1 988). These rather harmless experiments might give 
an answer on the question whether opening of arteriovenous anastomoses 
precedes the migraine attack or whether opening of arteriovenous 
anastomoses is just an epiphenomenon of the migraine attack. Opening 
of arteriovenous anastomoses might be a reflection of autonomic 
disturbances that occur during migraine attacks like vomiting, diarrhea, 
nasal stuffiness, Horner's syndrome and unilateral pupillary dilatation. 
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In conclusion, the drug-induced reduction in cranial arteriovenous 
anastomotic blood flow in experimental animals is a good model to study 
putative anti-migraine drugs, since 5-HT!-like receptor-mediated effects 
can be studied and ergotamine-like actions can be studied simultaneously. 
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SUMMARY 
The autacoid 5-hydroxytryptamine (5-HT; serotonin) plays a role in many 
(patho-) physiological processes. This thesis describes the effects of 5-HT 
on heart rate and carotid blood flow distribution in anaesthetized cats 
and pigs. Using selective antagonists and agonists the 5-HT receptor 
subtypes were characterized according to, now generally accepted, criteria 
(Chapter 2). After a review of the literature concerning heart rate 
changes in mammals (Chapter 3), the 5-HT-induced epicardial chemoreflex 
is described (Chapter 4). Topical application of 5-HT or nicotine on the 
epicardium of anaesthetized cats leads to stimulation of afferent vagal 
nerve fibers, mediating the epicardial chemoreflex: bradycardia, inhibition 
of sympathetic nerve activity and hypotension. Topical or intravenous 
administration of the selective 5-HTs receptor antagonist MDL 72222 
abolishes the reflex effects of 5-HT but not of nicotine, showing that 
MDL 72222 does not possess a local anaesthetic action. Furthermore, 
pretreatment with MDL 72222 revealed the presence of a tachycardic 
response to 5-HT, which is resistant to pretreatment with propranolol or 
phentolamine, but can be blocked by phenoxybenzamine. 
The 5-HT-induced tachycardia was also studied in anaesthetized 
vagotomized pigs (Chapter 5). However, the dose-dependent increase in 
heart rate induced by 5-HT cannot be blocked by any of the known 
antagonists for 5-HT receptors. This response is also resistant to 
antagonists at a- and 13-adrenoceptors, muscarinic, nicotinic, histamine 
and dopamine receptors, and calcium channels. 5-HT uptake inhibitors 
induce an increase in heart rate by themselves and potentiate the 5-HT 
response. Putative selective agonists at 5-HTl-like or 5-HT3 receptors do 
not induce tachycardia in the pig. Therefore one can conclude that the 
5-HT-nduced tachycardia in the pig is not mediated by 5-HTl-like, 5-HTz 
or 5-HT3 receptors, but may be mediated by a new type of 5-HT 
receptor. 
In Chapter 6 the role of arteriovenous anastomoses in the cardiovascular 
system is discussed, particularly their possible role in the pathophysiology 
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of migraine. Chapter 7 summarizes the effects of 5-HT in the carotid bed 
of several species. Using 15 11m radioactive microspheres the amount of 
blood flowing through arteriovenous anastomoses and arterioles can be 
estimated in experimental animals. Intracarotid infusion of 5-HT in the 
common carotid artery of anaesthetized, vagosympathectomized pigs 
results in a decrease in arteriovenous anastomotic blood flow and an 
increase in arteriolar blood flow, especially to the skin and ears, which 
become bright pink. These responses cannot be antagonized by the 5-HT2 
receptor antagonist ketanserin or the 5-HT3 receptor antagonist 
MDL 72222, but can be blocked by methiothepin, which blocks both 
5-HT1-like and 5-HT2 receptors. Furthermore, the selective 5-HT1-like 
agonist 5-carboxamidotryptamine mimicks the effects of 5-HT in the 
carotid bed. From this it can be concluded that the effects of 5-HT on 
both arteriovenous anastomotic blood flow and arteriolar blood flow are 
mediated by 5-HT!-like receptors (Chapter 8). Therefore, the effects of 
other putative 5-HT!-like receptor agonists were studied: 8-0H-DPAT & 
ipsapirone (Chapter 9) and RU 24969 (Chapter 10). Intracarotid infusion 
of 8-0H-DPAT and RU 24969 decrease carotid blood flow by a reduction 
in arteriovenous blood flow, whereas in contrast to 5-HT and 
5-carboxamido-tryptamine no important changes in arteriolar blood flow 
are observed. Ipsapirone does not have any effect on carotid blood flow 
and its distribution. The effects of 8-0H-DPAT and RU 24969 can be 
blocked by methiothepin but not by ketanserin, indicating that these 
effects are mediated by 5-HT!-like receptors. However, the effects of 
RU 24969 cannot be antagonized by the putative 5-HT!A and 5-HTla 
receptor antagonist pindolol. Lack of selective antagonists for the other 
putative 5-HTl receptor subtypes makes it difficult to characterize the 
actions of 8-0H-DPAT and RU 24969 more precisely. 
The antimigraine drug ergotamine is also known to reduce arteriovenous 
shunting in the cranial circulation of the dog and this drug has affinity 
for 5-HT! recognition sites in cerebral membranes. In order to study the 
possible involvement of 5-HT receptors, the effects of intravenous 
injection of ergotamine were studied in both cat and pig (Chapter 11). 
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Ergotamine induces a reduction in arteriovenous shunting in both species, 
but this effect cannot be antagonized by either the 5-HT2 receptor 
antagonist ketanserin or the 5-HTl-like and 5-HT2 receptor antagonist 
methiothepin, suggesting that this effect is not mediated by 5-HT1-like or 
5-HT2 receptors. Since phentolamine and pizotifen were ineffective 
antagonists in the dog carotid bed, a possible involvement of 
a-adrenoceptors or histamine H1 receptors is also unlikely. 
In conclusion this thesis shows that 1) the 5-HT-induced epicardial 
chemoreflex in cats is mediated by 5-HT3 receptors; 2) the 5-HT-induced 
tachycardia in pigs is not mediated by 5-HTl-like, 5-HT2 or 5-HT3 
receptors; 3) the effects of 5-HT on carotid blood flow and its 
distribution in pigs are mediated by 5-HTl-like receptors; 4) 8-0H-DPAT 
and RU 24969 are also acting on this type of 5-HT receptor; 
5) Ergotamine reduces arteriovenous anastomotic blood flow, which is not 
mediated by 5-HTl-like or 5-HT2 receptors. 
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SAMENV ATTING 
Het locale hormoon 5-hydroxytryptamine (5-HT; serotonine) speelt een rol 
in diverse (patho-) physiologische processen. Dit proefschrift beschrijft 
het effect van 5-HT op hartfrequentie en distributie van de Carotis-
doorbloeding in genarkotiseerde katten en varkens. Door gebruik te maken 
van selectieve antagonisten en agonisten werden de subtypes van 5-HT 
receptoren gekarakteriseerd volgens, nu algemeen, geaccepteerde criteria 
(Hoofdstuk 2). Na een uitgebreid literatuur-overzicht betreffende 
hartfrequentie-veranderingen in zoogdieren (Hoofdstuk 3), wordt de door 
5-HT opgewekte epicardiale chemoreflex beschreven (Hoofdstuk 4). Locale 
toediening van zowel 5-HT als nicotine op het epicard van 
genarkotiseerde katten wordt gevolgd door stimulatie van afferente 
zenuwvezels van de N.vagus, hetgeen leidt tot de epicardiale chemoreflex: 
bradycardie, afname van de sympathicus activiteit en hypotensie. Locale of 
intraveneuse toediening van de selectieve 5-HT3 receptor antagonist 
MDL 72222 heft de door 5-HT opgewekte reflex op, terwijl de door 
nicotine opgewekte reflex onveranderd blijft, hetgeen een locaal 
anesthetische werking van MDL 72222 uitsluit. Bovendien wordt door 
voorbehandeling met MDL 72222 de aanwezigheid van een positief 
chronotroop effect van 5-HT duidelijk, hetgeen niet door propranolol of 
phentolamine, maar wel door phenoxybenzamine geantagoneerd kan 
worden. 
De door 5-HT opgewekte tachycardie werd tevens onderzocht in 
genarkotiseerde varkens, waarbij een bilaterale cervicale vagotomie was 
uitgevoerd (Hoofdstuk 5). 5-HT veroorzaakt een dosis-afhankelijke 
toename in de hartfrequentie, hetgeen echter niet geblokkeerd kan worden 
door welke van de tot nu toe bekende 5-HT receptor antagonisten dan 
ook. Deze tachycardie wordt niet geantagoneerd door antagonisten voor a-
of 13-adrenerge, muscarine, nicotine, histamine of dopamine receptoren en 
ook niet door de calcium antagonist verapamil. Remmers van de opname 
van 5-HT veroorzaken een toename in de hartfrequentie en versterken de 
door 5-HT opgewekte tachycardie. Mogelijk selectieve agonisten voor 
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5-HTI-achtige en 5-HTz receptoren veroorzaken bovendien geen 
belangrijke veranderingen in hartfrequentie. Uit bovengenoemde resultaten 
kan men concluderen dat noch 5-HTI-achtige, noch 5-HTz of 5-HT3 
receptoren betrokken zijn bij door 5-HT opgewekte tachycardie in het 
varken. De aanwezigheid van een nieuw type 5-HT receptor in het 
varkenshart moet daarom overwogen worden. 
In hoofstuk 6 wordt de rol van arterioveneuse anastomosen in de 
bloedsomloop besproken, in het bijzonder hun rol in de pathophysiologie 
van migraine. Ret effect van 5-HT op het Carotis vaatbed in diverse 
species is samengevat in hoofdstuk 7. Met behulp van radioactieve 
microsferen met een diameter van 15 11m kan de doorbloeding van zowel 
arterioveneuse anastomosen als arteriolen bepaald worden. Infusie van 
5-HT direct in de A.carotis communis van genarkotiseerde varkens, 
waarbij een vagosympathectomie is uitgevoerd, leidt tot een afname in 
arterioveneuse doorbl oeding en een toe name in de arteriolaire 
doorbloeding, vooral in de huid en de oren, die helder rood worden. Deze 
effecten kunnen niet geantagoneerd worden door de 5-HTz receptor 
antagonist ketanserin of door de 5-HT3 receptor antagonist MDL 72222, 
maar wei door methiothepine, dat zowel 5-HTl-achtige als 5-HTz 
receptoren blokkeert. Bovendien leidt infusie van de selectieve 5-HTl-
achtige receptor agonist 5-carboxamidotryptamine tot dezelfde effecten als 
5-HT infusie. Uit het bovenstaande kan geconcludeerd worden dat zowel 
de afname van arterioveneuse anastomose doorbloeding als de toename in 
arteriolaire doorbloeding geinduceerd worden door stimulatie van 5-HTI-
achtige receptoren (Hoofdstuk 8). Met deze kennis werd besloten de 
effecten van andere agonisten voor mogelijk 5-HTl-achtige receptoren te 
onderzoeken: 8-0H-DPAT & ipsapirone (Hoofdstuk 9) en RU 24969 
(Hoofdstuk 10). Infusie van 8-0H-DPAT en RU 24969 vermindert de 
Carotis doorbloeding door een daling in de doorbloeding van de 
arterioveneuse anastomosen, terwijl, in tegenstelling tot 5-HT en 5-
carboxamidotryptamine, de arteriolaire doorbloeding nauwelijks verandert. 
Ipsapirone infusie heeft geen enkel effect op de Carotis doorbloeding en 
de distributie over arterioveneuse anastomosen en arteriolen. De effecten 
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van 8-0H-DPAT en RU 24969 kunnen geblokkeerd worden door 
methiothepine, maar niet door ketanserine, hetgeen erop duidt dat deze 
effecten geinduceerd worden door stimulatie van 6-HT1-achtige 
receptoren. Echter, de effecten van RU 24969 kunnen ook niet 
geblokkeerd worden door pindolol, een mogelijke antagonist van 5-HT1A 
en 5-HTls receptoren. Het ontbreken van selectieve antagonisten voor 
andere mogelijke subtypes van 5-HTl-achtige receptoren maakt het tot op 
heden moeilijk de effecten van 8-0H-DPAT en RU 24969 nader te 
karakteriseren. 
Het antimigraine geneesmiddel ergotamine heeft ook de eigenschap de 
arterioveneuse doorbloeding in de craniele circulatie te verminderen, zoals 
aangetoond is bij de hond, en bezit tevens affiniteit voor 5-HTl 
bindingsplaatsen in cerebrale membranen. Daarom werd de mogelijke 
betrokkenheid van 5-HT receptoren onderzocht in zowel de kat als het 
varken (Hoofdstuk 11). In beide species vermindert ergotamine de 
doorbloeding van de arterioveneuse anastomosen, maar dit effect kan niet 
geantagoneerd worden door de 5-HT2 receptor antagonist ketanserine of 
de 5-HTl-achtige en 5-HT2 receptor antagonist methiothepine, hetgeen er 
op duidt dat noch 5-HTl-achtige, noch 5-HT2 receptoren bij dit effect 
betrokken zijn. Aangezien phentolamine en pizotifen onwerkzaam waren in 
de hond, is een mogelijke betrokkenheid van a-adrenoceptors of 
histamine H1 receptoren ook onwaarschijnlijk. 
Samengevat, dit proefschrift toont aan dat 1) de door 5-HT opgewekte 
epicardiale chemoreflex in de kat geinduceerd wordt door stimulatie van 
5-HT3 receptoren; 2) de door 5-HT geinduceerde tachycardie in het 
varken niet via stimulatie van 5-HTl-achtige, 5-HT2 of 5-HT3 receptoren 
verloopt; 3) 5-HTl-achtige receptoren betrokken zijn bij de door 5-HT 
geinduceerde veranderingen in Carotis doorbloeding en de distributie over 
arterioveneuse anastomosen en arteriolen; 4) 8-0H-DPAT en RU 24969 
eveneens hun effect uitoefenen via dit 5-HT receptor subtype; 
6) ergotamine de doorbloeding van de arterioveneuse anastomoses 
vermindert, een effect waarbij echter noch 5-HTl-achtige, noch 5-HT2 
receptoren betrokken zijn. 
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